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ABSTRACT 
Mesenchymal Stem Cells (MSCs) are clonogenic cells that can 
grow ex vivo and differentiate in vivo and in vitro into multiple 
mesodermal phenotypes. They can be isolated from most fetal 
and adult tissues, including bone marrow, fat, teeth. Moreover, 
they can easily be expanded and differentiated in vitro. In recent 
years MSCs have raised great interest for their properties and 
characteristic as potential therapeutical tools for a wide spectrum 
of human pathologies. However, several aspects of their biology 
still need to be clarified. Developmental regulators coding for 
growth factors, receptors and transcription factors are involved in 
the regulation of stem and progenitor cells of different tissues. In 
this view, the present study has been mainly focused on 
homeodomain transcription factors of different families (Hox, 
Tale, and Otx) and on the receptor of the Stem Cell Factor (Kit), 
investigating their possible role in the control of mesenchymal 
stem and progenitor cells. Different experimental strategies have 
been employed, including both expression and functional studies 
in mouse models and human cells. 
A relevant question is whether MSCs derived from different 
sources exhibit equivalent biological properties. Here I have 
compared cellular and molecular characteristics of human MSCs 
derived from different body locations. Results have highlighted 
that they exhibit the same immunophenotipic profile, but distinct 
in vitro growth and differentiation properties, and are 
characterized by specific HOX codes and TALE signatures. Thus, 
they may not provide equivalent cell sources for regenerative 
medicine and tissue engineering. 
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The second issue addressed in my study is whether and how 
another homebox gene, Otx1, may contribute to the regulation of 
MSCs. Otx1 encodes a key factor in neural development and 
plays an important role also in blood cell production. Here I 
showed that Otx1 expression is modulated during the osteogenic 
differentiation of both murine and human MSCs and its 
inactivation is associated with phenotypical alterations and 
enhanced survival and proliferation of MSCs, as well as an 
impairment of their osteogenic capacity. These findings indicate 
that Otx1 is implicated in the control of both proliferation and 
differentiation of MSCs. 
Finally, another important pleiotropic molecule is Kit, coding for 
the Stem Cell Factor (SCF) tyrosine-kinase receptor. Kit is a 
pivotal regulator of several types of stem and progenitor cells. 
However, its role in MSCs is still controversial. My results have 
shown that Kit is active also in MSCs, providing the first 
evidence on its involvement in the adipogenic process. 
The identification of new molecular cues controlling self-
renewal, commitment and differentiation of mesenchymal stem 
and progenitor cells has both biological and clinical relevance. 
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Introduction 
1. THE STEM CELLS 
During embryogenesis, a single fertilized oocyte gives rise to a 
multicellular organism whose cells and tissues have adopted 
differentiated characteristics or fates to perform the specified 
functions of each organ of the body. As embryos develop, cells 
that have acquired their particular fate proliferate, enabling 
tissues and organs to grown. Even after an animal is fully grow, 
however, many tissues and organs maintain a process known as 
homeostasis, where as cells die, either by natural death or by 
injury, they are replenished. This remarkable feature has ancient 
origins, dating back to the most primitive animals. Some 
amphibians, for istance, can regenerate a limb or tail when 
severed, and the neurons of bird brains can readily regenerate. 
While mammals seem to have lost at least some of this wonderful 
plasticity, their liver can partially regenerate, provided that the 
injury is not too severe, and their epidermis and hair of their skin 
can readily repair when wounded or cut. Additionaly, the 
epidermis, hair, small intestine, and hematopoietic system are all 
examples of adult tissues that are naturally in a dinamic state: 
even in the absence of injury, these structures continually divide, 
terminally differentiate and die. 
The outstanding ability of an embryo to diversify and of certain 
adult tissues to regenerate throughout life is a direct result of stem 
cells. Stem cells have both the capacity to self-renew, that is, to 
divide and create additional stem cells, and also to differentiate 
along a specified molecular pathway. Embryonic stem cells are 
very nearly totipotent, as they have the ability of choosing all of 
the differentiation pathways that specify the animal. In contrast, 
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adult stem cells that reside within an adult organ or tissue have 
more restricted ability to differentiate, as they are able to select a 
differentiation program from only few possible pathways. In the 
last years, some spectacular findings have exploded many long-
standing dogmas in the stem cell world, giving adult stem cells a 
new lease on life (Fuchs and Segre, 2000). Adult stem cells have 
raised great interest for their properties and characteristics as 
potential therapeutical tools for a wide spectrum of pathologies. 
There is, therefore, considerable interest in understanding the 
regulatory transcriptional and signaling networks which underlie 
stem cell properties, such as pluri-multipotency and self-renewal, 
as well as specificity of commitment and differentiation. 
 
1.1 Embryonic Stem Cells 
Mammalian development commences when an oocyte is 
fertilized by a sperm forming a single celled embryo, the zygote. 
Consistent with the definition, the zygote is totipotent, meaning 
that this single cell has the potential to develop into an embryo 
with all the specialized cells that make up a living being, as well 
as into the placenta support structure necessary for fetal 
development. Thus, each totipotent cell is a self-contained entity 
that can give rise to the whole organism. This is said to be true 
for the zygote and for early embryonic blastomeres up to at least 
the 4-cell stage embryo. Experimentally, totipotency can be 
demonstrated by the isolation of a single blastomere from a 
preimplantiation embryo and subsequently monitoring its ability 
to support a term birth following transfer into a suitable recipient. 
This approach was pioneered in rats and has been realized in 
	  6	  	  
Introduction 
several mammalian species including nonhuman primates. As 
embryo development progresses to the 8-cell stage and beyond 
depending on the species, the individual blastomeres that 
comprise the embryo gradually lose their totipotency. It is 
generally believed that this restriction in developmental potential 
indicates irreversible differentiation and specialization of early 
embryonic cells into the first two lineages, the inner cell mass 
(ICM) that includes cells that will give rise to the fetus and the 
trophoectoderm (TE), and an outer layer of cells that is destined 
to an extraembryonic fate. At least some of the embryo’s ICM 
cells are pluripotent, meaning that they have the potential to 
differentiate into any of the three germ layers (endoderm, 
mesoderm or ectoderm) and they can form virtually every 
somatic and germ cell type in the body (Fig. 1). 
 
Figure 1: Pluripotency in vivo of embryonic stem cells 
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These ICM cells are self sustained and their pluripotency is 
maintained by endogenously expressed factors, as the 
transcription factors Oct4, Nanog and Sox2. In vivo, pluripotent 
cells within the ICM exist transiently; as the developmental 
program unfolds they differentiate into cells of the next 
embryonic or fetal stage. However, they can be isolated, adapted 
and propagated in vitro in an undifferentiated state as embryonic 
stem (ES) cells (Fig. 2) (Evans and Kaufman, 1981; Martin, 
1981; Brook and Gardner, 1997).  
 
Figure 2: ES in vitro. 	  
Murine ES cell remain undifferentiated when grown in the 
presence of cytokine leukemia inhibitory factor (LIF) and 
cultured on murine embryonic fibroblasts (MEFs) (Smith et al., 
1988; Williams et al., 1988). The effect of LIF is to inhibit 
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differentiation and support proliferation of undifferentiated stem 
cells. When LIF is withdrawn, most types of ES cells 
differentiated spontaneously to form aggregates known, in view 
of their similarity to post-implantation embryonic tissues, as 
embryoid bodies (Desbaillets et al., 2000; Itskovitz-Eldor et al., 
2000). These spherical structures are comprised of derivatives of 
all three germ layers and continued in vitro culture of embryoid 
bodies leads to the formation of a range of differentiated cell 
types including cardiomyocytes, hematopoietic cells, endothelial 
cells, neural cells, skeletal muscle, chondrocytes, adipocytes and 
pancreatic islets (Wiles M.V. and Keller, 1991; Schmitt et al., 
1991; Maltsev et al., 1993; Wang et al., 1994; Bain et al., 1995; 
Fraichard et al., 1995; Wobus et al., 1997; Dani et al., 1997; 
Kramer et al., 2000; Hamazaki et al., 2001; Lumelsky et al., 
2001). In each case, despite the use of growth factors favouring 
the differentiation of a particular cell type, the resulting cultures 
are heterogeneous. 
With similar techniques to those developed for mouse embryos, 
stem cell lines have been derived from human blastocysts 
(Thomson et al., 1998). Human ES cells derived from the inner 
cell mass removed from embryos grown into blastocysts. The 
embryo from which the initial human ES cells were derived were 
produced by in vitro fertilization and donated with informed 
consent of the parents. Another approach to deriving these cells is 
somatic nuclear transfer or cloning. This procedure uses the 
transfer of a somatic cell nucleus from an individual into an 
enucleated oocyte (McGrath and Solter, 1983; Campbell et al., 
1996; Wilmut et al., 1997). The cells are then allowed to undergo 
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embryonic development to the blastocyst stage prior the isolation 
of ES cells from the inner cell mass. These cells show several 
morphological and behavioural differences from murine ES cells: 
they grow slowlier and tend to form flat rather than spherical 
colonies (Amit et al., 2000; Odorico et al., 2001). LIF does not 
have the same effect on human ES cells and, in order to maintain 
them in an undifferentiated state, the presence of both MEFs 
feeder layers and basic fibroblast growth factor (bFGF) is 
required (Martin, 1981; Evans and Kaufman, 1981). As with 
murine ES cells, modification of culture medium in which human 
ES cells are grown can promote the differentiation of certain 
lineages (Schuldiner et al., 2000), displaying cells with the 
distinct morphology of neurons, epithelium, cardiomyocytes 
(Reubinoff et al., 2000; Odorico et al., 2001; Kehat et al., 2001). 
In addition, spontaneous in vitro formation of functionally active 
pancreatic β cells has also been observed (Assady et al., 2001). 
While no one doubts that ES cells are likely the most flexible of 
all stem cells, their use is the subject of intense debate 
particularly because of the ethical issues. Moreover, experimental 
results indicate that these cells can origin teratocarcinoma when 
injected subcutaneously in athymic mice (Martin, 1981). 
Therefore, the search is prompted for alternative stem cells 
sources. A major breakthrough was achieved in 2006, when it 
was shown that pluripotent stem cells could be obtained by 
transducing mouse embryonic and adult fibroblasts with a limited 
set of genes encoding four transcriptional factors (Oct4, Sox2, c-
Myc and Klf4). These reprogrammed cells, named induced 
pluripotent stem (iPS) cells, resembled ES cells in many of their 
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characteristic (Takahashi and Yamanaka, 2006). However, these 
iPS cells had a different global gene expression pattern from ES 
cells and failed to produce adult chimeric mice. In 2007, germline 
transmission was achieved with mouse iPS cells (Meissner et al., 
2007; Okita et al., 2007; Wernig et al., 2007), and iPS cells were 
generated from human fibroblasts (Takahashi et al., 2007; Yu et 
al., 2007; Park et al., 2008b). Given the potential to generate 
patient-specific cell populations without the need for human 
embryonic cells, iPS cell technology has been received with great 
excitement by research and medical communities. However, 
many questions regarding the actual molecular process of induced 
reprogramming remain unanswered and need to be addressed 
before iPS cells can go to the clinic. 
 
1.2 Adult Stem Cells 
In the adult organism many tissues and/or organs, as a 
consequence physiologic cell turn over or tissue injury, are 
capable of maintaining, generating and replacing terminally 
differentiated cells: this process of homeostasis is guaranteed by 
adult stem cells. Tissue-specific stem cells share common 
properties: self-renewal and multipotency. First, they can divide 
indefinitely, producing a population of identical progeny. Second, 
adult stem cells can undergo an asymmetric division to produce 
two dissimilar daughter cells. One is identical to the parent and 
contributes to maintain the stem cell population. The other is 
characterized by a reduced proliferative capacity and more 
restricted developmental potential than its parent, becoming a 
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“progenitor” or “precursor” cell, committed to terminal 
differentiation in the specialized cell types of the tissue where it 
is located (Fig. 3). Adult stem cells are often quiescent or 
relatively slow-cycling cells able to respond to specific 
environmental signals. When a stem cell undergoes a 
commitment to differentiate, it often first enters a transient state 
of rapid proliferation. Upon exhaustion of its proliferative 
potential, the transiently amplifying cell withdraws from its cycle 
and executes its terminal differentiation (Potten et al., 1979). 
 
Figure 3: The possible choices for a daughter cell of a stem cell division. It 
can either self-renew (that is, remain a stem cell) or commit to a pathway 
leading to differentiation. In many cases where it commits to differentiation, it 
first becomes a precursor cell, which proliferates before differentiating. 
 
Adult stem cells reside in most mammalian tissues, but the extent 
to which they contribute to normal homeostasis and repair varies 
widely. Along this spectrum, tissues generally fall into one of 
three categories. First, tissues with high turnover (such as blood, 
skin and gut) have a prominent stem-cell compartment and, by 
definition, have high regenerative capacity. Second, tissues with 
low turnover but high regenerative potential might use different 
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strategies to ensure effective repair in the setting of acute injury. 
In skeletal muscle, for example, differentiated myofibres are 
unable to proliferate to generate new tissue, so muscle must rely 
on resident stem cells for all turnover and repair. For the liver, it 
seems that differentiated hepatocytes can proliferate sufficiently 
to mediate effective tissue remodelling, repair and replacement 
normally, whereas stem cells might be recruited in the setting of 
severe injury. Third, tissues with low turnover and low 
regenerative potential might have stem cells that mediate only 
limited tissue repair. Although there is much interest in 
harnessing the potential of stem cells in the brain and heart for 
therapeutic purposes, for example, there is limited endogenous 
repair capacity of these tissues following acute injuries (Fig. 4) 
(Rando, 2006).  
 
Figure 4: Tissue heterogeneity and stem-cell functionality for homeostasis 
and repair. 
 
As a result, stem cells must be identified prospectively and 
purified carefully in order to study their properties. The dream to 
“rebuilt” human organs is turning slowly into reality. Many 
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researchers believe that stem cells therapy has the potential to 
dramatically change the treatment of human diseases and adult 
stem cells have captured the popular imagination with the 
promise of enhanced tissue repair, the treatment of degenerative 
diseases and even the amelioration of dysfunction associated with 
normal ageing. However, several stem cells therapies already 
exist. An example is provided by bone marrow stromal stem cells 
taken from the patient, expanded in vitro and then transplanted 
into the injured tendons or ligaments of the same patient. 
 
1.2.1 Hematopoietic stem cells (HSCs) 
Although it seems reasonable to propose that each tissue arises 
from a tissue-specific stem cell, the rigorous identification and 
isolation of the somatic stem cells has been accomplished only in 
a few instances. The best-characterized stem cells are those 
responsible for blood cell production, the hematopoiesis. All 
experimental strategies and conceptual paradigms applicable to 
stem cells in general were first defined in hematopietic system. 
The hallmark properties of the Hematopoietic Stem Cells (HSCs) 
were defined in 1963 by Till and Mc-Culloch (Siminovitch et al., 
1963). They defined HSCs as cells that are individually capable 
of both self-renewal and multilineage differentiation, yelding 
greatly expanded numbers of lymphocytes, myeloid cells and 
erythrocytes. In fact, around 2x1011 erythrocytes and 1010 white 
blood cells must be replaced each day to maintain adult human 
hematopoiesis. Terminally differentiated cells are by themselves 
incapable of further growth and must, therefore, be replaced 
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through proliferation and development of HSCs (Goldman, 
1982). The process, by which stem cells give rise to terminally 
differentiated cells, occurs through a hierarchy of progenitor 
cells, and during commitment, cells can undergo extensive 
proliferation and sequential differentiation, accompanied by a 
decrease in self-renewal capacity (Dexter et al., 1984; Golde, 
1991). The primary function of this transit population is to 
increase the number of mature cells produced by each stem cell 
division. The immediate progeny of HSCs in adult bone marrow 
are the common myeloid precursor (CMP) and the common 
lymphoid precursor (CLP) (Akashi et al., 2000; Hao et al., 2001; 
Manz et al., 2002). CLP is thought to give rise to all lymphoid 
lineage (B, T and NK), but little is known about its development 
(Spangrude and Cooper, 2000). CMP can be associated with two 
cell types that can form in vivo (CFU-S) and in vitro (CFU-Mix) 
colonies containing multiple cell types. CFU-S (Colony Forming 
Unit-Spleen) can produce colonies on the spleen of irradiated 
mice injected with bone marrow cells (Till and Mc-Culloch, 
1961). The other pluripotent progenitor is the CFU-Mix (Colony 
Forming Unit-Mix) that generate mixed colonies in cultures 
containing an appropriate cocktail of cytokines. CMP can give 
rise to progenitors committed to the generation of erythrocytes 
and megakaryocytes (MEP) or granulocytes and macrophages 
(CFU-GM). These cells, capable of developing along more than 
one lineage, undergo commitment and become progressively 
restricted to a specific differentiative fate, such as Colony 
Forming Unit-Granulocytes (CFU-G) and Colony Formin Unit-
Macrophages (CFU-M), the direct precursors of granulocytes and 
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monocytes, respectively. Similarly, two stages of different 
maturation have been identified within the erythroid lineage: an 
early cell (Burst Forming Unit-Erythroid or BFU-E) and a late 
precursor (Colony Forming Unit-Erythroid or CFU-E) capable of 
forming large and small erythroid colonies, respectively. 
Murine HSCs were initially identified on the basis of their ability 
to form colonies in the spleens of lethally irradiated mice 
following bone-marrow transfer. However, subsequent studies 
highlighted that spleen colonies were not always formed by 
multipotent cells (Magli et al., 1982; Metcalf, 1999)and that 
HSCs were defined by their ability to sustain long term 
hematopoiesis in vivo. Subsequently, a number of assays have 
been developed to monitor HSC activity in vitro and in vivo. In 
vitro clonogenic assays are a powerful means to quantitatively 
and qualitatively study a broad spectrum of progenitors (Metcalf, 
1999), but they do not sustain HSCs growth. The most widely 
accepted assay is the capacity of HSCs to provide lifelong 
reconstitution of all blood-cell lineages after transplantation into 
lethally irradiated recipients. The strictest version of this long-
term repopulating (LTR) assay, known as serial transplantation, 
requires that HSC-containing donor bone marrow can be re-
transplanted into secondary, and even tertiary, recipients while 
retaining both self-renewal and multi-lineage differentiation 
capacity (Okada et al., 1993; Harrison et al., 1978; Kim et al., 
2000). Multipotent long-term HSCs (LT-HSCs) reside in the 
bone marrow and through a process of asymmetric cell division, 
can self-renew to sustain the stem cell pool or differentiate into 
short-term HSCs (ST-HSCs) or lineage-restricted progenitors that 
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undergo extensive proliferation and differentiation to produce 
terminally differentiated, functional hematopoietic cells. ST-
HSCs or multipotent progenitors (MPPs) are only able to sustain 
hematopoiesis in the short term, whereas the LT-HSCs must 
persist for the lifespan of the organism to perpetually replenish 
the hematopoietic system. Despite many exhaustive studies, 
researchers have yet to find a single molecular marker that is 
expressed exclusively by HSCs. However, they can be isolated 
from bone marrow or peripheral blood using enrichment and/or 
single-cell sorting (fluorescence-activated cell sorting-FACS) 
based on cell surface markers and/or vital dye staining. The 
identification and purification of HSCs relies on the unique cell 
surface molecule expression found on these cells compared with 
the remainder of bone marrow cells including closely related 
hematopoietic progenitor cell counterparts. Almost all HSCs 
purification strategies revolve around the cell surface phenotype 
of positive selection for the markers c-Kit and Sca-1 and negative 
selection for markers of mature hematopoietic cell lineages 
(RBCs, T-cells, B-cells, NK-cells, monocytes and granulocytes). 
Although this c-Kit+Lin-Sca-1+ (KLS) phenotype greatly enriches 
for hematopoietic reconstituting activity, this bone marrow 
compartment contains progenitor cells in addition to long-term 
HSCs. In fact only 10% of KLS cells are bona fide long-term 
HSCs, and as such the KLS compartment should be regarded as 
merely enriched for HSCs. A variety of strategies have been used 
to further enrich bone marrow for HSCs, with or without the KLS 
as a foundation. These strategies include identification of HSCs 
as KLS-CD34-Flk-2-, KLS-CD150+CD48- cells, the Hoechst-
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effluxing side population (SP), and associated variations on that 
theme. The Hoechst dye is retained at low levels in HSCs because 
of their ability to efflux the dye via membrane transport pumps, 
which are highly active in these cells compared with other bone 
marrow cell types. The distinctive staining pattern of HSCs, 
easily observed when Hoechst fluorescence is displayed at two 
different wavelengths, results in their presence at the side of the 
Hoechst fluorescence profile, hence the ‘‘SP.’’ Several studies 
have shown that even without other markers such as KLS, the SP 
is remarkably enriched for HSC activity, and most of the SP cells 
bear other surface markers of HSC, such as KLS. In addition, 
virtually all of the long-term HSC activity is contained within this 
SP fraction (reviewed in Challen et al., 2009). Alternative 
methods use a signature of SLAM family of cell surface 
molecules. SLAM (Signaling lymphocyte activation molecule) 
family receptors is a group of molecules, all belonging to a subset 
of immunoglobulin gene superfamily, and originally thought to 
be involved in T-cell stimulation. A combination of SLAM 
molecules (CD150+CD244-CD48-) has been recently shown to 
mark HSCs from fetal liver stage through adult hematopoiesis, 
including mobilized and aging HSCs (Kiel et al., 2005; Kim et 
al., 2006; Yilmaz et al., 2006). Thus, SLAM markers introduce a 
code that may be more generally applicable for identifying HSCs. 
 
1.2.2 Cancer stem cells (CSCs) 
During the last years, a growing body of evidence indicate that 
also neoplastic tissues can harbour stem cells. Based on 
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functional and immunophenotypic analysis of cell subpopulation 
with modern technologies, cancer has started to be increasingly 
consider as a stem-cell disorder, in which the continuous growth 
and propagation of the whole tumor depends on a small 
population of self-renewing tumor stem cells. The prevailing 
theory of tumor initiation is that cells accumulate genetic and 
epigenetic alterations that ultimately confer a growth and/or 
survival advantage to the nascent cancer. It has been well-
accepted that these events occur in terminally differentiated cell 
types and that the progression of cancer is directly correlated to 
the ability of those cells to divide indefinitely. Attempts to target 
and destroy this transformed population of cells have been 
modestly effective, although it is becoming increasingly evident 
that targeted therapies alone cannot completely eradicate an 
established tumor. This observation suggests that there may be a 
separate and distinct subpopulation of cells that is resistant to the 
aforementioned therapy and can also repopulate the tumor with 
malignant cells, as needed. This minor subset of cells is more 
commonly referred to as Cancer Stem Cells (CSCs). Because of 
varying experimental strategies that isolate and characterize 
cancer stem cells, clearly defining the traits that identify cancer 
stem cells has become troublesome. The current definition 
includes two stipulations that help delineate these cells: (1) must 
possess the ability to self-renew and (2) must be able to resupply 
the tumor with the various lineages of cells of which it is 
comprised (Clarke et al., 2006). The existing definition has 
thereby yielded an alternative expression for CSCs that describes 
	  19	  	  
Introduction 
their functionality: thus, ‘‘tumor-initiating cell’’ has now become 
synonymous with cancer stem cell. 
Similarly to normal adult stem cells, they can committed and 
generate transient-amplifying cells. These progenitor cells are 
thought to be the cell type that most actively support tumor 
growth (Fig. 5). 
 
Figure 5: Overview of tumor stem cells in cancer. Cancer stem cells (tumor-
initiating cells) divide asymmetrically, resulting in self-renewal of the tumor-
initiating cell and production of a daughter cell known as a transient-
amplifying cell (progenitor cell). The transient-amplifying cell is not thought 
to possess self-renewing capabilities, but instead divides indefinitely to 
contribute to cancer progression. 
 
A relevant question asks if the tumor-initiating cell and the 
tumor-propagating cell are the same entity. Logic dictates that 
any cell that can initiate tumor formation should also possess the 
ability to continue supporting tumor growth. This simple premise, 
however, does not explain the heterogeneic cellular distribution 
within solid tumors; if the tumor-initiating cell and the tumor-
propagating cell are identical throughout development, once 
	  20	  	  
Introduction 
could argue that the cellular constituency of the tumor would be 
fairly homogenous. Because this is certainly not the case in solid 
tumors, one possible explanation is that the tumor-initiating cell 
continues to gradually acquire additional mutations that 
contribute to cellular heterogeneity; this also accounts for how 
the tumor-initiating cell and tumor-propagating cell may become 
distinct components over time (Fig. 6). 
 
Figure 6: Is the tumor-initiating cell also the tumor-propagating cell. Two 
primary models that speculate the individuality of the tumor-initiating cell 
and the tumor-propagating cell. a: If the tumor-initiating cell and the tumor-
propagating cell are the same entity, the cellular population of the solid tumor 
should be relatively genetically similar (indicated by violet spheres). b: 
Possible secondary model where the tumor-initiating cell gives rise to the 
tumor-propagating cell, which can acquire genetic mutations (yellow lightning 
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bolt) that further potentiate tumor growth, as well as lead to cellular 
heterogeneity (indicated by multiple sphere colors). 
 
However, this explanation does not discount the significance of 
the tumor-initiating cell to the cancer because it likely retains the 
ability to supply the growing tumor with malignant progenitors 
that are likely to subsequently become tumor-propagating cells 
(Lee and Herlyn, 2007). 
Cancer stem cells were first identified in acute myeloid leukemia 
when surface markers were used to distinguish the stem cell 
population from the remaining cells with limited proliferative 
potential (Dick, 2005). In solid tumors, cancer stem cells have 
been identified in breast cancer (Shackleton et al., 2006; Ponti et 
al., 2005), glioblastomas (Singh et al., 2003), lung cancer (Kim et 
al., 2005), ovarian cancer (Bapat et al., 2005), prostate cancer 
(Collins et al., 2005), and epithelial gastric cancer (Houghton et 
al., 2004). Isolating and defining tumor-initiating stem cells 
should lead to the development of highly effective, less toxic 
therapies for cancer patients. The relative efficacy of traditional 
chemotherapeutics is highly dependent on both the stage and the 
type of disease; future drug formulations may be able to bypass 
the shortcomings of those compounds by targeting only the 
tumor-initiating cells. 
 
1.2.3 Plasticity of Adult Stem Cells 
In the adult soma, stem cells generally have been thought of as 
tissue-specific, able to give rise only to progeny cells 
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corresponding to their tissue of origin. However, recent 
experiments have challenged this notion and called into question 
the lineage commitment of various adult stem cell populations by 
suggesting that under certain circumstances these cells may 
“transdifferentiate” to contribute to a much wider spectrum of 
differentiated progeny than previously anticipated. 
Transdifferentiation describes the conversion of a cell of one 
tissue lineage into a cell of an entirely distinct lineage, with 
concomitant loss of the tissue-specific markers and function of 
the original cell type, and acquisition of markers and function of 
the transdifferentiated cell type. The suggestion that adult stem 
cells may transdifferentiate has in turn given rise to the concept 
of stem cell plasticity, which holds that the lineage determination 
of a differentiating stem cell may not be rigidly defined, but is 
instead flexible, allowing these cells to respond to a variety of 
microenvironmental regenerative cues (Blau et al., 2001). 
Suggestions of stem cell plasticity in the adult could indicate a 
need to reexamine precursor-progeny relationships during the 
early developmental steps when germ layer specification occurs, 
especially if rare cells with high proliferative potential from one 
tissue (e.g., mesoderm) may be found within, and perhaps 
nurtured by, another tissue (e.g., endoderm). A telling precedent 
for rare cells within an organ giving rise to most mature cells 
within that organ derives from early studies on the development 
of thymic lymphocytes. In these experiments, transfilter 
incubation of thymic epithelium and mesenchyme appeared to 
implicate endoderm, not mesoderm, cells as thymocyte 
precursors (Auerbach, 1961); however, subsequent examination 
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showed that these cells, called hematocytoblasts, were in fact rare 
mesoderm-derived precursors nested within the thymic endoderm 
that gave rise to most, if not all, thymic lymphocytes (Moore and 
Owen, 1967). Moreover, the concept that adult HSCs function 
solely to maintain hematopoietic cell lineages was challenged by 
a series of papers suggesting that unfractionated bone marrow 
cells, or bone marrow cells enriched by various methods for 
hematopoietic stem cell activity, could be seen to contribute at 
low levels to multiple nonhematopoietic tissues following 
transfer into lethally irradiated, and often injured, recipient mice 
or humans (reviewed in Herzog et al., 2003 and Goodell, 2003). 
Such studies have reported the expression of donor-derived 
genetic markers in non- hematopoietic cells within the skin 
(Krause et al., 2001), lung epithelium (Krause et al., 2001; Theise 
et al., 2002), intestinal epithelium (Krause et al., 2001), kidney 
epithelium (Kale et al., 2003), liver parenchyma (Krause et al., 
2001; Lagasse et al., 2000; Petersen et al., 1999; Theise et al., 
2000; Vassilopoulos et al., 2003; Wang et al., 2003b), pancreas 
(Ianus et al., 2003), skeletal muscle (Brazelton et al., 2003; 
Camargo et al., 2003; Corbel et al., 2003; Ferrari et al., 1998; 
Fukada et al., 2002; Gussoni et al., 1999; LaBarge and Blau, 
2002), endothelium (Jackson et al., 2001), myocardium (Jackson 
et al., 2001; Barile et al., 2009), and CNS neurons in the cortex 
and cerebellum (Brazelton et al., 2000; Mezey et al., 2000; Priller 
et al., 2001; Weimann et al., 2003a, 2003b). Such findings were 
extended by some to a general hypothesis of adult stem cell 
plasticity, wherein adult stem cells from one tissue were 
considered to be roughly equivalent in developmental potential to 
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adult stem cells in another tissue, with the outcome of stem cell 
differentiation largely determined by different 
microenvironments encountered following differential trafficking 
from the bloodstream (Blau et al., 2001). Studies of bone marrow 
or stem cell transdifferentiation have been highly controversial 
(Anderson et al., 2001; Goodell, 2003; Raff, 2003). Clearly the 
mechanism invoked may depend on the cell populations and 
tissues analyzed and on the method of injury, if any, employed. In 
only a few cases has the actual mechanism, by which such 
unexpected contributions of cells across tissue lineage boundaries 
occur been studied, much less elucidated. Cell transdifferentiation 
is one mechanism by which stem cells potentially could 
contribute to cell types of different lineages. This lineage 
conversion was proposed to occur directly, by activation of an 
otherwise dormant differentiation program to alter the lineage 
specificity of the cell (Figure 7A). Lineage conversion also could 
theoretically occur via dedifferentiation of a tissue-specific cell to 
a more primitive, multipotent cell and subsequent 
redifferentiation along a new lineage pathway (Figure 7B). 
Extensive evidence suggests that urodele amphibians regenerate 
amputated limb, tail, eye, jaw, and heart structures through a 
process that appears to involve the dedifferentiation of mature 
cells near the edge of the wound, forming a cluster of “naive” 
progenitor cells referred to as the blastema, and subsequent 
activation of a regenerative process reminiscent of the 
developmental program that originally functioned to specify limb 
formation (Brockes and Kumar, 2002). It should be noted, 
however, that a possible role for preexisting multipotent adult 
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stem cells in amphibian regeneration can not be excluded 
entirely. Nonetheless, in these systems, blastema cells do not 
appear to become totally uncommitted pluripotent stem cells; 
instead, they retain memory of their earlier identity, as indicated 
by the fact that iris epithelial cells from the eye give rise to lens 
even if transplanted into an amputated limb (Reyer et al., 1973; 
Ito et al., 1999), and limb blastema transplanted into the eye still 
generates limb structures (Kim and Stocum, 1986). 
Dedifferentiation of cells in adult mammals has not been clearly 
and unequivocally documented, and at present, no evidence 
directly supports transdifferentiation or dedifferentiation events 
as an explanation for stem cell or BM cell plasticity in vivo 
(Tanaka, 2003). 
A third explanation for observations of adult stem cell plasticity 
relates to the purity or homogeneity of the test population. In 
order to demonstrate definitively transdifferentiation of a 
particular lineage-specific stem cell, it is essential to exclude the 
possibility that multiple, distinct stem cells could be contributing 
to the observed outcome, ideally by evaluating the potential of 
single, prospectively isolated, stem cells (Fig. 7C).  
Contributions across multiple tissue types also could arise 
through the action of a single, rare pluripotent stem cell present in 
bone marrow, and/or other tissues, which possibly copurifies in 
protocols designed to enrich for tissue-specific stem cells such as 
bone marrow HSCs (Figure 7D). The possible existence of 
pluripotent stem cells within the bone marrow of mice and 
humans has previously been proposed and this idea has gained 
support from the isolation through culture of multipotent (actually 
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pluripotent) adult progenitor cells (MAPC), which give rise to 
tissues of multiple germ layers following intravenous transplant, 
and contribute substantially to most, if not all, tissues following 
injection into blastocysts (Jiang et al., 2002a; Serafini et al., 
2007). However, whether cells with such extensive 
developmental potential exist normally in adult animals or are 
endowed with such properties via the culture conditions 
employed is currently unknown, and no direct evidence 
implicating these cells in bone marrow plasticity studies has been 
obtained.  
The final mechanism to explain observations of stem cell 
plasticity is cell-cell fusion (Figure 7E). Fusion between the egg 
and sperm is the initiating event in vertebrate development, and 
in adult animals, cell-cell fusion occurs naturally in the 
generation of multinucleated skeletal myofibers from myoblasts 
and of osteoclasts from monocyte/macrophage lineage cells 
(Anderson, 2000; Vignery, 2000). Cell-cell fusion has been 
implicated in contributions of transplanted bone marrow cells to 
liver hepatocytes, cardiac myocytes, and Purkinje neurons 
(Alvarez- Dolado et al., 2003; Vassilopoulos et al., 2003; Wang 
et al., 2003b; Weimann et al., 2003b). Several authors have 
proposed that heterotypic cell fusions represent a physiological 
process designed to rejuvenate and/or repair a wide variety of 
tissues (Alvarez-Dolado et al., 2003; Blau, 2002). However, the 
low frequency with which such events have been observed 
(typically less than 1% of cardiomyocytes and 0.1% of 
hepatocytes or Purkinje cells in nonselective transplant model; 
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Alvarez-Dolado et al., 2003) implies that this rare phenomenon is 
unlikely to contribute significantly to normal tissue regeneration. 
 
Figure 7: Schematic diagram depicting potential mechanisms and 
explanations for observations of adult stem cell plasticity. 	  
Given the current data available from both mouse and human 
studies, recruitment of cells from heterologous sources is unlikely 
to be a normal, robust, or highly utilized mechanism for adult 
tissue regeneration. Nonetheless, it is possible that by a concerted 
effort aimed at dissecting this rare phenomenon, rigorously 
identifying, purifying and potentially expanding the appropriate 
cell populations responsible for “plasticity,” characterizing the 
tissue-specific and injury-related signals that recruit, stimulate, or 
regulate plasticity, and determining the mechanism(s) underlying 
fusion or plasticity, it may eventually enhance tissue regeneration 
via this mechanism to clinically useful levels. 
 
1.2.4 Stem Cell Niche 
A stem cell niche can be defined as a spatial structure in which 
stem cells are housed and maintained by allowing self-renewal. 
Structurally, the niche is formed by supporting cells that provide 
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a microenvironment for stem cells as well as the signals 
emanating from the supporting cells. Although the concept of the 
stem-cell niche was initially proposed in vertebrates, the D. 
melanogaster ovarian and testicular niches controlling germline 
stem-cell maintenance and differentiation were the first to be 
characterized. In higher organisms, the analysis of stem-cell-
niche interactions has been hampered by their unknown location. 
However, during the past few years, substantial progress has been 
made in localizing adult stem cells in situ. Many studies have 
indicated that most adult tissue stem cells (such as HSCs, or 
epidermal stem cells (ESCs) in the skin) divide infrequently and 
can be quiescent for weeks or even months. In support of this 
notion, the adult stem cell pool is largely resistant to classical 
chemotherapeutic agents that target cycling cells. In addition, 
HSCs that efficiently engraft after transplantation are mainly 
quiescent and considered to be metabolically inactive. Moreover, 
when the DNA of adult stem cells is labelled during cellular 
proliferation by nucleotide analogues (such as 3H-thymidine or 
bromodeoxyuridine (BrdU labelling)), or by the histone H2B-
enhanced-green-fluorescent-protein fusion protein (H2B-EGFP), 
the DNA label can be retained for months and has consequently 
been used to locate quiescent stem cells in situ. 
The vast majority of cell divisions are symmetrical, producing 
identical daughter cells and leading (in the absence of apoptosis) 
to increased numbers of cells. This process is readily observed for 
cells in culture and also occurs during organogenesis, where 
substantial cellular expansion (including stem cells) occurs 
during embryogenesis. By contrast, under homeostatic conditions 
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in the adult, the number of tissue stem cells in a particular organ 
remains relatively constant, despite the fact that they proliferate, 
because they not only self-renew but also produce differentiated 
progeny. 
The ability of adult stem cells to both self-renew and differentiate 
is critical for tissue homeostasis. The stem cell population would 
become depleted if cell differentiation overwhelmed self-renewal. 
Similarly, unchecked stem cell self-renewal would expand the 
stem cell population excessively, risking tumorigenesis (Jones 
and Fuller, 2004). An important function of the stem cell niche, 
therefore, is to regulate the balance between cellular self-renewal 
and differentiation. One mechanism that ensures this balance is 
the control of asymmetric/symmetric stem cell division. This 
balance could be achieved if the number of stem cells dividing 
symmetrically to generate two identical daughter cells with stem-
cell function was equivalent to the number of stem cells giving 
rise to two differentiated daughter cells. However, because this 
mechanism does not function at the single-cell level, and would 
require close coordination of two separate stem-cell populations, 
it is commonly assumed that an individual stem cell can give rise 
to two non-identical daughter cells, one maintaining stem-cell 
identity and the other becoming a differentiated cell. There are 
two mechanisms by which this asymmetry can be achieved, 
depending on whether it occurs pre- (divisional asymmetry), or 
post- (environmental asymmetry) cell division (Fig. 8). 
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Figure 8: A model of asymmetric cell division. a) During divisional 
asymmetry, cell-fate determinants are asymmetrically localized to only one of 
the two daughter cells, which retains stem-cell fate, while the second daughter 
cell differentiates. b) During environmental asymmetry, after division, one of 
two identical daughter cells remains in the self-renewing niche 
microenvironment while the other relocates outside the niche to a different, 
differentiation-promoting microenvironment. 
 
In divisional asymmetry, specific cell-fate determinants in the 
cytoplasm (mRNA and/or proteins) redistribute unequally before 
the onset of cell division. During mitosis, the cleavage plane is 
oriented such that only one daughter cell receives the 
determinants. Therefore, two non-identical daughter cells are 
produced, one retaining the stem-cell fate while the other initiates 
differentiation (Fig. 8a). An alternative way to achieve 
asymmetry is by exposure of the two daughter stem cells to 
different extrinsic signals provided by distinct local 
microenvironments. Therefore, a stem cell would first undergo a 
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symmetric self-renewing division, producing two identical 
daughter cells. While one daughter cell would remain in the niche 
microenvironment, conserving its stem-cell fate, the other would 
contact (passively or actively) a different microenvironment that 
would no longer preserve its stem-cell phenotype but would 
instead produce signals initiating differentiation (Spradling et al., 
2001; Ohlstein et al., 2004). Therefore, as with divisional 
asymmetry, the final product would be two non-identical 
daughter cells but achieved post-cell-division and not pre-cell-
division (Fig. 8b). 
It is specific cues from specific sites that allow stem cells to 
persist, and to change in number and fate. Importantly, it is also 
the niche that provides the modulation in stem-cell function 
needed under conditions of physiologic challenge. It is this 
dynamic capability that makes the ‘niche’ concept particularly 
important and central to the realization of regenerative medicine. 
It is the ability of the niche to impose functions on stem cells that 
makes the concept important in disease. 
Cells and extracellular-matrix components in the stem-cell niche 
are relatively predictable, although the complexity and integration 
of these elements is far from being understood. Early studies 
provided evidence that heterologous cell types created a three-
dimensional structure in which stem cells reside. Recent data 
raises the possibility that a regulatory microenvironment might 
include stem cells simply resident on the basement membrane 
with homologous cell-cell interactions. Cells, matrix 
glycoproteins and the three-dimensional spaces they form provide 
ultrastructure for a stem-cell niche. The contact between these 
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elements allows molecular interactions that are critical for 
regulating stem-cell function. Secreted proteins offer a paracrine 
measure of control, but non-protein components of the local 
microenvironment also affect stem-cell function (Fig. 9) 
(Scadden, 2006). 
 
Figure 9: Inputs feeding back on stem-cell function in the niche. 
 
It is currently unclear whether all postulated stem-cell-niche 
functions (storage of quiescent stem cells, self-renewal and 
inhibition of differentiation) can be provided by a single niche, or 
whether different types of niches coexist (Fig. 10). Resting (G0) 
stem cells are stored in quiescent niches. Specialized niche cells 
generate a differentiation- and/or division-repressive 
environment. Under conditions of stress these might be mobilized 
to generate mature cells as required, and might then return to 
empty niches for storage or self-renewal (Fig. 10a). The main 
function of a self-renewing niche would be to guarantee that (by 
environmental and/or divisional asymmetry) one of the two 
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daughters of a dividing stem cell maintains the stem-cell fate 
while the other produces differentiating progenitors (Murphy et 
al., 2005). Such a self-renewing stem-cell niche would be more 
complex than a quiescent-storage niche but would be the essential 
unit that maintains normal tissue homeostasis. In this type of 
niche, one can propose that quiescent stem cells would be 
anchored in the center of the niche, whereas self-renewing stem 
cells would be located close to the border separating the niche 
from the non-niche microenvironment, which could provide 
signals that would induce differentiation and/or cell division (Fig. 
10b). 
 
Figure 10: Different types of niches. a) Quiescent-storage niche. b) Self-
renewing niche. 	  
The best-characterized stem-cell niche is the bone HSCs niche. 
The term ‘niche’ for the specific HSC bone-marrow 
microenvironment was first coined by Schofield, who proposed 
that HSCs are in intimate contact with bone, and that cell-cell 
contact was responsible for the apparently unlimited proliferative 
capacity and inhibition of maturation of HSCs (Schofield, 1978). 
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More recently, several mutant mice, in which hematopoiesis is 
defective as a consequence of primary defects in bone 
development or remodeling, have implicated osteoblasts and/or 
osteoclasts in the formation and function of the bone-marrow 
HSC environment or niche. For example, mice lacking core 
binding factor α1 (CBFα1; also known as Runx2), which is one 
of the earliest osteoblast-specific transcription factors, have 
defective bone-marrow hematopoiesis and extensive 
extramedullary hematopoiesis, owing to defects in osteoblast 
differentiation and the consequent failure to form bone (Deguchi 
et al., 1999; Ducy et al., 2000). A direct role for the involvement 
of osteoblasts in HSC regulation and/or maintenance in vivo has 
been obtained from two studies in which osteoblast numbers were 
experimentally increased or decreased. In the first study 
osteoblast-specific expression of a constitutively active form of 
parathyroid hormone (PTH) or the PTH/PTH-related protein 
receptor (PPR), which is an important regulator of calcium 
homeostasis, and therefore bone formation and resorption, was 
achieved using the type 1 collagen α1 (Col1a1) promoter. This 
resulted in a simultaneous increase in the number of both 
osteoblasts and HSCs in the bone marrow. Moreover, the 
maintenance of HSCs in vitro was more efficient when supported 
by stromal cells that were isolated from these transgenic mice, 
presumably because of an increase in the proportion of 
osteoblasts in the stromal-cell population compared to stromal 
cells from wild-type mice (Calvi et al., 2003). 
In a second study mice lacking bone morphogenetic protein 
(BMP) receptor 1A (BMPR1A, which is normally expressed on 
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osteoblasts lining the endosteum) in the bone-marrow stroma 
showed a simultaneous increase in the number of both osteoblasts 
and repopulating HSCs, although the number of more 
differentiated cells remained unchanged (Zhang et al., 2003). 
Moreover, Lin– LRCs and osteoblasts were shown to be in direct 
contact through homotypic N-cadherin interactions. Therefore, 
specialized spindle-shaped N-cadherin-expressing osteoblasts 
(SNOs) located in the endosteum were postulated to be essential 
components of the HSC bone-marrow niche. Both studies show 
that an increase in the number of osteoblasts directly correlates 
with the number of functional LTR HSCs, indicating that 
osteoblasts (or a subset of these cells) are an essential part of the 
niche and are limiting for niche size and/or activity. Although N-
cadherin-expressing PPR+BMPR1A+ osteoblasts seem to be 
necessary and rate-limiting for niche function, it is probable that 
other cell types, such as osteoclasts, stromal fibroblasts and 
endothelial cells, also contribute to niche formation, activity or 
architecture. In fact, activating osteoclasts through either RANKL 
(necessary for osteoclastogenesis) or stress results in mobilization 
of the HSCs into the circulation (Fig. 11) (Kollet et al., 2006; 
Purton and Scadden, 2006). 
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Figure 11: Osteoblasts and osteoclasts seem to participate as cellular 
components of the endosteal hematopoietic stem cell niche. Activation of 
the respective cellular elements are associated with different phenomena. 
Increasing osteoblast activity through stimulation of the parathyroid hormone 
receptor or inactivation of the bone morphogenic protein receptor-1a results in 
an increase in the number of hematopoietic stem cells (HSC). In contrast, 
activating osteoclasts through either RANKL or stress results in mobilization 
of the HSC into the circulation. 	  
The presence of a second specialized HSC microenvironment in 
the bone marrow has recently been postulated, as a large 
proportion of CD150+ HSCs were observed to be attached to the 
fenestrated endothelium of bone-marrow sinusoids (Kiel et al., 
2005). A close interaction between HSCs and endothelial cells is 
not unexpected because both lineages arise from a common 
embryonic precursor, the hemangioblast (Huber et al., 2004). 
Bone-marrow sinusoidal endothelial cells constitutively express 
cytokines such as CXC-chemokine ligand 12 (CXCL12) and 
adhesion molecules such as endothelial-cell (E)-selectin and 
vascular cell-adhesion molecule 1 (VCAM1) that are important 
for HSC mobilization, homing and engraftment (Fig. 13) (Rafii et 
al., 1997; Avecilla et al., 2004; Sipkins et al., 2005). A vascular 
bone-marrow HSC niche has previously been predicted to form 
during HSC mobilization after myeloablation. Quiescent HSCs 
detach from the endosteal niche and migrate towards the center of 
the bone marrow to the vascular zone from where they re-
establish hematopoiesis (Heissig et al., 2002; Kopp et al., 2005). 
The recent finding that CD150+ HSCs are attached to the 
sinusoidal endothelium now raises the possibility that a vascular 
bone-marrow HSC niche might also exist during homeostasis 
(Kiel et al., 2005). Why have two apparently distinct HSC niches 
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in the bone marrow? Putative HSCs that have been identified by 
LRC assays are almost exclusively located in the endosteal niche, 
indicating that this niche might contain the most dormant HSCs 
and therefore serve as a quiescent-storage niche, or a self-
renewing niche comprising both quiescent and self-renewing 
HSCs. In contrast to label-retaining HSCs that have not divided 
for many weeks, the CD150+ HSC population comprises both 
long-term quiescent and self-renewing HSCs, because 3.8% of 
the cells are proliferating at any given time. Because many of the 
proliferating cells are in contact with bone-marrow sinusoidal 
endothelial cells, it is probable that the vascular bone-marrow 
HSC niche contains self-renewing, rather than long-term 
dormant, HSCs. The location of CD150+ HSCs, in close 
proximity to sinusoids, would enable them to constantly monitor 
the concentration of blood-borne factors that reflect the status of 
the hematopoietic system. Under hematological stress, a rapid 
and robust response could be mounted, and if necessary more 
HSCs could be recruited from endosteal niches (Fig. 12). It is 
probable that the pool of HSCs located in the vascular and self-
renewing endosteal niches are freely exchanged to maintain 
homeostasis in a constantly changing hematopoietic environment. 
In addition, HSCs that are located in the self-renewing endosteal 
niche produce multipotential progenitors (MPPs) by divisional 
and/or environmental asymmetry (Fig. 12). Because deletion of 
osteoblasts results in extramedullary hematopoiesis (Visnjic et 
al., 2004), the vascular bone-marrow HSC niche alone might not 
be sufficient to maintain long-term hematopoiesis. This indicates 
that in the bone marrow the vascular niche might be a secondary 
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niche, requiring an influx of HSCs from the primary endosteal 
niches (Fig. 12). Collectively, the vascular and endosteal niches 
strongly cooperate to control HSC quiescence and self-renewing 
activity (and therefore HSC number), as well as the production of 
early progenitors to maintain homeostasis or re-establish it after 
injury. 
 
Figure 12: Model of bone-marrow HSCs niches. 
 
Although the vast majority of HSCs in the adult mouse are 
located in the bone marrow, HSCs show remarkable motility. In 
response to specific signals they can exit and re-enter the 
endosteal bone-marrow HSC niche, processes known as 
mobilization and homing, respectively (Fig. 13). These opposing 
biological processes are controlled by overlapping but distinct 
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molecular mechanisms (Papayannopoulou, 2003; Lapidot et al., 
2005; Cancelas, 2005). HSCs bound to the bone-marrow niche 
are mobilized in response to granulocyte colony-stimulating 
factor (G-CSF) or cyclophosphamide, or after peripheral 
myeloablation following treatment with 5-fluorouracil (5-FU). 
After extravasation from the bone-marrow cords into the 
microvasculature, HSCs enter the circulation and are distributed 
to peripheral tissues such as the spleen or liver. HSCs locate close 
to endothelial cells in the splenic red pulp. They home to the 
bone-marrow cords through the circulation, a process that is 
controlled by a number of adhesion molecules such as very late 
antigen 4 (VLA4), VLA5, lymphocyte function-associated 
antigen 1 (LFA1) or selectins. After entering the bone marrow, 
HSCs specifically lodge in the niche, a process requiring 
membrane-bound stem-cell factor (SCF), CXC-chemokine ligand 
12 (CXCL12), osteopontin (OPN), hyaluronic acid, and their 
corresponding receptors (Fig. 13) (reviewed in Wilson and 
Trumpp, 2006). 
 
Figure 13: Mobilization, homing and lodging. 
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Although little is known about the signals that are exchanged 
between HSCs and osteoblasts in situ, several receptors, 
membrane-anchored proteins and secreted factors are expressed 
by both cell types (Taichman, 2005). Comparative gene-
expression profiling has recently been performed on HSC-
supporting and non-supporting stromal cell lines, identifying a 
number of new molecules that might regulate endosteal bone-
marrow HSC-niche activity (Fig. 14). 
Several Notch receptors and Notch-receptor ligands are expressed 
in the bone marrow (Radtke et al., 2004), leading to the 
suggestion that Notch signaling has a role in HSC self-renewal 
and/or clonal expansion. Support for this hypothesis has been 
provided by in vitro culture of purified HSCs on various stromal 
cell lines (Varnum-Finney et al., 2000; Duncan et al., 2005). 
Moreover, as expression of the Notch ligand Jagged-1 is 
upregulated on osteoblasts that are exposed to PTH, the 
concomitant increase in HSCs has been postulated to be caused 
by increased Notch signaling (Calvi et al., 2003). 
One mechanism by which osteoblasts might regulate the number 
of HSCs in the bone marrow is through secretion of osteopontin 
(OPN), an acidic glycoprotein, into the bone matrix (Denhardt 
and Guo, 1993). OPN-deficient mice have a two-fold increase in 
HSCs and, because the same effect was observed by transplanting 
wild-type HSCs into lethally irradiated OPN mutant recipients, 
OPN production by osteoblasts has a negative effect on HSC 
number (Stier et al., 2005). In addition, OPN has been postulated 
to act as a negative regulator of HSCs by actively maintaining 
their quiescence (Nilsson et al., 2005). 
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The steel (Sl) locus encodes both membrane-bound SCF and 
secreted SCF. The latter is produced by alternative splicing 
followed by proteolytic cleavage of membrane-bound SCF 
(Flanagan et al., 1991). SCF binds and activates KIT, which is 
expressed by LTR HSCs as well as other stem cells. Mutations at 
either of these loci affect migration and differentiation of 
primordial germ cells, neural-crest-derived melanoblasts, and 
hematopoietic cells (Lyman et al., 1998). Analysis of the different 
SCF and KIT mutant mice showed that although not essential for 
the generation and initial clonal expansion of HSCs in the embryo 
and fetal liver, they are crucial for long-term maintenance and 
self-renewal of adult HSCs, raising the possibility that the SCF-
KIT pathway mediates endosteal bone-marrow HSC niche 
activity (Fig. 14). Importantly, membrane-bound SCF is 
expressed by osteoblasts and has a higher and more sustained 
capacity to activate KIT on the cell surface of HSCs than secreted 
SCF (Miyazawa et al., 1995). In addition, membrane-bound SCF 
is a potent stimulator of adhesion of HSCs or hematopoietic 
progenitor cells to stromal cells (Kinashi and Springer, 1994) 
because it can activate VLA4 and VLA5, indicating that 
membrane-bound SCF can affect the adhesive properties of the 
endosteal niche by modifying the functional state of specific 
integrins (Kovach et al., 1995). 
N-cadherin is expressed by both SNOs and a subset of LSK 
HSCs (Wilson et al., 2007). In addition, N-cadherin expression 
by HSCs localizes asymmetrically to the side of their attachment 
to SNOs. Therefore, homotypic N-cadherin interactions have 
been postulated to be an important component of the anchor that 
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links HSCs to SNOs in the endosteal niche. Indirect support for 
the importance of N-cadherin has been obtained from studies 
showing that MYC and tyrosine kinase receptor 2 (TIE2) control 
N-cadherin expression by HSCs in an antagonistic manner. The 
effects of MYC and TIE2 on HSCs and on N-cadherin expression 
correlate with a key function for N-cadherin in the retention of 
HSCs in the endosteal niche (Arai et al., 2004; Suda et al., 2005; 
Murphy et al., 2005). 
In adult bone marrow, TIE2 (which is expressed specifically by 
LT-HSCs) is activated by angiopoietin-1 (ANG1), which is 
secreted by osteoblasts, leading to upregulation of N-cadherin 
expression by HSCs, providing the first example of a secreted 
factor promoting HSC-osteoblast adhesion. Interestingly, the 
ANG1-TIE2 signaling pathway prevents HSC division and 
maintains HSC quiescence, both in vitro and in vivo (Fleming et 
al., 1993; Cheng et al., 2000). Collectively, these data strongly 
support the hypothesis that N-cadherin-expressing ANG1+ 
osteoblasts form a niche that maintains quiescence and prevents 
self-renewal or differentiation through TIE2 signaling (Fig. 14). 
TIE2-mediated quiescence is potentially caused by positively 
regulating the cyclin-dependent-kinase inhibitor p21 (also known 
as CIP1 and WAF1). HSCs express high levels of p21, and mice 
lacking p21 show increased HSC proliferation at the expense of 
long-term self-renewal, indicating that p21 is essential for 
maintenance of quiescence in HSCs. In contrast to TIE2, 
transcription of the gene encoding p21 is negatively regulated by 
MYC, which is expressed at low levels by HSCs but increases 
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during initiation of HSC differentiation in a converse expression 
pattern to that of p21 (Cheng et al., 2001; Wu et al., 2003). 
It has recently been shown that the transmembrane metallo- 
proteinase ADAM10 (a disintegrin and metalloproteinase-10) is 
able to cleave N-cadherin that is expressed at the cell surface of 
fibroblasts and neuronal cells. This leads to the redistribution of 
β-catenin (which is associated with the intracellular portion of N-
cadherin) from the cell surface to the cytoplasmic β-catenin pool, 
thereby decreasing the signaling threshold required for the 
expression of target genes of the canonical WNT signaling 
pathway (which is mediated through β-catenin signal transduction 
cascades), such as the genes encoding cyclin D1 and MYC (Reiss 
et al., 2005). A similar re-distribution of β-catenin has also been 
reported after E-cadherin cleavage (Ito et al., 1999), indicating 
that high levels of expression of cadherins, as observed for HSCs, 
might decrease cytoplasmic β-catenin levels and therefore 
negatively regulate expression of β-catenin target genes. It is 
intriguing that the N-cadherin, TIE2, MYC, p21 and β-catenin 
pathways are apparently interconnected, leading to the suggestion 
that they might cooperatively control quiescence, self-renewal 
and initiation of HSC differentiation through interaction with the 
niche (Murphy et al., 2005). 
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Figure 14: A model of the endosteal niche-stem-cell synapse. 	  
The picture emerging from accumulating genetic and functional 
data indicates that molecular crosstalk between HSCs and niche 
cells (particularly osteoblasts) involves a large number of 
molecules (cadherins, integrins, chemokines, cytokines, signaling 
molecules and receptors) that mediate at least two types of 
interaction. First, adhesive cell-extracellular-matrix (ECM) 
interactions such as CD44 binding to OPN or hyaluronic acid, 
and cell-cell interactions, such as those mediated by heterotypic 
VLA4-VCAM1 interactions and homotypic N-cadherin 
interactions. The main function of these interactions would be to 
maintain HSCs in close proximity to cells in the endosteal bone-
marrow niche. In addition, most adhesion receptors are also 
linked to intracellular signaling cascades and actively participate 
in the signaling network controlling HSC maintenance. Second, 
ligand-receptor interactions, through which intracellular signaling 
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pathways are activated after ligand binding to receptors that are 
expressed by HSCs or SNOs (Fig. 14). 
Most secreted signaling molecules are bound to the cell surface or 
ECM, and consequently do not diffuse far. Therefore, the tight 
adhesion and juxtaposition of HSCs to niche osteoblasts is 
essential for the formation of an intercellular space in which 
efficient ligand-receptor interaction can occur. Some osteoblast-
derived signals might be crucial to maintain HSCs in an 
undifferentiated state and these include the ligand-receptor pairs 
membrane-bound SCF-KIT, and ANG1-TIE2-MYC. Conversely, 
other ligand-receptor pairs, such as BMP-BMPR1A are important 
for the number and/or activity of niche osteoblasts. Therefore, in 
analogy to the neuronal and immunological synapses, it has been 
proposed the term ‘stem-cell-niche synapse’ for this adhesion and 
signaling unit (Fig. 14) (reviewed in Wilson and Trumpp, 2006). 
Recently, it has been showed that mesenchymal stem cells 
(MSCs), identified using nestin expression, constitute an essential 
HSCs niche component. Nestin+ MSCs are spatially associated 
with HSCs and adrenergic nerve fibres, and highly express HSCs 
maintenance genes. These genes, and others triggering 
osteoblastic differentiation, are selectively downregulated during 
enforced HSCs mobilization. Whereas parathormone 
administration doubles the number of bone marrow nestin+ cells 
and favours their osteoblastic differentiation, in vivo nestin+ cell 
depletion rapidly reduces HSCs content in the bone marrow. 
Purified HSCs home near nestin+ MSCs in the bone marrow of 
lethally irradiated mice, whereas in vivo nestin+ cell depletion 
significantly reduces bone marrow homing of haematopoietic 
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progenitors. These results uncover an unprecedented partnership 
between two distinct somatic stem-cell types and are indicative of 
a unique niche in the bone marrow made of heterotypic stem-cell 
pairs (Mèndez-Ferrer et al., 2010). 
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2. MESENCHYMAL STEM CELLS (MSCs) 
The bone cavity is filled with soft bone marrow and blood 
vessels. The developing hematopoietic cells within the bone 
cavity are retained in the bone marrow until they have matured 
and are released into the vascular system (Fliedner, 1998). HSCs 
and their progeny are surrounded by stromal cells in bone 
marrow. Mesenchymal stem cells (MSCs) also reside in the bone 
cavity and are proposed to give rise to the majority of marrow 
stromal cell lineages, including chondrocytes, osteoblasts, 
fibroblasts, adipocytes, and myocytes, as demonstrated in vitro 
and in vivo (Fig. 15) (Friedenstien et al., 1970; Prockop, 1997). 
However, thus far the location and lineage commitment of MSCs 
in vivo are much less characterized than those of HSCs. It is 
known that a close relationship exists between osteogenesis and 
hematopoiesis and that MSCs and osteoblast cells play an 
important role not only in skeletal development but also in the 
regulation of hematopoiesis (Moore, 2004; Taichman, 2005). 
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Figure 15: Mesenchymal Stem Cells (MSCs) and the mesenchymal system. 	  
The discovery of MSCs is credited with Alexander Friedenstein 
and associated, who over 40 years ago demonstrated that pieces 
of bone marrow transplanted under the renal capsule of mice 
formed a heterotopic osseous tissue that was self-maintaining, 
self-renewing, and capable of supporting host cell hematopoiesis. 
Furthermore, Friedenstein showed that the osseous-forming 
activity of bone marrow was contained within the fibroblastoid 
cell fraction isolated by preferential attachment to tissue culture 
plastic. These finding confirmed that bone marrow contained 
separable stem cell populations capable of generating 
hematopoietic and connective tissue lineages. These studies also 
demonstrated that marrow-derived, plastic adherent fibroblastic 
(stromal) cells were capable of supporting the growth and 
differentiation of various hematopoietic cell types. These cells 
were then used as feeder layers to establish long-term bone 
marrow cultures in vitro, which provided new insights on the 
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molecular mechanisms regulating hematopoiesis. In the decades 
following Friedenstein’ s seminal publications, various groups 
worked to define the biological nature and differentiation 
potential of plastic adherent cells from bone marrow. These 
efforts revealed much information about their surface phenotype, 
proliferative and differentiation potential, and culminated in the 
demonstration that clonally derived murine and human 
populations were multipotent, capable of differentiating into 
adipocytes, chondrocytes, osteoblasts and hematopoiesis-
supporting stromal cells. The latter findings confirmed the 
existence of a stem cell in marrow capable of generating most 
connective tissue cell types. Consequently, the marrow-derived, 
plastic adherent cells first referred to as colony-forming unit 
fibroblast (CFU-F) by Friedenstein, then in hematological 
literature as marrow stromal cells, mesenchymal stem cells, and 
subsequently became known as multipotent mesenchymal stromal 
cells to define these cells owing to the fact that a definitive 
description of the bona fide and the molecular mechanisms that 
regulated its self-renewal versus differentiation remain 
forthcoming (Friedenstien et al., 1970; Prockop, 1997; Pittenger 
et al., 1999). 
In recent years MSCs have attracted much attention owing to 
their broad therapeutic efficacy. Initially, MSCs administration to 
children afflicted with osteogenesis imperfecta was found to have 
a significant positive impact by reducing the severity of this 
disease. Promising results were subsequently reported using 
MSCs or related cells from bone marrow in the treatment of 
Hurler’ s syndrome, metachromatic leukodystrophy, graft 
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versus/host disease and to enhance engraftment of heterologous 
bone marrow transplants. Most recently, MSCs have been shown 
to afford a therapeutic benefit in the treatment of myocardial 
infarction, stroke, lung diseases, spinal cord injury, and other 
neurological disorders (Giordano et al., 2007). These results, 
together with the fact that MSCs can be readily isolated from 
small volume bone marrow aspirates, expanded to large numbers 
ex vivo and engineered genetically have made them extremely 
attractive as therapeutic cellular vectors.  
Despite these advantages, it has been difficult to assess the 
overall therapeutic use of MSCs owing to conflicting reports in 
the literature regarding their engraftment levels in tissues in vivo, 
their overall differentiation potential in vitro and in vivo, as well 
as their therapeutic efficacy in disease models. Although some of 
these discrepancies are related to limitations associated with 
experimental methodologies, critical differences in the 
preparation and expansion of donor cells used for the experiments 
certainly contribute to this problem. Consequently, there is a need 
to develop standardized methods to isolate, phenotype and 
evaluate the quality of MSCs. 
 
2.1 Isolation of MSCs 
MSCs have been conventionally isolated from bone marrow 
(Pittenger et al., 1999; Kopen et al., 1999) and, more recently, 
from some fetal and adult tissues (Zuk et al., 2001; De Bari et al., 
2001; Seo et al., 2004; Sabatini et al., 2005; da Silva Meirelles et 
al., 2006; Sethe et al., 2006). Long-term MSCs cultures could be 
established from all virtually post-natal organs and tissues. The 
	  51	  	  
Introduction 
cell populations thus obtained can be operationally defined as 
MSCs, because they exhibit the capacity of prolonged self-
renewal and differentiate along mesenchymal cell lineages. The 
MSC cell populations originating from brain, spleen, liver, 
kidney, kidney glomeruli, lung, bone marrow, muscle, thymus 
and pancreas presented similar morphology and, to a certain 
extent, surface marker profile. On the other hand, the 
differentiation assays showed some variation among the cultures 
in the frequency of cells which actually differentiated in the 
osteogenic or adipogenic phenotype, as well as on the degree of 
differentiation, related to their site of origin (da Silva Meirelles et 
al., 2006). This might be due to the influence of the local 
environment from which they originate, reflecting the importance 
of the niche in establishing the phenotype of the stem cells it 
interacts with (Fuchs et al., 2004). The characteristics of MSC 
populations obtained from the different organs were however 
very similar, suggesting a closer relationship between them. Since 
literature reports have suggested that MSCs derive from 
perivascular cells (Doherty et al., 1998; Bianco et al., 2001; Shi 
and Gronthos, 2003; Farrington-Rock et al., 2004), it is possible 
that MSCs are actually derived from the vasculature (Fig. 16). 
Early in vivo experiments have suggested that pericytes may act 
as a source of undifferentiated cells during adipose (Richardson 
et al., 1982) and osseous (Diaz-Flores et al., 1992) tissue repair. 
Osteogenic and adipogenic differentiation capabilities of 
pericytes, along with their self-renewal capacity, allow to 
hypothesize	   that MSCs belong to the large family of pericytes 
(Crisan et al., 2008; Caplan, 2008). Taking these results as a 
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whole, it could be concluded that the MSC compartment extends 
through the whole post-natal organism as a result of its 
perivascular location. 
 
Figure 16: Perivascular location of pericyte. 
 
Although MSCs have not been isolated as pure population, they 
can be separated from hematopoietic cells through repeated 
adhesion to plastic, and selected on the basis of negative and 
positive markers. The cells are negative for hematopoietic surface 
markers: CD34, CD45, CD14, HLA-DR and positive for a variety 
of markers: Stro-1, CD29, CD73, CD90, CD105, CD166 and 
CD44 (Dominici et al., 2006; Foster et al., 2005). More recent 
studies have shown that stage-specific embryonic antigen 1 
(SSEA-1) and SSEA-4 are markers for primitive mesenchymal 
cells in human and murine bone marrow (Anjos-Afonso and 
Bonnet, 2007; Gang et al., 2007). Moreover, other studies have 
shown that bone marrow-derived MSCs express the perycite-
specific marker CD146, consistent with the fact that specialized 
vascular pericytes in bone marrow are thought to represent the 
closest in vivo approximation to MSCs (Bianco et al., 2001; 
Brachvogel et al., 2005; Sorrentino et al., 2008). 
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Due to the lack of specific markers that define multipotent MSCs, 
these cells are usually defined in functional terms based on in 
vitro and in vivo functional assays. The classical assay utilized to 
identify MSCs in vitro, is the CFU-F assay that identifies 
adherent spindle shaped cells that proliferate to form colonies and 
can be induced to differentiated into adipocytes, osteoblasts and 
chondrocytes (Prockop, 1997; Bianco and Gehron Robey, 2000; 
Sethe et al., 2006). In addition, in vivo ‘the gold standard’ assay 
for MSC stemness is based on the ability of the cells to form 
ectopic bone and bone marrow microenvironment supporting 
hematopoesis upon implantation in an open system (subcutaneous 
implantation) in immune deficient severe combined 
immunodeficiency disease mice. This assay has also been 
employed to demonstrate the ability of the multipotenital MSC 
cells to exhibit self-renewal and maintenance of ‘stemness’ 
capacity during serial implantations (Piersanti et al., 2006). 
Further complications in defining MSCs arise from the fact that 
different laboratories have employed different sources, extraction, 
and cultivation methods. These variables are responsible for the 
phenotype and function of resulting cell populations. Whether 
these conditions selectively promote the expansion of different 
populations of MSCs or cause similar cell populations to acquire 
different phenotypes is not clear (Beyer Nardi and da Silva 
Meirelles, 2006). For this reason, it is not possible to define the 
relationships between MSCs and other stem cell populations 
similar to MSCs but which have been defined with a different 
nomenclature, such as the bone marrow stromal stem cells, 
stromal precursor cells, recycling stem cells, marrow isolated 
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adult multineage inducible stem cells (MIAMI cells), and multi-
potent adult progenitor cells (MAPC) (Reyes et al., 2001; 
D’Ippolito et al., 2004; Beyer Nardi and da Silva Meirelles, 
2006). MIAMI and MAPC stem cells have a higher proliferative 
and differentiative potential compared to classical MSCs. It has 
been suggested that these may represent a more primitive subset 
of stem cells that could be the common precursor of MSCs and 
HSCs (Reyes et al., 2001; D’Ippolito et al., 2004; Beyer Nardi 
and da Silva Meirelles, 2006). If this is the case, then the 
relationship between these cell populations and the 
hemoangioblasts that are considered the mesodermal precursors 
of hematopoietic and EC lineages has to be determined (Park et 
al., 2005; Sethe et al., 2006). Recently, it has been isolated from 
human bone marrow, a new mesodermal progenitor population 
able to differentiate into mesenchymal cells upon appropriate 
culture conditions. When cultured in presence of autologous 
serum, mesodermal progenitors cells (MPCs) are strongly 
adherent to plastic, resistant to trypsin detachment, and resting. 
MPCs may be pulsed to proliferate and differentiate by 
substituting autologous serum for human cord blood serum or 
fetal calf serum. By these methods cells proliferate and 
differentiate towards mesenchymal cells and thus may further 
differentiate into osteoblats, chondrocytes, or adipocytes. 
Moreover MPCs are capable to differentiate in endothelial cells 
(ECs) showing characteristics similar to microvessel endothelium 
cells. MPCs have a defined phenotype and carry embryonic 
markers (OCT-4 and NANOG) not present in mesenchymal cells. 
Moreover, MPCs strongly express aldehyde dehydrogenase 
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activity, usually present in hematopoietic precursors but absent in 
mesenchymal cells. When these progenitors are pulsed to 
differentiate, they loose these markers and acquire the 
mesenchymal ones. Interestingly, mesenchymal cells may not be 
induced to back differentiate into MPCs (Petrini et al., 2008; 
Pacini et al., 2010). 
 
2.2 Immunoregolatory and trophic activity of MSCs 
MSCs secrete a broad spectrum of bioactive macromolecules that 
are both immunoregulatory and serve to structure regenerative 
microenvironment in fields of tissue injury. These 
immunoregulatory effects strongly inhibit T-cell recognition and 
expansion by inhibiting TNF-α and INF-γ production and, thus, 
increasing IL-10 levels. Moreover, new studies have further 
shown that MSCs interact and suppress the activity of natural 
killer (NK) cells (Stagg, 2006). Although all of the 
immunomodulatory effects of the hMSC-secreted bioactive 
factors are yet to be described, the data available clearly support 
the concept that allogeneic MSCs can be used as therapeutic 
agents (Pittinger et al., 1999; Devine et al., 2001; Maitra et al., 
2004; Beyth et al., 2005). The intrinsic secretory activity of 
MSCs also establishes a regenerative microenvironment at sites 
of tissue injury or damage. Initially this was tested in the context 
of cancer therapy by adding culture-expanded human MSCs to 
bone marrow transplantations with the assumption that the MSCs 
would home to and rejuvenate the bone marrow stroma of 
chemotherapy/radiation-treated patients (Lazarus et al., 1995, 
2005; Koc et al., 2000). Successful animal and human data for 
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both auto- and allogeneic MSCs have been reported (Koc et al., 
2000; Lazarus et al., 2005), although the detailed mechanism for 
how MSCs improve these transplants is not clear. More recently, 
animal or human MSCs have been used in animal models to 
affect heart infarct ischemia (Shake et al., 2002), stroke ischemia 
(Li et al., 2005), meniscus regeneration (Murphy et al., 2003), 
tendinitis (Harman et al., 2006), and spinal cord interruption 
(contusion or cuts), (Lange et al., 2005; Keilhoff et al., 2006). 
The mechanism governing all of these cases seems to be the 
same: the MSCs secrete bioactive factors that inhibit scarring and 
apoptosis (narrow or contain the field of injury), stimulate 
angiogenesis, and stimulate the mitosis of tissue-intrinsic stem or 
progenitor cells. This complex, multifaceted activity caused by 
the secretory activity of MSCs is referred to as ‘‘trophic activity’’ 
as distinctive from the capacity of MSCs to differentiate. These 
capacities define and embody the concept of regenerative 
medicine (Caplan, 2007). 
 
2.3 Osteogenesis 
Osteoblasts produce extracellular matrix proteins and regulators 
of matrix mineralization during skeletal development, remodeling 
and regeneration. They arise from mesenchymal precursors 
through osteoblastic commitment, proliferation, and terminal 
differentiation. Mature osteoblasts produce a characteristic 
extracellular collagenous matrix that subsequently becomes 
mineralized by deposition of hydroxyapatite crystals. In addition 
to protective and structural functions, mineralized bone is the 
major calcium and phosphorous reservoir and provides a 
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supportive niche for hematopoiesis. Deregulation of bone 
formation and maintenance is an important component of 
common human diseases such as osteoporosis and arthritis, as 
well as numerous rare diseases and disorders, and is also involved 
in the pathology of metastatic bone disease that afflicts many 
cancer patients. Osteoblastic bone formation and repair underlies 
the healing of orthopedic injuries and of craniofacial and dental 
restorative procedures. Understanding the cellular and molecular 
mechanisms that drive osteoblast formation is thus of great 
importance for the development of better therapeutic options for 
these and other clinical conditions. In recent years, much progress 
has been made in understanding the factors that regulate the gene 
expression program that underlies the induction, proliferation, 
differentiation and maturation of osteoblasts. A large and 
growing number of transcription factors make important 
contributions to the precise control of osteoblast formation and 
function. It has become increasingly clear that these diverse 
transcription factors and the signals that regulate their activity 
cannot be viewed as discrete, separate signaling pathways 
(BMPs, TGF-β, Wnt, FGFs, Notch). Rather, they form a highly 
interconnected, cooperative network that permits gene expression 
to be closely regulated (Jensen et al., 2010). 
The lineage commitment of multipotent mesenchymal cells is 
driven by the selective expression of master transcriptional 
regulators, mainly Runx2 and Osteix. Following lineage 
commitment, osteoprogenitors undergo a proliferative stage, and 
subsequently, they exit mitosis, expressing genes such as alkaline 
phosphatase (Alp), bone sialoprotein and type I collagen, as they 
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commence to produce and mature an osteogenic extracellular 
matrix. Finally, they express genes involved in mineralization of 
the extracellular matrix such as osteocalcin, osteopontin and 
collagenase (Stein et al., 1989). This highly regulated program of 
gene expression and cellular differentiation is governed by the 
expression and activity of transcription factors including Msx2, 
Dlx3-5-6, Runx2, osterix, SMADs, TCF/LEF. These factors do 
not act in isolation, but interact to integrate diverse signals and 
fine-tune gene expression (Fig. 17). In addition to these 
transcription factors, recent work has discovered microRNAs as 
important regulators of osteoblast gene expression (Mizuno et al., 
2009; Itoh et al., 2009; Kapinas et al., 2009). 
 
Figure 17: Regulation of osteogenesis. 
 
Bone morphogenetic proteins (BMPs) belong to the transforming 
growth factor β (TGF-β) superfamily and they have long been 
recognized as vital regulators of skeletal physiology (Cheng et 
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al., 2003; Suttapreyasri et al., 2006). BMPs initiate their signaling 
cascade by binding to a dimeric complex of two transmembrane 
serine-threonine kinase receptors. The activated receptor kinases 
leads to phosphorylation and nuclear translocation of receptor-
activated SMADs (rSMADs), which interact directly with DNA 
and associate with other transcription factors to regulate gene 
transcription. rSMADs direct mesenchymal cells into the 
osteoblast lineage through induction of Runx2 expression (Lee et 
al., 2000). They also interact with the Runx2 protein to 
synergistically regulate transcription (Bae et al., 2007; Hanai et 
al., 1999; Javed et al., 2008). The SMAD-interaction domain in 
Runx2 has been identified and is continuous with the nuclear 
matrix targeting sequence, which is necessary for Runx2 function 
(Javed et al., 2009; Afzal et al., 2005). SMADs are inactivated by 
Smurf-directed ubiquitination, resulting in their proteolytic 
degradation. An interesting feedback loop between 
BMP/SMAD/Runx2 signaling is indicated by recent studies that 
showed that BMPs act through Runx2 to induce expression of 
SMAD6, an inhibitory SMAD protein that represses BMP 
signaling (Wang et al., 2007). SMAD6 stimulates Runx2 
ubiquitination and degradation by Smurf1 (Shen et al., 2006). 
This process would be a potential mechanism to prevent excess 
BMP/Runx2-mediated osteogenesis. 
Wnt signaling is believed to act downstream of BMP signaling in 
the differentiation of pre-osteoblastic cells, as induction of 
osteoblasts by Wnt3a or activated β-catenin is independent of 
BMP signaling, whereas attenuated Wnt signaling impairs 
BMP2- induced expression (Bain et al., 2003; Qiang et al., 2008; 
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Rawadi et al., 2003). Activation of the canonical Wnt signal 
transduction pathway stabilizes β-catenin, which translocates to 
the nucleus and associates with Tcf/Lef1 (T-Cell 
Factor/Lymphoid Enhancer Factor 1) transcription factors, 
displacing co-repressors while recruiting additional co-activators 
to stimulate gene expression, such as Runx2 expression (Behrens 
et al., 1996; Billin et al., 2000; Chen et al., 1999; Daniels and 
Weis, 2005; Hecht et al., 2000; Arnsdorf et al., 2009). Likewise, 
although Runx2 is directly enhanced through canonical Wnt 
signaling through TCF-7 (Gaur et al., 2005), Runx2’s 
transcriptional activity is repressed by binding to Tcf/Lef 
transcription factors in osteoblasts, providing a novel means for 
feedback between Wnts signaling and Runx2 (Kahler and 
Westendorf, 2003). Wnt-responsive transcription in osteoblasts is 
also antagonized by fibroblast growth factors (FGFs) signaling, 
through decreased expression of frizzleds and TCF/LEFs 
(Ambrosetti et al., 2008). 
Notch proteins are transmembrane receptors that control cell-fate 
decisions. Upon ligand binding, Notch receptors undergo 
proteolytic cleavage leading to the release of their intracellular 
domain (NICD). Overexpression of NICD impairs 
osteoblastogenesis by decreasing the trans-activating effect of 
Wnt3a, cytoplasmic beta-catenin levels, and Wnt-dependent gene 
expression (Deregowski et al., 2006). 
Together, these studies demonstrate functional complexity within 
the TCF/LEF family and illustrate some of the opportunities for 
regulatory crosstalk to integrate diverse signals and modulate 
gene expression in osteoblasts. 
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The mesh-like homeobox gene 2 (Msx2) is involved in the 
proliferation of osteo-progenitor cells and it is a negative 
regulator of osteogenic differentiation, as it inhibits the 
expression of osteogenic genes, such as Runx2 and Alp (Hassan et 
al., 2006; Hyun et al., 2005). The distal-less homeobox gene 5 
(Dlx5) plays a key role in the differentiation and maturation of 
the osteoblast phenotype. Dlx5 works in conjunction with other 
transcription factors such as Dlx6 and Msx2 (Shirakabe et al., 
2001; Ducy, 2000). In the case of Msx2 the Dlx5 transcript may 
act as an indirect negative regulator, down-regulating the Msx2 
transcript as the osteoblasts cease to proliferate (Ryoo et al., 
1997). Msx and Dlx homeoprotein families form homo- and 
heterodimeric complexes. Dimerization of Msx and Dlx proteins 
is mediated by their homeodomains and the residues required for 
this interaction correspond to those necessary for DNA binding. 
The transcriptional properties of Msx and Dlx proteins display 
reciprocal inhibition. Specifically, Msx proteins act as 
transcriptional repressors and Dlx proteins act as activators, while 
in combination, Msx and Dlx proteins counteract each other's 
transcriptional activities. Therefore, functional antagonism 
through heterodimer formation provides a mechanism for 
regulating the transcriptional actions of Msx and Dlx 
homeoproteins (Merlo et al., 2000). Dlx5 mediates BMP-2 
induced Runx2 expression and osteoblast differentiation (Lee et 
al., 2003). 
Runt-related transcription factor 2 (Runx2) is frequently 
described as the master regulator of osteoblastogenesis (reviewed 
by Stein et al., 2004). It acts throughout the induction, 
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proliferation, and maturation of osteoblasts and regulates 
expression of many osteoblast genes. Many of the signaling 
pathways and transcription factors that influence 
osteoblastogenesis do so by influencing the production or activity 
of Runx2. RUNX2 haploinsufficiency causes cleidocranial 
dysplasia, a condition characterized by hypoplastic clavicles, 
various dental defects, delayed ossification of the skull bones and 
a number of other skeletal abnormalities, while homozygous 
mutation of Runx2 in mice is lethal due to a complete lack of 
mineralized bone (Komori et al., 1997; Otto et al., 1997; Mundlos 
et al., 1997). Runx2 expression is poorly correlated with 
expression of its target genes, indicating that Runx2’s activity is 
regulated by additional factors. Indeed, Runx2 is subject to post-
translational regulation by phosphorylation, acetylation and 
ubiquitination. In addition to its Runt-class DNA binding motif, 
the Runx2 protein contains multiple domains that mediate either 
transcriptional activation or repression through associations with 
co-activators or co-repressors (Jensen et al., 2007; Schroeder et 
al., 2005). These many modes of control enable Runx2 to 
function as a master regulator, integrating diverse signals to 
activate or repress transcription in a precise spatio-temporal 
manner and in response to changing physiological needs. Runx2 
has a dual role in osteogenesis, as it regulates the expression of 
multiple genes involved both in cell-cycle progression and 
cellular differentiation. Consistent with a role in suppression of 
proliferation, Runx2 protein was absent or nonfunctional in six 
out of seven osteosarcoma cell lines. Both spontaneous and 
induced osteoblast differentiation are associated with increased 
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p27KIP1 mRNA and protein expression. Ectopic expression of 
Runx2 induced an Rb- and p27KIP1-dependent growth arrest. This 
was due in part to increased expression of p27KIP1 protein, which 
inhibited S-phase Cdk complexes and the dephosphorylation of 
pRb. Interestingly, Runx2 is shown to interact preferentially with 
the hypophosphorylated form of pRb, a known coactivator of 
Runx2. Although p27KIP1 expression is associated with osteoblast 
differentiation, loss of p27KIP1 had only a minor effect on 
osteoblast differentiation in vitro and in vivo. Notably, the 
irreversibility of both the osteogenic phenotype and terminal cell 
cycle exit in vitro is dependent on expression of p27KIP1. 
Therefore Runx2 establishes a terminally differentiated state 
through Rb- and p27KIP1-dependent mechanisms, and these 
processes are disrupted in osteosarcomas (Thomas et al., 2004). 
In addition, Runx2 deficiency and defective subnuclear targeting 
contribute to the ex vivo growth advantage of null osteoblasts 
through a p21-dependent mechanism (Zaidi et al., 2007). 
Moreover, numerous investigations have indicated its role in the 
regulation of a broad spectrum of osteoblastic genes. In fact, 
Runx2 interacts with the promoter regions and directly stimulate 
the transcription of genes such as alkaline phosphatase (Alp), 
osteocalcin, osteopontin, collagen I, bone sialoprotein (Ducy et 
al., 1997; Selvamurugan et al., 1998; Kern et al., 2001; Harada et 
al., 1999; Shimizu-Sasaki et al., 2001; Newberry et al., 1997; 
Otto et al., 2003). 
Another master gene of osteogenesis is Osterix (Osx, also known 
as Sp7), coding for a zinc-finger transcription factor expressed in 
osteoblasts and, like Runx2, required for bone formation 
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(Nakashima et al., 2002). Osx-null mice die at birth due to their 
lack of mineralized skeletons. Bones formed by intramembranous 
ossification are entirely non-mineralized, while endochondral 
bones exhibit regions of mineralized cartilage, indicating that Osx 
functions specifically in osteoblasts. Despite its evident 
importance in bone formation, relatively little is known about 
regulation of Osx expression, its functional partners, or its direct 
target genes. Osx expression was believed to be downstream of 
Runx2, because Runx2 expression is normal in Osx-null mice, 
while Osx expression is absent in Runx2-knockout mice 
(Nakashima et al., 2002). This was confirmed through 
characterization of a Runx2-binding element in the Osx gene 
promoter (Nishio et al., 2006). Osterix activation of the Collagen 
IA1 promoter is enhanced by binding of NFATc1 to Osx, an 
interaction that is disrupted by calcineurin (Koga et al., 2005). 
Despite these interesting findings, the details concerning the 
regulation and function of Osx are incompletely understood. 
 
2.4 Adipogenesis 
The worldwide epidemic of obesity over the past fifty years has 
caused a great interest in the study of adipose tissue biology. 
Obesity is the result of an imbalance between energy intake and 
expenditure, and is often characterized by an increase in both 
adipocyte size and numbers. Two functionally different types of 
adipose tissues are classically described in mammals, which 
differ in several important properties: BAT (brown adipose 
tissue) and WAT (white adipose tissue). BAT and WAT are both 
involved in energy balance, but assume opposite functions. BAT 
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is specialized in energy dissipation as heat during cold- and diet-
induced thermogenesis, whereas WAT is mainly involved in 
energy storage and mobilization in the form of triacylglycerols. In 
addition, white adipocytes have intracrine, autocrine/paracrine 
and endocrine properties, such as the secretion of leptin and 
adiponectin (Ailhaud and Hauner, 2003). WAT is found in 
several depots throughout the body, and location varies between 
species. For mammals and birds, the largest fat tissues are intra-
abdominal and subcutaneous, but WAT can also be found in 
other areas, such as the face and extremities, and within bone 
marrow. Different depots are not metabolically equivalent 
(reviewed in Rosen and MacDougald, 2006; Gesta et al., 2007). 
For example, adipose tissue in the breasts and thighs respond to 
sex hormones, whereas depots of the neck and upper back are 
more sensitive to glucocorticoids. Similarly, different adipose 
tissues show significantly different patterns of gene expression 
(Vidal, 2001; Vohl et al., 2004; Gesta et al., 2006; Tchkonia et 
al., 2007). These distinct molecular and physiological properties 
might partly explain why variations in WAT distribution are 
associated with metabolic disorders (Bjorntorp, 1990; Lafontan 
and Berlan, 2003). For instance, they might account for the 
higher risk of cardiovascular diseases observed in patients with 
an increased ratio of visceral to subcutaneous WAT. The distinct 
properties of different depots also suggest possible differences in 
their developmental origin. In accordance with this hypothesis, 
WAT depots exhibit a different timing of appearance during 
development (Gesta et al., 2007). In rodents, WAT develops 
mainly after birth, first in the peri-gonadal and subcutaneous 
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depots, and only later in the omental depot. In humans, WAT 
formation begins during the second trimester of gestation and by 
birth both the visceral and subcutaneous depots are apparent. 
Adipogenesis is generally described as a two-step process. The 
first step comprises the generation of committed adipocyte 
precursors (or pre-adipocytes) from MSCs. The second step 
involves the terminal differentiation of these pre-adipocytes into 
mature functional adipocytes. The differentiation of pre-
adipocytes into adipocytes has been extensively studied in vitro 
(Farmer, 2006; Rosen and MacDougald, 2006). This was made 
possible by establishment of immortal pre-adipocyte cell lines 
that were selected from disaggregated mouse embryos or from 
adult adipose tissue for their ability to accumulate cytoplasmic 
triacylglycerols (Green and Kehinde, 1976; Negrel et al., 1978). 
These cell lines are believed to be faithful models of pre-
adipocyte differentiation and they have provided important 
insights into the control of the late steps of adipogenesis. In 
contrast, the early steps leading to the generation and the 
commitment of MSCs to the adipocyte lineage remain largely 
unknown. Although there have been attempts to characterize the 
distinct cellular intermediates between MSCs and mature 
adipocytes, such studies have been hampered by the lack of 
specific cell-surface markers to identify and prospectively isolate 
these cells in vivo (Billon et al., 2008). 
The differentiation of pre-adipocytes into adipocytes is regulated 
by an elaborate network of transcription factors that coordinate 
expression of hundreds of proteins responsible for establishing 
the mature fat-cell phenotype. At the center of this network are 
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the two principal adipogenic factors, PPARγ and C/EBPα, which 
oversee the entire terminal differentiation process. PPARγ in 
particular is considered the master regulator of adipogenesis; 
without it, precursor cells are incapable of expressing any known 
aspect of the adipocyte phenotype (Rosen et al., 2002). On the 
other hand, cells deficient in C/EBPα are capable of adipocyte 
differentiation; however, these C/EBPα-deficient cells are insulin 
resistant (El-Jack et al., 1999; Wu et al., 1999). Much of our 
knowledge of this complex network and the importance of 
PPARγ and C/EBPα comes from studies performed in established 
pre-adipocyte cell lines as well as mesenchyme-derived precursor 
cells. More recently, data from a variety of knockout mice have 
confirmed these in vitro studies showing that many components 
of this network are required regulators of adipocyte development 
and function. 
The role of PPARγ as the master regulator of adipogenesis is 
supported by overwhelming evidence from both in vivo and in 
vitro studies. A series of gain-of-function studies in which PPARγ 
was ectopically expressed in nonadipogenic mouse fibroblasts 
showed that PPARγ alone can initiate the entire adipogenic 
program, giving rise to fat cells that are capable of many of the 
functions of mature adipocytes (Tontonoz et al., 1994). In 
attempting to understand the importance of PPARγ in the 
development of adipocytes, investigators found that ablation of 
PPARγ in ES cells leads to embryonic lethality at E10 due to a 
defect in placentation as a result of PPARγ’s participation in 
formation of the trophoblast (Barak et al., 1999). To circumvent 
this problem, alternative strategies for obtaining knockout mice 
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were developed that supported a role for PPARγ in the formation 
of all fat depots, including both BAT and WAT (Barak et al., 
1999; Rosen et al., 1999). PPARγ is expressed as two isoforms, 
PPARγ1 and PPARγ2, generated by alternative promoter usage of 
the same gene. PPARγ1 is expressed in many tissues, whereas 
PPARγ2 expression is restricted almost exclusively to adipose. 
Studies performed in PPARγ-/- mouse embryonic fibroblasts 
(MEFs) demonstrate that ectopic PPARγ1 is as capable of 
inducing adipogenesis as PPARγ2 (Mueller et al., 2002). 
Furthermore, adipose-selective knockout of PPARγ2 in the mouse 
gives rise to insulin-insensitive animals with reduced fat; 
however, they still contain substantial amounts of adipose tissue, 
suggesting that PPARγ1 can compensate for many of the 
adipogenic functions of PPARγ2 (Zhang et al., 2004). The fact 
that the PPARγ2-deficient mice are insulin resistant suggests that 
PPARγ2 may play a selective role in regulating insulin 
sensitivity. 
Recognition that C/EBPα functions as a principal player in 
adipogenesis also resulted from gain-of-function studies in 
cultured cells as well as establishment of appropriate knockout 
mice. In the former case, ectopic expression of C/EBPα in a 
variety of fibroblastic cells could induce adipogenesis (Freytag et 
al., 1994). As PPARγ loss-of-function is embryonic lethal, also 
C/EBPα knockout mice die soon after birth due to the pups’ 
inability to produce glucose. This phenotype results from the 
requirement of C/EBPα for gluconeogenesis in the liver (Wang et 
al., 1995). Ablation of C/EBPα in all tissues except the liver 
revealed that C/EBPα is required for formation of WAT. 
	  69	  	  
Introduction 
Interestingly, C/EBPα is not required for the formation of BAT, 
an observation that currently is not understood (Linhart et al., 
2001). 
PPARγ can induce adipogenesis in C/EBPα-deficient MEFs, 
whereas C/EBPα is incapable of driving the adipogenic program 
in the absence of PPARγ (Rosen et al., 2002). This observation 
suggests that C/EBPα and PPARγ participate in a single pathway 
of adipose development, in which PPARγ is the dominant factor. 
It must be mentioned that C/EBPα does provide a critical 
function during terminal adipogenesis since failure to express 
C/EBPα results in insulin resistance in cell culture models and an 
inability to develop WAT in vivo (El-Jack et al., 1999; Linhart et 
al., 2001; Wu et al., 1999). It has been suggested that, in addition 
to controlling insulin action, C/EBPα is required for maintaining 
expression of PPARγ in the mature fat cell (Wu et al., 1999). It is 
possible that establishment of the adipogenic phenotype in 
C/EBPα-deficient brown adipocytes is due to other mechanisms 
that function to maintain PPARγ production. Well before the 
discovery of PPARγ as the master regulator of adipogenesis, 
several investigators attempted to identify the mechanisms 
responsible for determining the differentiation of precursor cells 
into adipocytes. It is now established that a cascade of 
transcription factors eventually leads to expression of PPARγ and 
C/EBPα. Two other members of the C/EBP family, C/EBPβ and 
C/EBPδ, are expressed earlier than C/EBPα during adipogenesis, 
and play important roles in inducing expression of C/EBPα and 
PPARγ. This was shown by the identification of functional 
C/EBP regulatory elements in the promoters of C/EBPα and 
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PPARγ (Christy et al., 1991; Clarke et al., 1997). In an attempt to 
define the sequence of events leading to terminal adipogenesis, it 
was proposed that C/EBPβ and C/EBPδ simultaneously control 
expression of both PPARγ and C/EBPα. Alternatively, some 
investigators have suggested that C/EBPβ induces C/EBPα and 
that, together, these factors regulate PPARγ expression. More 
recently, studies have shown that ectopic expression of C/EBPβ 
in fibroblasts induces PPARγ as expected but is incapable of 
inducing C/EBPα to any significant extent in the absence of a 
potent PPARγ ligand. Moreover, retroviral expression of C/EBPβ 
in PPARγ-/- MEFs also shows that C/EBPβ, in the absence of 
active PPARγ, is incapable of stimulating expression of C/EBPα 
(Zuo et al., 2006). It appears, therefore, that the principal pathway 
of adipogenesis involves induction of C/EBPβ and C/EBPδ, 
which then facilitate expression of PPARγ. PPARγ along with 
these C/EBPs then activates C/EBPα expression. 
The precise role of C/EBPβ and C/EBPδ in regulating this 
cascade of factors has been questioned, however, in knockout 
mice. Specifically, Tanaka et al. (1997) demonstrated that 
neonatal mice lacking both C/EBPβ and C/EBPδ have a defect in 
their ability to produce adipose tissue; however, this defect 
appears to be downstream of both PPARγ and C/EBPα since both 
factors are expressed in the poorly differentiated adipose tissue. 
In contrast, MEFs obtained from these knockout mice do not 
express C/EBPα or PPARγ and are incapable of undergoing 
adipogenesis in culture when compared to wild type cells. These 
data suggest that there is some redundancy in the early steps of 
adipogenesis in vivo where alternative pathways operate to ensure 
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expression of PPARγ and C/EBPα. Furthermore, it appears that 
C/EBPβ and C/EBPδ, in addition to inducing expression of 
PPARγ and C/EBPα, provide other functions during terminal 
adipogenesis since their absence prevents terminal adipogenesis 
at a step downstream of PPARγ or C/EBPα. One possible 
function might include induction of programs responsible for 
production of PPARγ ligands (Hamm et al., 2001). 
Identifying the factors that regulate C/EBPβ and C/EBPδ 
expression as well as cooperate with these C/EBPs in an 
adipogenic-specific manner should provide additional insight into 
the mechanisms regulating the commitment of mesenchymal 
stem cells to the adipogenic lineage. Some studies provide 
convincing evidence that the cAMP regulatory element-binding 
protein, CREB, which is activated very early during 
adipogenesis, participates in the induction of C/EBPβ expression 
(Zhang et al., 2004). This observation is consistent with earlier 
studies showing a role for cAMP signaling in controlling C/EBPβ 
expression (Cao et al., 1991) and also explains the need for 
inducers of cAMP (isobutylmethylxanthine) in cocktails that 
initiate the adipogenic program. In contrast, induction of C/EBPδ 
is facilitated by glucocorticoids and C/EBPβ (Cao et al., 1991). 
Recent studies suggest that many additional transcription factors 
are potential components of this complex network of factors 
responsible for inducing adipogenic gene expression (Fu et al., 
2005; Soukas et al., 2001). Investigators have identified Krox20 
as a factor that acts early in the adipogenic program and appears 
to contribute to induction of C/EBPβ expression. Krox20 (also 
known as early growth response gene 2, or Egr2) is a 
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transcription factor that is induced immediately following 
exposure of cells to mitogens. Krox20 is activated early in the 
adipogenic program and not only promotes expression of C/EBPβ 
but also cooperates with C/EBPβ to facilitate terminal 
adipogenesis (Chen et al., 2005). The fact that these early events, 
including activation of CREB, Krox20, and C/EBPβ, precede 
induction of PPARγ and C/EBPα transcription by 1 to 2 days 
suggests that additional processes are required in order to 
facilitate terminal adipogenesis. Lane and associates, in an 
attempt to explain this lag, suggested that C/EBPβ does not attain 
the capacity to bind to C/EBP response elements in the promoters 
of its target genes until several hours after its appearance in the 
nucleus because it is bound to satellite DNA (Tang and Lane, 
1999). They proposed that its release from this compartment is 
facilitated by changes in chromatin structure that occur during 
clonal expansion and terminal adipogenesis. More recently, these 
investigators suggested that this lag in C/EBPβ activity also 
results from a delay in its phosphorylation by MAPKs and GSK3, 
which is required for its DNA-binding activity (Tang et al., 
2005). Other studies have also identified an important site of 
phosphorylation within a regulatory domain of C/EBPβ, but, 
unlike the studies of Lane, these studies suggest that 
phosphorylation regulates C/EBPα expression (Park et al., 2004). 
More recent investigations suggest that the lag between the 
appearance of C/EBPβ and the expression of PPARγ2 results 
from the time required for synthesis of additional proteins that 
facilitate the activity of C/EBPβ. Specifically, transcription of the 
Kruppel-like factor KLF5 is activated by C/EBPβ and C/EBPδ 
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and, in concert with these C/EBPs, contributes to induction of 
PPARγ2 (Oishi et al., 2005). Neonatal heterozygous KLF5 
knockout mice have a significant deficiency in adipose tissue 
formation (Oishi et al., 2005). Additionally, MEFs obtained from 
these KLF5+/− mice are compromised in their ability to undergo 
adipogenesis in culture. Studies also suggest a role for other 
members of the KLF family including KLF6 and KLF15 in 
promoting adipogenesis (Li et al., 2005; Mori et al., 2005) (Fig. 
18). 
 
Figure 18: Regulation of adipogenesis. 
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3. HOMEOBOX-CONTAINING GENES 
Homeobox-containing genes encode a phylogenetically 
widespread family of eukaryotic DNA-binding proteins that play 
a central role in the genetic control of development. Historically, 
homeotic mutations were observed in genetic Drosophila 
melanogaster research. Examples are mutations resulting in 
transformations of the third thoracic segment towards a second 
thoracic segment, which on phenotype level leads to four-winged 
flies (Lewis, 1978), or mutations that result in the replacement of 
the antennae on a fly’s head by legs (Gehring, 1966). With the 
advent of gene cloning techniques, these mutations could be 
located to their genes: the homeobox was discovered (McGinnis 
et al., 1984; Scott and Weiner, 1984). Subsequently, hundreds of 
homeoboxes were discovered which are spread over a large 
variety of species ranging from yeast to human (Duboule, 1994). 
Furthermore, homeobox-containing genes were found at all levels 
of the developmental hierarchy: in the establishment of 
morphogenetic gradients, in the structure formation of groups of 
body segments, or in the defining the unique identity of single 
segments (Duboule, 1994). For this reason, the homeodomain has 
become one of the most studied eukaryotic DNA-binding motif. 
It is a self-folding, stable protein domain of about 60 amino acids, 
which is composed of three α helixes (Qian et al., 1989). A 
comparison of its three-dimensional structure with other DNA-
binding protein domain reveals a high degree of structural 
similarity to the helix-turn-helix motif which is part of many 
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prokaryotic repressor (Brennan and Matthews, 1989). In 
particular, it consists of a flexible stretch of nine residues, 
referred to as the N-terminal arm, followed by three α helixes 
(Fig 19). 
 
Figure 19: Tridimensional structure of the homeodomain. 	  
X-ray crystallographic analysis and nuclear magnetic resonance 
studies have revealed that two regions of homeodomain make 
base specific contacts with DNA (Otting et al., 1990). The third α 
helix (recognition helix) lies along the major groove while the N-
terminal arm reaches behind the phosphate backbone to contact 
bases via the minor groove (Otting et al., 1990). On the DNA 
side, specific contacts from the recognition helix are usually 
restricted to a fragment of five base pairs (Billeter, 1996). From 
the central base pair, the bases of both strands may interact with 
protein side chains, while from the peripheal base pairs usually 
only bases of one strand are close enough to the protein 
(Billenter, 1996). This is the consequence of the fact that the 
recognition helix is not oriented exactly in the direction of DNA 
! !
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major groove, and that the protein side chains are distributed over 
the exposed helix surface (Billenter, 1996).  
Homeobox-containing (HB) genes are broadly divided into two 
classes. Class I includes clustered HB (Hox) genes, recognized 
for their role in antero-posterior patterning during embryogenesis, 
while the class II divergent HB (non-Hox) genes are dispersed 
throughout the genome. The Hox gene loci are believed to have 
arisen from gene duplication and consist of 13 paralogous groups 
organized into four clusters (A-D) on chromosomes 7, 17, 12 and 
2, respectively. Hox genes exhibit high homology to the HOM 
genes of Drosophila, with groups 1-8 being most closely related 
to Drosophila antennapedia (Antp) and groups 9-13 more closely 
related to Drosophila abdominal-B (Abd-B) (Gehring et al., 
1994a; Gehring et al., 1994b). 
The non-Hox genes include a large number of genes scattered 
throughout the genome that, nevertheless, can be organized in 
distinct families on the basis of sequence homologies and 
functional similarities (Mark et al., 1997). They include PAX 
family, the POU, CDP, DLX, PBC and LIM families, and a 
number of individual homeobox-containing genes such as HOX11 
and Hlx (Magli, 1998). 
A number of studies have highlighted the pivotal role of HB 
genes in the development/differentiation of most prenatal and/or 
postnatal tissues. Furthermore, increasing evidence indicates that 
these genes are involved in normal and malignant hematopoiesis. 
HB genes have been involved in translocation events in certain 
leukemic cells, suggesting that mutant form of these genes may 
be important in oncogenesis. In addition, other studies have 
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indicated that modulation of HB genes expression may induce 
alterations in proliferative, differentiative, or phenotypic 
characteristics of hematopoietic cells. Moreover, some studies 
have demostrated abnormalities in the blood forming organs of 
HB gene knockout mice (Magli et al., 1998). 
 
3.1 Hox genes 
Mice and humans have four copies of the Hox gene cluster, called 
Hoxa-d (HOXA-D), which are believed to have arisen from two 
or three ancient duplication events (McGinnis and Krumlauf, 
1992). Each cluster is located on a different chromosome and 
each contains a subset of 13 gene types. The types are defined by 
sequence similarity and are called paralogs. Paralogs in the four 
complexes share greater homeodomain sequence similarity than 
do different members of a single complex. As in flies, the fiscal 
order of mammalian genes within the cluster corresponds to the 
order in which Hox genes are expressed along the anterior-
posterior axis in multiple tissues, such as hindbrain, somites, gut 
and limb (colinearity) (Manak and Scott, 1994). In particular, in 
mammalian embryos, Hox genes start to be expressed at 
gastrulation. They collectively control the identity of various 
regions along the body axis from branchial area through the tail 
(Graham, 1989). The action occurs following the rules of 
temporal and spatial colinearity, with 26 Hox genes expressed 
early in development and controlling anterior regions, followed 
by progressively more 13 genes expressed later in development 
and controlling more posterior regions (Dekker et al., 1992). In 
particular, 16 Hox genes of groups 1 to 4 primarily control the 
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development of the embryonic region corresponding to the 
hindbrain (Lumsden and Krumlauf, 1996). Central Hox genes of 
groups 5 to 8 control the thoracic portion of the body, whereas 20 
Hox genes of groups 9 to 13 control the lumbosacral regions (Fig. 
20). 
 
Figure 20: Genomic organization of the Hox gene clusters. A schematic of 
the Hox gene clusters in the genome of D. melanogaster and M. musculus. 
Genes are coloured to differentiate between Hox family members, and genes 
that are orthologous between cluster and species are labelled in the same 
colour. Genes are shown in the order in which they are found on the 
chromosomes. 	  
The functional significance of the conserved gene order in these 
clusters is still poorly understood. However, a likely reason for 
the maintenance of the clustered arrangement for more than 500 
million years is that different genes in the cluster are controlled 
by the same DNA regulatory regions. Conservation of Hox 
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protein sequence and expression pattern suggested that vertebrate 
Hox genes control axial patterning in a manner similar to that in 
flies (Burke et al., 1995). This was confirmed when Hox mutants 
mouse were obtained and homeotic transformations were found 
in the skeleton of mutant embryos. For example, in Hoxc8 
homozygous mutant mice the most obvious transformations were 
the attachment of the 8th pair of ribs to the sternum and the 
appearance of a 14th pair of ribs on the 1st lumbar vertebra (Le 
Mouellic et al., 1992). 
Studies in both Drosophila and mouse show that homeotic 
transformations in Hox loss-of-function mutants usually cause the 
affected body structures to resemble more anterior ones. 
Conversely, many gain-of-function mutant phenotypes are due to 
ectopic expression of more posterior Hox genes, which are 
capable of “cancelling” the function of more anterior ones and 
specifying extra posterior structures. The ability of a more 
posterior Hox gene to impose its function on more anterior genes 
is called posterior prevalence, or phenotypic suppression 
(Duboule, 2007). 
Studies in Drosophila have highlighted that generation of stable 
Hox expression domains is a two-step process. The initiation 
phase is controlled by the products of coordinate, gap and pair-
rule genes that establish initial boundaries of Hox expression. In 
mammals, little is know about the upstream mechanisms for 
initiating Hox expression pattern. A few documentated examples 
include: the requirement of a zinc-finger transcription factor, 
Krox20, for the activation of Hoxb2 in the hindbrain of 
developing mice (Sham et al., 1993); involvement of the Maf/b-
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zip protein Kreisler in Hoxb3 activation (Manzanaser et al., 
1997); the role of the retinoic acid receptors (RAR proteins) in 
controlling the boundaries of expression of multiple Hox genes 
(Marshall et al., 1996). 
Some studies have provided further evidence for conservation at 
the next phase of Hox expression. In both flies and mice the 
initial zones of Hox expression are stabilized and maintained by a 
direct action of the proteins from the Trithorax and Polycomb 
groups (TrxG and PcG, respectively). Extensive characterization 
of PcG and TrxG functions in Drosophila has shown that PcG 
proteins are transcriptional repressors of a variety of genes, 
including Hox genes. Conversely, TrxG proteins are 
transcriptional activators of Hox genes (reviewed in Simon, 1995; 
Pirrotta, 1998; Gould, 1997; Schumacher and Magnuson, 1997). 
In mouse embryos that are mutants for PcG genes such as Bmi1 
or eed, Hox genes are expressed in more cells than in wild type 
embryos, and such expanded expression domains can cause 
homeotic transformations (Van Der Lugt et al., 1994; 
Schumacher et al., 1996; Schumacher et al., 1998). Conversely, 
loss of-products mutants in mouse TrxG genes have diminished 
levels of Hox gene products, with phenotypes resembling 
mutations in the Hox genes themselves (Yu et al., 1995). The 
biochemical functions of TrxG and PcG members are achieved in 
multimeric protein complexes. In some cases, these complexes 
are regulating chromatin structure (Alkema et al., 1997; Sewalt et 
al., 1999; Shao et al., 1999). In mammals, TrxG and PcG 
members are involved in developmental pathways, such as 
hematopoiesis, and cell proliferation, in addition to their role in 
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Hox gene transcription on the A/P body axis (Jacobs et al., 1999; 
Lessard et al., 1999). For example, chromosomal rearrangements 
involving the human HRX gene (the homolog of Drosophila 
Trithorax), known also as MLL or ALL1, often result in 
leukemias, which may be in part due to the deregulation of Hox 
genes in blood cells (reviewed in Gregorini et al., 1998; Cimino 
et al., 1998). 
In addition to TrxG and PcG control, the maintenance of Hox 
gene expression is facilitated by multiple auto- and cross-
regulatory interactions. Thus, Drosophila proteins Lab and Dfd 
maintain their own transcription through autoactivation enhancers 
(Chouinard and Kaufman, 1991; Grieder et al., 1997) and similar 
autoactivation control has been found in the murine homologs of 
these genes, Hoxb1 and Hoxb4 (Popperl et al., 1995; Gould et al., 
1997). 
 
3.1.1 Hox genes in skeletal development 
In vertebrates the development of two major systems, the 
hindbrain and the paraxial mesoderm depends on the process of 
segmentation for their functional organization. The paraxial 
mesoderm generates somites, which give rise to the axial 
skeleton. The cellular processes of segmentation depend on 
ordered patterns of Hox gene expression as a mechanism for 
generating a combinatorial code that specifies unique identities of 
the segments and their derivaties. 
The newly formed somite consists of a mesenchymal core 
surrounded by epithelial cells. During development, somite 
differentiation proceeds progressively in an anterior to posterior 
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direction. The somite undergoes a number of morphological 
changes in response to signals arising from the neighboring 
tissues such as the notochord, neural tube, ectoderm and lateral 
plate mesoderm (Christ et al., 2004) (Figure 21a). Somites are 
polarized along their A-P, D-V, and mediolateral axes. The 
ventral half of the somite undergoes an epithelial-to-
mesenchymal transition to form the sclerotome, which generates 
the vertebrae of the axial skeleton. The dorsal half of the somite 
retains its epithelial character and forms the dermomyotome, 
giving rise to the dorsal dermis and muscles of the back and 
limbs. 
Although they respond in stereotyped ways to inductive cues, the 
sclerotomes differentiate into vertebrae that are clearly different 
from each other according to their position along the A-P axis. 
This is illustrated by the different anatomical types of vertebrae, 
i.e., cervical, up-perthoracic, lower thoracic, lumbar, sacral, and 
caudal vertebrae. However, defined morphological characteristics 
can be seen between vertebrae within an anatomical unit (Figure 
21b–d) and along the entire vertebral column. Newly formed 
somites already possess the A-P information needed to generate 
their ultimate vertebral identity, because somites moved from one 
A-P level to another will generate a vertebral structure 
characteristic of its origin and not its new location (Fomenou et 
al., 2005; Nowicki and Burke 2000). This A-P information is 
thought to be governed by early differences in the developmental 
programs regulated by the Hox code. 
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Figure 21: Somite differentiation and vertebral morphology. 
 
Analyses on patterning of the axial skeleton have provided some 
of the strongest evidence in vertebrates that Hox genes exert their 
functions as selector genes by regulating regional identity. The 
distinct features of individual structures along the A-P axis of the 
vertebral column have facilitated phenotypic analyses in Hox 
loss- and gain-of-function mutations in mice. The defects include 
malformed vertebrae, vertebral fusions, rib fusions, and vertebral 
homeotic transformations. Homeotic transformations in the 
context of the vertebral column describe a class of phenotypes in 
which a vertebra acquires the characteristics of its immediate 
anterior or posterior neighbour, whereas the total number of 
vertebrae remains constant. A number of patterns have emerged 
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from these studies that clarify the function of Hox genes in global 
patterning of the paraxial mesoderm. 
Several of the Hox genes are essential for normal skeletal 
development. The nonparalogous Hoxa10 and Hoxd11 genes 
cooperate in the development of the forelimb and axial skeleton 
and are required to globally pattern the mammalian skeleton 
(Boulet and Capecchi, 2004; Favier et al., 1996; Salsi and 
Zappavigna, 2006; Wellik and Capecchi, 2003). Strengthening 
the argument that Hox genes function in the presomitic mesoderm 
to assign axial identity to the somites, it has been demonstrated 
that overexpression of Hoxa10 in the presomitic mesoderm and 
newly formed somites results in homeotic transformations within 
the vertebral column (Carapuco et al., 2005). Overexpression of 
this gene specifically within the somites leads to vertebral 
dysmorphogenesis rather than homeotic transformations, 
illustrating later roles for the Hox proteins as well. Moreover, 
inactivation of the paralogous Hoxa10 and Hoxd10 genes results 
in alterations in the formation of the forelimbs and hindlimbs. 
Hoxa10-/- mice revealed an active role for the gene in modeling 
the femur, tibia and fibula (Carpenter et al., 1997; Wahba et al., 
2001). Deletion of an enhancer responsible for the early 
activation of Hoxc8 delays the anterior expansion from 8 dpc 
until 8.5 dpc and is sufficient to induce homeotic transformations 
in the cervical and upper thoracic regions similar to a null allele 
of the gene (Juan and Ruddle, 2003). This further supports the 
idea that the global patterning of somites occurs prior to somite 
formation. 
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Based on loss-of-function mutations, most members of the Hox 
paralogous groups 3-13 play roles in specifying the identity of the 
postcranial axial skeleton. Vertebral homeotic transformations 
caused by Hox gene mutations do not always involve the 
transformation of an entire vertebra to that of another along the 
rostrocaudal axis but instead may lead only to the transformation 
of specific vertebral features (Horan et al., 1995). In other cases, 
the mutation of a Hox gene leads to more complete homeotic 
transformations of one or many vertebrae. Although there is a 
general trend for the phenotypes resulting from single Hox gene 
mutations to reflect the spatial colinearity of Hox gene 
expression, there are numerous exceptions (Figure 22a). In 
contrast, a comparative study of mice with mutations in an entire 
paralogous group demonstrated colinearity of Hox function along 
the vertebral column and evidence for functional compensation 
between groups (Figure 22b) (McIntyre et al., 2007). However, 
there is also evidence that paralogous groups perform distinct 
roles in vertebral patterning, even when the same vertebrae are 
affected. 
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Figure 22: Patterns of homeotic transformations in Hox mutant mice. 
 
Based on the phenomenon of phenotypic suppression, which was 
first characterized in Drosophila, a posterior prevalence model 
has been postulated to account for how the function of posterior 
Hox proteins overrides the function of coexpressed anterior Hox 
proteins (Gonzalez-Reyes and Morata, 1990). According to this 
model, segmental identity is imparted by the most 5′ Hox 
paralogous group that is expressed at a given axial level (Duboule 
and Morata, 1994). In many cases, loss-of-function Hox alleles 
lead to defects in much broader domains than expected from a 
strict interpretation of the posterior prevalence model, i.e., the 
defects extend into regions where more 5′ Hox genes are 
expressed. There is also evidence that levels of expression can 
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influence function in more posterior territories. Therefore, 
although this accounts for many of the observed Hox mutant 
phenotypes in the axial skeleton, there are numerous exceptions 
to the posterior prevalence-based models. 
The combinatorial model posits that a somite acquires its 
segmental identity from the specific complement of Hox genes it 
expresses (Kessel and Gruss, 1991). A corollary of this model is 
that distinct Hox proteins have unique functions. However, many 
studies have shown that Hox genes within the same 
paraloralogous group and between different paralogous groups 
may be functionally equivalent (Zhao and Potter, 2001). For 
instance, the coding sequences of Hoxa3 and Hoxd3 were shown 
to be functionally interchangeable (Greer et al., 2000). By 
comparing compound mutants, there is further evidence that 
dosages or levels of gene expression play an important role in 
determining which genes may share functions in patterning a 
region. Despite the difficulties in generating a unified model to 
account for function, these models provide important clues into 
the nature and readout of the vertebral Hox code and, 
cumulatively, illustrate that multiple mechanisms are likely to be 
employed in a context-dependent manner (Alexander et al., 
2009). 
Hoxa10, which is essential for skeletal patterning, have a 
principal role also in contributing to osteoblast cell fate and 
differentiation. Hoxa10 contributes to osteogenic lineage 
determination through activation of Runx2 and directly regulates 
osteoblastic phenotypic genes. In response to bone morphogenic 
protein BMP2, Hoxa10 is rapidly induced and functions to 
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activate the Runx2 transcription factor essential for bone 
formation (Fig. 23). 
 
Figure 23: Schematic illustration of the BMP2-induced Hoxa10, 
homeodomain proteins Dlx3/Dlx5, and Runx2 gene expression 
representing the initiation phase of osteogenesis. Together these genes 
establish the osteoblast phenotype by direct and Runx2-dependent activities on 
target genes. 
 
A functional element with the Hox core motif was characterized 
for the bone-related Runx2 P1 promoter. Hoxa10 also activates 
other osteogenic genes, including the alkaline phosphatase, 
osteocalcin, and bone sialoprotein genes, and temporally 
associates with these target gene promoters during stages of 
osteoblast differentiation prior to the recruitment of Runx2. 
Exogenous expression and small interfering RNA knockdown 
studies establish that Hoxa10 mediates chromatin hyper-
acetylation and trimethyl histone K4 (H3K4) methylation of these 
genes, correlating to active transcription (Fig. 24). Hoxa10 
therefore contributes to early expression of osteogenic genes 
through chromatin remodeling. 
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Figure 24: Schematic illustration to show how Hoxa10 belongs to an 
epigenetic coregulatory complex for remodeling chromatin to induce 
transcription of osteogenic genes. 	  
Importantly, Hoxa10 can induce osteoblast genes in Runx2 null 
cells, providing evidence for a direct role in mediating osteoblast 
differentiation independent of Runx2. Hoxa10 activates Runx2 in 
mesenchymal cells, contributing to the onset of osteogenesis, and 
Hoxa10 subsequently supports bone formation by direct 
regulation of osteoblast phenotypic genes (Hassan et al., 2007). 
 
3.1.2 Hox genes as positional cell memory 
It is increasingly clear that Hox genes might have an enduring 
role in maintaining positional identity throughout the lifetime of 
an organism. For instance, unbiased global gene expression 
analysis of adult human fibroblasts, cultured ex vivo, showed that 
such cells maintain large-scale differences, that reflect the 
anatomic origin of cells. This scale of differential gene expression 
between subtypes of fibroblasts is similar with the level of 
differential expression seen among currently accepted, distinct 
cell types, such as in the many types of white blood cell (Chang 
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et al., 2002). Systematic comparison of the gene expression 
programs of fibroblasts from numerous finely mapped anatomic 
sites across the human body confirmed that adult fibroblasts 
consistently expressed distinct patterns of HOX genes that were 
sufficient to indicate the position of the cell along three 
developmental axes (Rinn et al., 2006). Differential expression of 
the HOXA and HOXD genes reflected the location of the 
fibroblast on the proximal-distal axis along the upper and lower 
limbs, whereas differential expression of HOXC genes most 
strongly correlated with anterior-posterior location along the 
trunk, and expression of HOXB genes was associated with origin 
from internal organs rather than from skin (Fig. 25). 
 
Figure 25: HOX genes as the address code of the human body. As 
illustrated by the decision tree, differential expression of HOX genes reflects 
the anatomic origin of adult human fibroblasts along the anterior (A)-posterior 
(P), dorso (D)-ventral (V), and proximal (Px)-distal (Ds) axes, in addition to 
their origin from cutaneous versus internal organs. Red indicates high 
expression; green indicates low expression. 	  
The remarkable retention of HOX expression and positional 
identity is not limited just to fibroblasts. Smooth muscle cells 
(Chi et al., 2007) and skeletal muscle cells (Donoghue et al., 
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1992; Grieshammer et al., 1992) are also organized by site-
specific patterns of gene expression and, in some cases, also 
preserve features of the HOX code ex vivo. Fat deposits also have 
site-specific differences, as revealed by transcriptional profiling 
(Gesta et al., 2006). It seems that MSCs derived from different 
bones can have distinct developmental potentials, and these are 
correlated with anatomic site-specific differences in the 
expression of numerous HOX genes by the MSCs. In fact, murine 
MSCs from different organs are characterized by distinct 
topographic Hox codes (Ackema and Charite, 2008). Together, 
these data suggest that a subset of developmental regulators, 
particularly the HOX genes, not only governs what a segment of 
an embryo will become (e.g. the forelimb), but they also ensure 
the development of specific types of skin, muscle, nerve or fat, in 
specific body segment. 
Despite the strength of these observations, several important 
caveats remain. First, the position-specific pattern of HOX genes 
(termed the ‘HOX code’) in adult cells is notably more sparse and 
simple compared with the HOX code in the embryo, which has 
been extensively studied in mouse development. For instance, 
although the developing limb bud shows at least three nested 
patterns of HOX expression along the proximal-distal axis in 
adult fibroblasts, which demarcate the upper arm, forearm and 
hand, only two patterns are evident that demarcate the hand from 
the remainder of the arm (Rinn et al., 2006). Likewise, whereas 
each segment of the spine is demarcated by sequential expression 
of additional HOX genes during embryogenesis, the HOX 
expression in adult fibroblasts shows a biphasic pattern, which 
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switches along the antero-posterior axis at the umbilicus. These 
discrepancies might have arisen for several reasons. The adult 
HOX code has been mapped in just a few cell types, and the 
combination of HOX expression from multiple cell types might 
generate a more detailed address code. Alternatively, perhaps 
maintenance of positional identity in adulthood requires a simpler 
set of address codes than during initial pattern formation and 
organogenesis. A second caveat is that, in some cases, the adult 
HOX expression pattern does not simply reflect a remnant of the 
embryonic expression pattern. As an example, whereas the HOX 
expression pattern in MSCs approximately follows the 3’-5’ 
colinearity rule based on the bone of origin, the HOX expression 
patterns in MSCs do not strictly match the HOX expression 
pattern of the individual bones, at least during bone development 
(Ackema and Charite, 2008). This discrepancy raises the 
possibility that some instances of HOX gene expression in adult 
cells might not reflect positional memory per se but, rather, could 
be examples of the HOX transcription factor being deployed for 
gene regulation in a manner that is independent of embryonic 
segmental identity. 
 
3.1.3 Epigenetic control of Hox activity 
Classical genetics and biochemistry have previously identified 
powerful epigenetic mechanisms that maintain the appropriate 
ON and OFF state of Hox genes (Ringrose and Paro, 2007; 
Schuettengruber et al., 2007), and new epigenomic mapping 
efforts have provided new clues as to how positional identity can 
be faithfully transmitted from embryogenesis into adulthood and 
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old age. Epigenetics refers to heritable changes in phenotype or 
gene expression caused by mechanisms other than changes in the 
underlying DNA sequence; these changes can persist through cell 
divisions. The trithorax family of factors encodes protein 
complexes that possess enzymatic activity to methylate Lys4 on 
the N-terminal tail of histone H3 (H3K4) and trithorax proteins, 
also known as mixed-lineage leukemia (MLL) proteins, are 
required for maintaining Hox gene activation (Schuettengruber et 
al., 2007). Conversely, the Polycomb group proteins promote 
histone H3 Lys27 methylation, leading to Hox gene silencing 
(Sparmann and van Lohuizen, 2006). 
Recent epigenomic mapping studies combine chromatin 
immunoprecipitation, a method that retrieves DNA sequences 
associated with a particular histone modification, with 
hybridization to tiling microarrays or high throughput sequencing 
to read out all of the DNA sequences associated with a particular 
histone modification or chromatin-binding factor (Collas and 
Dahl, 2008). These studies have provided the picture of the 
chromatin landscape of a typical gene; the promoter, gene start 
and gene body are each associated with a canonical pattern of 
nucleosome occupancy and histone modifications (Barski et al., 
2007; Mikkelsen et al., 2007). Di- and tri-methylated Lys4 on 
histone H3 is associated with the promoter and the first several 
hundred bases of transcribed genes. H3K27me3 and associated 
Polycomb group proteins occupy the promoters of a subset of 
transcriptional silent genes. Interestingly, the HOX loci emerge as 
an exception to this chromatin landscape. In differentiated cells 
that possess transcriptional memory of HOX, such as fibroblasts, 
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the HOX loci show extended chromosomal domains of histone 
modifications and occupancy by their cognate enzymes that 
encompass multiple adjacent HOX genes and intergenic regions. 
The chromosomal domains of H3K4 and H3K27 methylation are 
mutually exclusive and can be programmed in a modular manner 
based on the anatomic origin of the cells. Furthermore, numerous 
sites of extensive transcription of long non-coding RNAs 
(lncRNAs) are found within the HOX loci that interweave the 
intergenic and genic regions. At least 231 transcribed regions 
have been recently discovered within the four human HOX loci. 
The majority of the HOX lncRNAs are expressed in a spatially 
patterned manner in the tissue and in fact constitute the 
predominant site-specific output of the HOX loci (Rinn et al., 
2007). LncRNAs turn out to have key roles in configuring this 
epigenetic landscape. Evidence in Drosophila and mammalian 
studies showed that lncRNA transcription can activate or silence 
Hox genes in cis or in trans (Sanchez-Elsner et al., 2006; Petruk 
et al., 2006). For instance, a lncRNA in the HOXC locus, named 
HOTAIR, is required in trans to silence across 40 kilobases of the 
HOXD locus in adult fibroblasts. HOTAIR accomplishes this task 
through its interactions with the Polycomb repressive complex 2 
(PRC2), targeting H3K27 trimethylation to HOXD (Rinn et al., 
2007). 
Several features of the Hox chromatin landscape lend substantial 
robustness to its transcriptional memory. First, the broad domains 
of histone modifications favor faithful duplication of the 
chromatin landscape during DNA replication. As chromatin is 
unraveled during DNA replication, post-translationally modified 
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histones should partition randomly to both daughter strands, 
along with new, unmodified histone proteins. Thus, a single 
modified nucleosome has a probability of being lost during DNA 
replication, but this probability is greatly reduced for an extended 
chromatin domain ranging over kilobases and comprising dozens 
of homogenously modified nucleosomes (Dodd et al., 2007). 
Second, the concomitant association of the histone modification 
enzymes, namely Polycomb or MLL complexes, along with their 
cognate histone marks on chromatin ensures that any deviation 
from the desired chromatin pattern can be corrected; for instance, 
incorporation of an unmodified histone during DNA replication 
can be modified to the desired state. Furthermore, recent 
biochemical studies have uncovered families of histone 
demethylases, enzymes that reverse histone methylation events. 
Notably, a H3K27 demethylase is physically associated with 
MLL2 and MLL3 H3K4 methylase complexes (Lan et al., 2007; 
Agger et al., 2007; Lee et al., 2007), whereas a H3K4 
demethylase is physically associated with the Polycomb H3K27 
methylase complex (Pasini et al., 2008). These associations 
ensure the univalent nature of H3K4 versus H3K27 methylation 
in differentiated cells, and prevent any ambiguity in the 
conveyance of ON versus OFF state of the Hox genes. Finally, 
the extensive transcription of lncRNAs confers an additional 
element of stability. Because the Hox lncRNAs are co-regulated 
with the Hox genes and also control the chromatin states of the 
Hox loci, Hox lncRNAs function as a positive feedback loop to 
continually reinforce the chromatin state. In cis, extensive and 
interweaved transcription of lncRNAs can help maintain an active 
	  96	  	  
Introduction 
chromatin state with high RNA polymerase II occupancy across 
an extended chromosomal region. In trans, lncRNAs such as 
HOTAIR can also functionally demarcate silent chromatin 
domains on distantly located Hox genes and provide cross 
regulation over multiple Hox loci. These unique features can also 
explain in part why Hox genes have stayed together as compact 
loci during evolution and seem particularly resistant to insertion 
of repetitive elements (Lee et al., 2006). Finally, because Hox 
lncRNAs are coordinately regulated with their neighboring Hox 
genes, ectopic activation of the Hox loci by de novo mechanisms 
in adult cells could also set the lncRNAs in motion, thereby 
creating an epigenetic state for their persistent expression. 
 
3.1.4 Hox code and tissue regeneration 
Positional identity not only governs what a segment of an embryo 
will become-for example, the forelimb-but it also ensures the 
development of specific types of skin, muscle, nerve or fat that 
belong in that particular body segment. The retention of 
positional identity in adult differentiated cells might contribute to 
its faithful homeostasis but limits its plasticity, leading to a loss 
of regenerative ability in higher vertebrates. The importance of 
positional memory in regeneration is demonstrated elegantly in 
the fresh-water flatworm planarian (Gurley et al., 2008; Petersen 
and Reddien, 2008). Planarians regenerate a head if the head is 
cut off, and regenerate a tail if the tail is cut off. The polarity 
changes in the adult organism are possible through modulation of 
levels of β-catenin, which is the output of the normal 
developmental Wnt pathway that specifies anterior-posterior 
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polarity (tails have high β-catenin). Silencing of β-catenin after 
wounding resulted in the inappropriate regeneration of a head 
instead of a tail (Gurley et al., 2008). Furthermore, the silencing 
of this posterior signal can transform some adult heads into tails 
in uncut animals. These results again illustrate the existence of an 
ongoing regulatory program that specifies position identity, 
which maintains dynamic control of tissue homeostasis. Where a 
wound requires newly regenerated tissue to integrate with the old, 
this presumably occurs through the use of sustained instructive 
cues (Gurley et al., 2008; Petersen and Reddien, 2008). Earlier 
studies showed that related planarian species do possess Hox 
genes, and that the Hox genes become ectopically expressed in 
the regenerated tissue (Orii et al., 1999). Whether planarian Hox 
genes are required for proper regeneration has not been tested. 
Nonetheless, a robust system of positional identity and memory 
must be in place to sense what structures in the animal have been 
lost and to use the remaining cells to regenerate the missing 
structures. This regenerative ability is presumed to be dependent 
on the totipotent, somatic stem cells called neoblasts present in 
the adult planarian (Salo, 2006). 
Do mammalian stem cells possess positional information? 
Embryonic stem cells seem to repress Hox gene expression and, 
in doing so, preserve their pluripotency (Soshnikova and 
Duboule, 2008) but it is simply not known if this is the case in 
adult stem cells. Tissues that undergo continual remodeling, such 
as skin and bone, must have a means by which stem cells are 
informed of the phenotypic identity of their ancestors. Perhaps 
this information comes from the environment (Rinn et al., 2008); 
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alternatively, adult stem cells themselves might carry this 
ancestral information and one mechanism by which this might be 
accomplished is via retention of a Hox code. 
Support for this hypothesis comes from the recent observation 
that adult skeletal stem or progenitor cells retain at least part of 
the Hox code established during fetal development. Limb 
mesenchymal cells that are destined to form the lower leg bones 
(tibia and fibula) express several Hox genes during development, 
including Hoxa11. These bones undergo constant remodeling and 
yet, even so, Hoxa11 expression persists in adult tibial osteoblasts 
and osteocytes (Leucht et al., 2008). Not all parts of the skeleton 
are derived from Hox-expressing cells: for example, 
mesenchymal cells in the first branchial arch that are destined to 
form the lower jaw (mandible) do not express any Hox genes 
during development and this Hox-negative status is maintained 
into adulthood. Clearly then, Hox expression is not a prerequisite 
for bone formation in either the embryo or in the adult (Leucht et 
al., 2008; Creuzet et al., 2002). So what function(s) might this 
Hox code serve? 
The role of Hox expression in adult stem or progenitor cells was 
addressed in a series of experiments that exploited two unique 
features of bone (Figure 26). First, bone has remarkable 
regenerative potential; and second, skeletal stem or progenitor 
cells are easy to isolate. Relative to other tissues, bones harbor an 
abundance of stem cells, which make it possible for our skeletons 
to undergo continual remodeling (our entire skeletons are 
replaced every decade or so) and also to repair without leaving 
behind any scar tissue. This process of bone repair follows the 
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same general program as bone development and bone 
remodeling: skeletal stem cells give rise to transient amplifying 
osteo-chondro-progenitor cells that proliferate and then 
eventually differentiate into osteoblasts or chondrocytes. The 
only notable differences between bone remodeling and bone 
repair seem to be the stimulus for new bone formation (i.e. 
trauma versus hormonal regulation) and the spatial and temporal 
restriction of osteogenesis to a site of injury versus over the entire 
skeleton. 
 
Figure 26: Hox status and bone regeneration in mouse. Cells expressing 
Hox genes (for example Hoxa11) are in light blue and those not expressing 
Hox are indicated in light grey. Hox+ skeletal stem cells can only heal 
orthotopic Hox+ bone injury site (tibia). (a) Hox+ skeletal stem cells cannot 
repair a Hox- injury site (mandible). (b) Conversely, Hox- skeletal stem cells 
will express the ectopic Hox gene when transplanted into a Hox+ injury site 
and regenerate the ectopic bone (Wang et al., 2009). 	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Taking advantage of these two attributes, Leucht and colleagues 
asked whether or not the Hox status of a bone is recapitulated 
during regeneration in mice (Leucht et al., 2008). Hox-expressing 
tibial bones were injured, and the osteo-chondro-progenitor cells 
occupying the injury site re-expressed Hoxa11. Likewise, Hox-
free mandibular bones were injured and, here, the osteo-chondro-
progenitor cells in those injury sites seemed to retain their Hox-
free status. Again, these results emphasize that Hox status does 
not confer differentiation potential onto cells (Hox-negative cells 
can make both bone and cartilage). However, when Hox-positive 
skeletal stem cells from the tibia were grafted into a Hox-negative 
(mandibular) injury, the grafted cells showed a persistence of 
Hoxa11 expression in the Hox-negative environment of the 
mandible. Furthermore, the grafted cells failed to differentiate 
into osteoblasts and instead formed a cartilaginous callus. In the 
lexicon of bone healing, this could be referred to as ‘scarring.’ 
However, Hox-negative skeletal stem cells from the mandible 
readily expressed Hoxa11 when transplanted into a Hox-positive 
tibial injury sites. These grafted cells formed a regenerate new 
bone, with no evidence of the cartilage ‘scar.’ 
Together, these data demonstrate that at least some adult stem 
cells are equipped with a Hox code that is retained, even after 
transplantation. This positional identity is first established during 
the embryonic period (Grapin-Botton et al., 1995; Couly et al., 
1998) and seems to be rigorously maintained throughout the life 
of an organism and during the regenerative process. Elegant 
embryonic experiments first carried out using the quail-chick 
chimera system championed by Nicole le Douarin (Le Douarin, 
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2004) demonstrate that, at least during early life, the Hox status 
of a cell confers upon it a sense of positional identity and that this 
identity is unchanged when cells are placed into a new 
environment. There is a ‘flip side’ to this: embryonic cells that 
normally lack Hox gene expression integrate into their new 
environment. In accordance with this finding, the ‘Hox-free’ 
condition of cranial neural crest cells has been strongly associated 
with an extraordinary plasticity that is a key contributor to the 
evolution of the craniofacial skeleton (Helms et al., 2005). The 
finding that Hox-negative skeletal stem cells begin to express 
Hox genes when placed into a Hox-positive environment implies 
that injury sites have specific Hox codes. Furthermore, synchrony 
between the cells occupying the injury site and the injury 
environment itself could be a crucial component of normal 
healing. Future experiments will also have to directly test whether 
or not a disparity in Hox gene expression underlies the ability of 
any grafted cell to heal wounds more efficiently. 
Beyond the Hox code, the pattern of Hox cofactors in the wound 
site or adult cells is probably also important. Hox proteins 
typically rely on transcriptional cofactors that refine and constrain 
their activities (Mann and Affolter, 1998). For example, 
recruitment of one of the cofactors, a member of the forkhead 
family of transcription factors FoxP1, has recently been 
demonstrated to have a crucial role in fine- tuning motor-neuron 
diversification in mice (Dasen et al., 2008; Rousso et al., 2008). It 
is conceivable that convergent and/or divergent activities of the 
Hox proteins and their cofactors in injured tissues and the injury 
environment contribute to the assembly of local gene regulatory 
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networks that coordinate maintenance or changes in positional 
identity. Comparisons of the promoters of Hox genes and of their 
cofactors from different organisms should enable us to better 
understand how genes can be co-opted from one context, such as 
development, to be used in another, such as regeneration and 
repair (True and Carrol, 2002). 
 
3.2 TALE genes 
Hox proteins monomers bind very similar DNA sequences in 
vitro, and even when a slight preference in such binding is 
observed, the resulting sequence recognition variations are not 
sufficient to provide the necessary patterns of expression when 
tested in vivo (Ekker et al., 1994). To reconcile these apparently 
contradictory observations, it was hypothesized that other 
proteins, called modulators or cofactors, would assist Hox 
proteins in assembling specific activation or repression 
complexes on the regulatory elements of Hox target genes 
(Kornberg, 1993; Mann and Chan, 1996). About the cofactor 
theory, one of the best-studied examples is Drosophila 
Extradenticle (Exd). Indeed, Exd was found to form stable 
heterodimer complexes on DNA with a variety of Hox proteins 
(Fig. 27) (Chan and Mann, 1996). Moreover, Hox-Exd 
heterodimer binding sites have been found in the regulatory 
regions of some known Hox targets, and mutations in the target 
sequences that abolish Hox-Exd binding often result in a loss of 
reporter expression in vivo. 
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Figure 27: Tridimensional structure of Hox-Exd heterodimer complex on 
DNA. 	  
Exd encodes a divergent homeodomain protein related to a 
vertebrate protein, Pbx1, that was independently identified due to 
its mutation by t(1:19) chromosomal translocations leading to 
human preB cell acute lymphoblastic leukemia (Kamps et al., 
1990; Nourse et al., 1990; Rauskolb et al., 1993). Exd and Pbx 
comprise the PBC subclass of the TALE (Three Amino acid Loop 
Extension) homeodomain proteins, referring to the conserved 
PBC motif N-terminal to the TALE homeodomain (Burglin, 
1997, 1998) (Fig. 28). In vitro, Pbx/Exd cooperates with a broad 
subset of Hox proteins to bind a paired recognition element on 
DNA with high specificity (Chang et al., 1995). Based on a 
limited number of such recognition elements, early work 
suggested that the sequence specificity of a given Hox protein in 
the presence of Pbx/Exd was defined (Chang et al., 1997; Ryoo et 
al., 1999). However, recent evidence has indicated that the 
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sequence requirements for DNA binding by Hox complexes are 
difficult to predict (Ebner et al., 2005). 
The primary interaction between Pbx/Exd and Hox is via the 
three amino acid loop in the Pbx homeodomain, which binds a 
tryptophan-containing hexapeptide motif (N-Y/F-P/D-W-M-K/R) 
N-terminal to the homeodomain in all Hox proteins except those 
of paralog groups 11-13 (Chang et al., 1995; Neuteboom et al., 
1995; Passner et al., 1999; Phelan et al., 1995; Piper et al., 1999). 
However, recent structure-function analyses of the hexapeptide 
motif of Drosophila Hox proteins Ubx and AbdA in vitro and in 
vivo suggest that the physical interaction is more complex, since 
Exd binds Hox proteins through other residues in the absence of 
the Hox hexapeptide motif (Galant et al., 2002; Merabet et al., 
2003). Indeed, one of the earliest studies of Pbx-Hox interactions 
had implicated 15 amino acids downstream of the Pbx 
homeodomain in this interaction (Chang et al., 1995). 
The in vivo effects of cofactor binding on Hox function are still 
controversial. Depending on the target, Hox-Exd or Hox-Pbx 
complexes can act as transcriptional activators or as 
transcriptional repressors. This has suggested that the ‘‘sign’’ of 
the transcriptional effect is determined not by the presence or 
absence of cofactors, but by the recruitment of other factors into 
the complex depending on the specific regulatory sequence 
involved and/or on the extracellular signals (Gebelein et al., 
2004; Kobayashi et al., 2003; Saleh et al., 2000). However, others 
have found that normally repressed targets become activated 
when the Hox hexapeptide is mutated (Galant et al., 2002; 
Merabet et al., 2003), suggesting that in some contexts cofactor 
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binding may determine the way in which Hox proteins regulate 
their targets (Peifer and Wieschaus, 1990; Pinsonneault et al., 
1997). 
Although cofactor binding clearly affects Hox DNA-binding 
specificity, the effect on DNA-binding affinity differs for 
different Hox proteins. For some Hox proteins, interaction with 
Pbx confers vastly increased DNA-binding affinity, whereas for 
others the interaction appears to have minimal effect (LaRonde-
LeBlanc and Wolberger, 2003). 
Another class of TALE homeodomain proteins, the MEIS class, 
regulates Hox activity both as components of the DNA-bound 
Hox complex and by regulating Pbx/ Exd activity in the absence 
of DNA (Berthelsen et al., 1998; Chang et al., 1997; Knoepfler et 
al., 1997; Moskow et al., 1995). The MEIS class includes 
Homothorax (Hth) in flies and the Meis and Prep proteins in 
vertebrates (Fig. 28). Meis/Prep proteins interact directly with 
Pbx/Exd and participate in the DNA-bound Hox complex, 
recognizing a split sequence on the regulatory regions of target 
genes (Ebner et al., 2005; Ferretti et al., 2000; Jacobs et al., 1999; 
Mann and Affolter, 1998; Ryoo et al., 1999). Meis/Prep proteins 
also promote the nuclear localization (Abu-Shaar et al., 1999; 
Berthelsen et al., 1999; Jaw et al., 2000; Mercader et al., 1999; 
Rieckhof et al., 1997) and stability (Jaw et al., 2000; Longobardi 
and Blasi, 2003; Waskiewicz et al., 2001) of Pbx proteins. 
Finally, Meis/Prep proteins have been observed to interact 
directly with a subset of Hox proteins in a manner that is 
independent of the Hox hexapeptide; however, the functional 
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outcomes of these interactions have not been determined (Shen et 
al., 1997; Williams et al., 2005). 
 
Figure 28: Structure of TALE homeodomain proteins. Prototype members 
of PBC and MEIS classes are shown here. ‘‘a’’ and ‘‘b’’ refer to splice 
isoforms of Pbx and Meis proteins. All TALE homeodomain proteins contain a 
divergent homeodomain (HD) containing a 3 amino acid loop extension 
(TALE) between the first and second a-helices. The TALE motif virtually 
always bears a proline (P)-tyrosine (Y)-proline (P) in positions 24-26 (Burglin, 
1997, 1998) and contacts the hexapeptide motif of Hox proteins (Piper et al., 
1999). Pbx proteins contain an additional DNA-contacting a-helix (a4; HCM) 
C-terminal to the canonical homeodomain (Piper et al., 1999). The PBC-A and 
PBC-B domains are conserved among Pbx, Exd and Ceh-20, and the PBC-A 
domain interacts with Meis/Prep proteins (Ryoo et al., 1999). Conversely, the 
HM1 and HM2 domains (Burglin, 1997; Mann and Affolter, 1998) are 
conserved among Meis/Prep proteins and are required for interactions with 
Pbx proteins (Ryoo et al., 1999). Posterior Hox genes of the AbdB subclass are 
unusual in that they can interact directly with Meis proteins via a C-terminal 
region (CTD) of Meis including the homeodomain; this region is indicated by 
a black bar (Williams et al., 2005). 	  
Vertebrate genomes contain multiple Pbx family members. Pbx2 
and Pbx3 were discovered based on their homology to Pbx1 
(Monica et al., 1991). Pbx4 was identified in a forward genetic 
screen in the zebrafish as a mutant in which Hox-dependent 
patterning events were disrupted (Popperl et al., 2000; 
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Waskiewicz et al., 2002). A subsequently identified mammalian 
Pbx4 gene expressed exclusively in the testis (Wagner et al., 
2001) is not orthologous to zebrafish pbx4. Work in the zebrafish 
suggests that the functional differences between pbx genes are 
likely due to differences in their expression rather than in their 
biochemical activities (Popperl et al., 2000). Ectopic expression 
of any of the zebrafish pbx genes can completely rescue the 
embryonic phenotype of pbx4 mutants. Indeed, Drosophila Exd 
can effect the same rescue, underlining the high degree of 
functional conservation across this protein family. Consistent 
with this observation, the in vitro DNA-binding properties of 
different Pbx proteins appear very similar: Pbx1, Pbx2 and Pbx3 
exhibit identical DNA cooperative binding with a subset of Hox 
proteins in vitro (Chang et al., 1995). This predicts that, where 
the expression of Pbx family members overlaps, their functions 
may be partially redundant. Different Pbx proteins are expressed 
in temporally and spatially distinct patterns during organogenesis 
and in adult mice, and, in these contexts, single mutant 
phenotypes have been informative. However, overlapping 
expression of more than one Pbx gene in numerous developing 
tissues and organs has been observed (Kim et al., 2002; Rhee et 
al., 2004; Schnabel et al., 2001; Selleri et al., 2001, 2004; Wagner 
et al., 2001; Waskiewicz et al., 2002), and double mutant analysis 
is now required to understand Pbx function in these contexts. 
Several lines of evidence demonstrate that Pbx proteins function 
as Hox cofactors in vertebrates as they do in Drosophila. The first 
evidence that Pbx proteins function as Hox cofactors in vertebrate 
development came with the identification of paired Hox/Pbx 
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regulatory elements in the promoters of mammalian Hox genes 
themselves. Hox gene expression, particularly in the vertebrate 
hindbrain, is highly auto- and cross-regulated (reviewed in 
Nonchev et al., 1997). For example, among the Hox paralog 
group 1 genes, Hoxa1 is required for the normal onset of Hoxb1 
expression, while Hoxb1 is required for its own maintenance 
(Popperl et al., 1995; Studer et al., 1998). In these and other 
examples of Hox-dependent gene regulation in vertebrates, the 
Hox recognition element consists of a paired Hox/Pbx binding 
site (often with a nearby Meis/Prep site), and mutating either the 
Hox- or the Pbx-binding element prevents reporter expression in 
transgenic mice (Ferretti et al., 2000; Maconochie et al., 1997; 
Manzanares et al., 2001; Popperl et al., 1995; Samad et al., 2004). 
In Drosophila, examples of Exd-independent repression by 
multiple monomeric Hox binding sites have been described 
(Galant et al., 2002; Hersh and Carroll, 2005; Pederson et al., 
2000). However, no such example has been identified to date in 
vertebrates.  
Targeted mutations in mouse Pbx1, Pbx2 and Pbx3 genes 
suggested that redundancy between the mouse genes may exist at 
early stages of development. The single mouse mutants thus 
allow a comparison to later Hox-dependent functions, and aspects 
of the mouse Pbx1 and Pbx3 mutants recapitulate later Hox loss-
of-function phenotypes. Pbx1 homozygous mutant (Pbx1-/-) 
embryos develop normally until 11.5 dpc, after which they 
exhibit pleiotropic phenotypes. Interestingly, most of the defects 
found in Pbx1-deficient embryos affect organ systems (skeleton, 
hematopoietic, thymus, thyroid, heart, intestines, pancreas, 
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spleen, kidneys, gonads) where specific Hox proteins have been 
shown to control the respective developmental programs. The 
observed skeletal malformations spatially overlap with domains 
whose patterning is determined by hexapeptide-containing Hox 
proteins and positionally and morphologically mimic those of 
specific Hox mutants, although they do not precisely recapitulate 
those seen in individual Hox gene knockout mice. For example, 
Pbx1-/- mice exhibit a partial transformation of second pharyngeal 
arch cartilages to structures resembling first arch cartilages 
(Selleri et al., 2001), a phenotype resembling that observed in 
Hoxa2 mutants (Gendron-Maguire et al., 1993; Rijli et al., 1993). 
Phenotypic overlaps with Hox loss-of-function mutants are also 
observed in caudal pharyngeal pouch-derived organs of Pbx1-/- 
embryos, such as thymus, parathyroids and ultimo-branchial 
bodies. For example, the thymus in Pbx1-/- embryos is mostly 
ectopic, the lobes do not fuse and do not descend into the 
mediastinum (Manley et al., 2004). A similar thymic phenotype is 
observed in mice that are compound mutants for three paralogous 
3 Hox genes (Hoxa3+/-, b3-/- and d3-/-) (Manley and Capecchi, 
1998) consistent with a scenario where Pbx1 acts together with 
multiple Hox proteins and in multiple cell types to regulate 
pharyngeal development. 
A role for Pbx1 in patterning the vertebrate limbs was suggested 
by its restricted expression within the proximal domains of the 
limb bud, as its homolog Exd (Mercader et al., 1999). Indeed, 
skeletal structures of the proximal limbs and limb girdles, which 
normally express nuclear Pbx1 in early development, are 
strikingly abnormal in Pbx1-/- embryos, while, in contrast, distal 
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limb elements and joints appear normal (Selleri et al., 2001). This 
parallels the situation in the fly, where nuclear-localized Exd is 
restricted to the proximal limb and is required for the 
specification of proximal and not distal limb identities (Mercader 
et al., 1999). However, despite the lack of limb phenotypes in 
Pbx2-/- mice (Selleri et al., 2004), analysis of Pbx1-/-;Pbx2+/- 
double mutants reveals overlapping functions for Pbx1 and Pbx2 
in determining distal limb development as well (Moens and 
Selleri, 2006). These results suggest that mechanisms of 
proximal-distal limb patterning are poorly conserved from flies to 
vertebrates. Indeed, vertebrate limb patterning involves Hox 
genes, while the proximal-distal axis of the fly leg is established 
in a Hox- independent manner (Mann and Morata, 2000). 
Pbx1-/- embryos exhibit profound anemia which is primarily cell 
autonomous and results in a 5-fold decrease in common myeloid 
progenitor (CMP) cells in the fetal liver of mutant embryos 
(DiMartino et al., 2001). Targeted disruption of Hox genes also 
causes hematopoietic defects (reviewed in Owens and Hawley, 
2002), suggesting that Hox and Pbx may cooperate in the 
myeloid lineages. 
The absence of early patterning defects in mouse Pbx mutants 
suggests either that some Hox functions do not require 
interactions with Pbx proteins or that, like in the zebrafish, 
different Pbx genes are partially redundant for early Hox 
functions. Like in the zebrafish, Pbx2-/- mice are viable and do not 
display phenotypic abnormalities (Selleri et al., 2004). However, 
recent results demonstrate that Pbx1;Pbx2 mutant embryos die 
earlier in utero than Pbx1-/- embryos and display drastic 
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exacerbation of the skeletal phenotype and appearance of novel 
skeletal abnormalities, including distal limb defects, not observed 
in Pbx1-/- embryos (Moens and Selleri, 2006). These results 
unequivocally point to overlapping functions of Pbx family 
members, at least in select organ systems and in tissues with 
overlapping expression patterns. Situations in which mutations in 
two genes synergize to cause a much more severe phenotype than 
either mutation alone are often taken as evidence of an important 
interaction between these two genes in controlling that process. In 
the mouse, Pbx1 and Hoxa2 genetically interact to pattern 
Branchial Arch 2-derived craniofacial structures. These genetic 
interactions strongly support the model in which Hox proteins 
function together with Pbx proteins to control developmental 
processes (Moens and Selleri, 2006). 
The Meis/Prep proteins are also required for the normal function 
of the Hox-Pbx complex. Hox/Pbx binding sites upstream of Hox 
target genes are often associated with essential Meis/Prep sites, 
and Meis/Prep proteins bind these targets cooperatively with Hox 
and Pbx in vitro (Berthelsen et al., 1998; Chang et al., 1997; 
Ebner et al., 2005). In Drosophila, where the function of the Meis 
protein Homothorax (Hth) has been well studied, Hth is essential 
for Exd function (reviewed in Mann and Affolter, 1998; Ryoo et 
al., 1999). The in vivo analysis of vertebrate Meis/Prep function 
has lagged behind the analysis of Pbx function. In the mouse, 
Meis1 and Prep1 mutants are embryonic lethal and exhibit a 
variety of abnormalities including hematopoietic and angiogenic 
defects and severe organ hypoplasia (Azcoitia et al., 2005; Hisa et 
al., 2004). The similarity of zebrafish pbx and meis/prep 
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phenotypes is consistent with a model, based on biochemical 
data, in which a tripartite Hox-Pbx-Meis/Prep complex is 
required for Hox-dependent gene regulation. However, Meis/Prep 
and Pbx are also known to interact in the absence of DNA. Thus, 
the observed effects of Meis/Prep manipulations on Hox function 
could be due to indirect effects on Pbx availability. 
An emerging view was that the function of TALE proteins is not 
restricted to Hox cofactors; they also act upstream from Hox 
genes, and as partners of non-Hox proteins, both with and without 
a homeodomain. In addition, it should be stressed that 
homeodomain proteins might not only be transcription factors, 
but could also be regulators of translation. For instance, Pbx1-
mutant mice have craniofacial malformations that affect 
maxillary and frontonasal mass derivatives, in which the 39 
murine Hox genes are not expressed. Selleri reported that the 
limbs of the same embryos also show pronounced phenotypes 
with decreasing Pbx dosage on the Pbx1-mutant background. The 
similarity of the skeletal phenotype in the distal regions of the 
limb (zeugopod and autopod) to those recently reported in mice 
lacking the HoxA and HoxD complexes (Kmita et al, 2005) could 
indicate the requirement for Pbx proteins as Hox partners in limb 
development. However, analysis of the Pbx-mutant limb buds 
revealed that all Hox genes were downregulated, suggesting that 
they are involved in the Pbx-mutant phenotype as downstream 
targets rather than as essential cofactors. This was also apparent 
for some members of the Meis/Prep superfamily. For instance, 
inactivation of Prep1.1 in zebrafish produced a phenotype that 
affected, among other structures, the formation of cartilages from 
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the facial and branchial region, apparently as a consequence of 
increased apoptosis. These cartilages were in both Hox-positive 
and Hox-negative areas of the embryo, suggesting a common 
Hox-independent mechanism. A similar finding was reported for 
haematopoiesis; inactivation of Meis1 in the mouse results in a 
severe impairment of the stem and progenitor cell compartments, 
and the absence of the megakaryocytic lineage, which leads to 
embryonic lethality. Importantly, Meis1 is strongly expressed in 
the aortic-gonad-mesonephros region, where haematopoietic stem 
cells are generated, but Hox transcription is undetectable in this 
area (Mallo and Magli, 2006). 
TALE proteins could also act as partners of other non-Hox 
homeodomain proteins. For instance, it has been reported that 
Emx2 and Pbx1 interact genetically in the patterning of the most 
proximal part of the mouse forelimb, which is an area that 
apparently does not depend on Hox gene activity (Kmita et al, 
2005). Moreover, TALE proteins can interact with non-
homeodomain proteins. It has been shown that the p160Myb-
binding protein can compete with Pbx1 for binding to Prep1 to 
regulate murine haematopoiesis (Diaz et al., 2007). Finally, an 
even more divergent mechanism for Pbx functional activity was 
proposed by Tapscott and collaborators, in the muscle lineage. 
Pbx proteins, together with Meis1, could ‘instruct’ MyoD by 
labelling specific promoter target sites in the genome for MyoD-
dependent activation (Maves et al., 2007). This interaction seems 
to be essential for transcriptional activation, as it has been 
reported that knocking down Pbx activity in zebrafish embryos 
resulted in downregulation of myogenin without any apparent 
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effects on MyoD expression. Therefore, Pbx proteins can act as 
cofactors of other non-homeodomain-containing developmental 
regulators (Mallo and Magli, 2006). 
 
3.3 Otx genes 
A large family of homeobox genes encodes transcription factors 
containing homeodomains of the paired class which preferentially 
bind as cooperative dimers to palindromic DNA sequences 
(Wilson et al., 1993). Thus, this type of homeodomain is capable 
by itself to recognize longer and more specific DNA sequences, 
without the assistance of other domains. The major class includes 
Pax proteins that have a second conserved DNA-binding motif, 
the paired-domain, originally discovered in certain segmentation 
genes (Bopp et al., 1986), as well as other members, like Otx 
genes, which do not possess any other DNA-binding domain 
(Treisman et al., 1991). 
Otx genes (Otx1, Otx2, Otx3 and Crx) encode for DNA binding 
proteins belonging to the paired-class family of transcription 
factors, characterized by an extremely conserved homeodomain, 
which has a lysine at position 9 of the third (recognition) helix. A 
lysine in this position is relatively unusual and confers Otx 
proteins a capacity for high affinity and selective binding to 
TAATCC/T sites on DNA (Treisman et al., 1989). 
Otx1 starts to be expressed at early stages (2-5 somite stage, 8.2-
8.5 dpc) in the developing mouse embryo throughout the 
presumptive forebrain and midbrain neuroepithelium. In 
particular, during cerebral cortex development, post mitotic 
neurons migrate along radial glial cells, through the overlying 
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intermediate zone (IZ), and to the cortical plate (CP), which will 
later create the typical layered organization of the adult cortex. 
The layers are generated in an inside-out pattern, in which cells of 
the deepest layers (6 and 5) are born first in the ventricular zone 
(VZ) and those of the upper layers (4, 3 and 2) progressively 
later. At mid-late gastrulation, high level transcription of Otx1 
occurs only in ventricular cells, which at these stages are 
precursors of deep layer neurons. By the time upper layer neurons 
are generated, Otx1 expression decrease in the VZ and becomes 
progressively prominent in the cortical plate which consists of 
postmigratory neurons of layer 5 and 6. Otx1 is absent in later 
differentiated neurons of upper layers 1-4. Its expression in layer 
5 is more prominent in the posterior and lateral cortex but absent 
in the frontal, insular and orbital cortices, while in layer 6 it is 
more uniform throughout the neocortex. Moreover, Otx1 is also 
expressed at early stages in precursor structures of sense organs 
corresponding to the olfactory placode, otic and optic vescicles. 
Later, it is transcribed in the olfactory epithelium, the saccule, the 
cochlea and the lateral semicircular canal of the inner ear as well 
as in the iris, the ciliary process in the eye and the lachrymal 
gland primordial (Simeone et al., 1993). From birth onwards, 
Otx1 is also expressed at a relatively low levels in the anterior 
lobe of the pituitary gland (Acampora et al., 1998).  
Mouse mutant models have been generated and analysed 
(Acampora et al., 1996, 1998a, 1999a,b) to gain insight into the 
different roles that Otx1 plays during brain, cortex and sense 
organ development. Heterozygous (Otx1+/-) mice are healthy and 
their intercross generates homozygous mice (Otx1-/-) in the 
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expected Mendelian ratio. However, about 30% of the mutants 
die before the first postnatal month. 
Otx1-/- adult brains are reduced in weight and size and, at the 
anatomo-histological inspection, show reduction in thickness of 
the dorsal telencephalic cortex, a dorsally displaced sulcus 
rhinalis and shrunken hippocampus with a divaricated dentate 
gyrus. The cortex is particularly affected at the level of the 
temporal and perirhinal areas, where 40% reduction in cell 
number is detected. Furthermore, in these same areas, cortical 
layer organisation is less evident (Acampora et al., 1996), 
although the expression of layer-specific molecular markers 
demonstrates that the laminar identities are preserved (Weimann 
et al., 1999). 
The origin of the overall reduction of the Otx1-/- brains as been 
investigated through experiments aimed at determining possible 
changes of the normal number of apoptotic or proliferating cells 
within the neuroepithelium of the developing telencephalon. No 
differences at apoptosis were observed by comparing wild-type 
and Otx1 mutant embryos. By contrast, Bromodeoxyuridine 
(BrdU) labelling experiments revealed a reduction of 
proliferating cells (by about 25%) in the dorsal telencephalic 
neuroepithelium of 9.75 dpc Otx1-/- embryos (Acampora et al., 
1998a). A defective proliferation of neuronal progenitors at these 
early stages may thus be responsible of the adult phenotype of the 
Otx1 mutant mice.  
Otx1-/- mice exhibit both spontaneous high speed turning 
behaviour and epileptic behaviour (Acampora et al., 1996). The 
latter consists of the combination of focal seizures characterized 
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by automatism (head bobbing and teeth chattering) and 
electroencephalographic (EGG) recording of spikes in 
hippocampus. Moreover, generalized seizures characterized by 
convulsions and high voltage synchronized EGG activity in 
hippocampus and cortex. 
Otx1 is postnatally transcribed and translated in the pituitary 
gland. Cell culture experiments indicate that Otx1 may activate 
transcription of the growth hormone (GH), follicle-stimulating 
hormone (b-GSU) genes, luteinizing hormone (b-LH), and a 
glycoprotein subunit (a-GSU) genes. Analysis of Otx1-null mice 
indicates that, at the prepubescent stage, they exhibit transient 
dwarfism and hypogonadism due to low levels of pituitiry GH, 
FSH and LH hormones which, in turn, dramatically affect 
downstream molecular and organs targets. Nevertheless, Otx1-/- 
mice gradually recover from most of these abnormalities: after 
the prepubescent stage, at 4 months of age, Otx1 mutant mice 
show normal levels of GH, FSH and LH which are paralleled by 
a restored normal body weight, differentiation and size of both 
testis and ovary, as confirmed also by their sexual fertility, and by 
normal levels of downstream molecular targets such as 
testosterone and insulin growth factor 1 (IGF1). 
Otx1-/- mutants show inner ear and eye abnormalities that are 
consistent with Otx1 expression pattern (Acampora et al., 1996). 
Lack of Otx1 results in the absence of the lateral semicircular 
canal and lateral ampulla, in abnormal utriculosaccular and 
cochleosaccular ducts and in the poorly hook (the proximal part) 
of the cochlea (Acampora et al., 1996; Morsli et al., 1999). In 
these mutants the ciliary process is absent, the iris is thinner and 
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the lachrymal and Harderian glands do not develop, failing the 
differentiation to a glandular cell-type (Acampora et al., 1996). 
In the mouse, another cognate for otd has been identified by 
virtue of the high conservation of its homeobox sequence, Otx2 
(Simeone et al., 1992). Gene targeting studies have revealed its 
pivotal role in early head patterning, since null mutant mice lack 
a large portion of the anterior head region (Acampora et al., 1995; 
Matsuo et al., 1995). In fact, mice lacking Otx2 die early in 
embryogenesis, as they lack the rostral neuroectoderm fated to 
become forebrain, midbrain and hindbrain. 
During brain regionalization, Otx1 and Otx2 are transcribed in 
largely overlapping expression domains with a posterior border 
coincident with the mesencephalic and lateral cortex, but absent 
in the frontal, insular side of the isthmic constriction (Simeone et 
al., 1992, 1993; Acampora et al., 1997). This evidence suggests 
that Otx genes might contribute to the specification of regional 
diversity between adjacent territories, as well as to the positioning 
and/or establishing of morphogenetic boundaries. In order to 
verify these hypothesis, the level of Otx proteins was modified by 
altering the Otx gene dosage in vivo (Acampora et al., 1997; Suda 
et al., 1997). Only Otx1-/-;Otx2+/- embryos showed 100% 
penetrance of gross brain malformations that included a 
remarkable reduction of the Ammon’s horn, as well as 
morphological and molecular transformation of the pretectum, 
dorsal thalamus and mesencephalon into an enlarged 
metencephalon. However, the presence of an additional 
functional copy either Otx2 (Otx1-/-;Otx2+/+) or Otx1 (Otx+/-
;Otx2+/-) completely recovers the abnormal phenotype, thus 
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indicating that a critical threshold of Otx gene product is required 
for correct brain morphogenesis and that Otx1 and Otx2 may 
cooperate in specifying correct brain patterning through a gene 
dosage mechanism (Acampora et al., 1997). 
Even though mammalian Otx1 and Otx2 proteins share extensive 
similarities in their sequences, down-stream of the Otx1 
homeodomain, the regions of homology to Otx2 are separated by 
stretches of additional amino acids (Simeone et al., 1993). To 
determine whether these differences code for Otx1- and Otx2-
specific biochemical properties, Otx1 gene was replaced by a 
human OTX2 full-coding cDNA (hOTX21/hOTX21) or the Otx2 
gene was replaced by a human OTX1 full-coding cDNA 
(hOTX12/hOTX12) (Acampora et al., 1998b). In homozygous 
mice in which Otx1 was replaced with the human OTX2 cDNA, 
cortex development appears normal, epilepsy was absent and a 
normal cell proliferation in the normal neuroephitelium was 
restored (Acampora et al., 1999a). This finding suggests that the 
differential transcriptional control of Otx1 and Otx2, rather than 
their amino acid divergence, is responsible for the contrasting 
phenotypes of Otx1-/- and Otx2-/- mutants. hOTX21/hOTX21 mice 
also showed a significant improvement in mesencephalon, eye 
and lachrymal gland defects. In contrast, the lateral semicircular 
canal of the inner ear was never restored, suggesting that the 
ability to specify this structure may be an Otx1-specific property 
(Acampora and Simeone, 1999a). 
The homology between Otd and Otx gene products is quite 
restricted. Indeed, sequence homology is confined to the 
homeodomain and a few flanking amino acids (Simeone et al., 
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1993). Thus although the ability to recognize the same target 
sequence might be evolutionarily conserved, murine Otx genes 
might have also acquired additional functional features, outside 
the homeodomain, that are different from those encoded by the 
Drosophila otd gene. This suggests that some conserved features 
of the invertebrate Otd gene product might now coexist in Otx 
genes, together with additional new functions required for 
specific mammalian developmental processes. In fact, in mice 
generated replacing Otx1 with full-coding Drosophila otd, the 
abnormalities of Otx1-/- mutants were fully rescued by otd 
(Acampora et al., 1998a). In contrast, the lateral semicircular 
canal of the inner ear of Otx1-/- mice was never restored.  
In a complementary experiment performed in Drosophila, 
overexpression of human OTX1 and OTX2 genes rescued the 
brain and ventral nerve cord phenotypes of otd mutants 
(Leuzinger et al., 1998). 
These cross-phylum rescues are surprising not only because of 
the different anatomy and complexity of insect and mammalian 
brains, but also because of the very limited region of homology 
shared by the proteins and restricted essentially to the 
homeodomain. The molecular nature of this extended Otd/Otx 
equivalence is still unclear, however, and remains to be 
investigated in detail. In particular, these results raise the question 
as to whether functional equivalence is only an operative 
definition, employed to justify the recovery of phenotypic 
impairments observed in the absence of the replaced gene, or it 
means that downstream targets or morphogenetic pathways 
controlled by otd/Otx genes are the same or they are different but 
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functionally equivalent (Simeone et al., 2002). Experimental data 
support the notion that otd/Otx functions have been established in 
a common ancestor of fly and mouse and retained throughout 
evolution, whereas the regulatory control of their expression has 
been modified and re-adapted by evolutionary events that might 
have contributed to the specification of the increasingly complex 
vertebrate brain (Sharman et al., 1998; Acampora et al., 2001). 
Morphogenetic event might have coincided with duplication, 
recruitment and stabilization of conserved genetic functions into 
new cell types that, in turn, have either modified or created new 
versions of pre-existing developmental pathways (Acampora et 
al., 2001; Holand, 1999). Indeed, it might be that conserved 
functions such as those encoded by Otd/Otx proteins became able 
to perform new roles even while retaining an evolutionary 
functional equivalence because they have acquired the ability to 
be expressed in new cell types. Then, it is expected that drastic 
evolutionary events have acted on the regulatory control 
(transcription and translation) of Otx-related genes rather than on 
their coding sequences (Simeone et al., 2002). 
Otx1, besides being a crucial regulator of brain and sense organs 
morphogenesis, is also involved in the control of blood cell 
production (Levantini et al., 2003). Otx1 is differentially 
expressed in hematopoietic organs: it is present in the bone 
marrow and spleen of adult mice as well as in fetal liver, whereas 
it is not detected in the thymus (Levantini et al., 2003). Otx1 is 
expressed in pluripotent hematopoietic precursors and its 
expression persists in the bipotential progenitors of the erythroid-
megakaryocytic and granulocytic-macrophage lineages. 
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Furthermore, Otx1 signal is present in erythroid precursors and 
can still be detected in mature cells of the erythroid and 
megakaryocytic pathway (Levantini et al., 2003). These results 
indicate that Otx1 may act at the commitment of pluripotent 
progenitors to a particular differentiation pathway and at various 
stages of erythropoiesis, suggesting that Otx1 may play a role in 
cell-lineage determination and be required for normal production 
of erythroid cells. 
Analysis of peripheral blood cells of wild type and Otx1-/- mice 
by clonogenic assays and cell-counts showed a decreased number 
of red blood cells in null mutants. Moreover, these animals 
exhibited a marked reduction of early (BFU-E) and late (CFU-E) 
erythroid progenitors. In contrast, it has not been observed 
significant variations in the number of circulating leukocytes and 
myelo-monocytic precursors. This decreased erythropoiesis is not 
caused by impaired microenvironment, but it is a cell autonomous 
defect. In fact, lethally irradiated animals reconstituted with Otx1-
deficient cells exhibited a dramatic drop in the number of red 
blood cells and erythroid precursors (BFU-E and CFU-E), as 
compared to mice injected with wild type bone marrow cells 
(Levantini et al., 2003), thus reproducing the hematopoietic 
phenotype of null mice. 
In agreement with these results, molecular analysis of Otx1-/- 
bone marrow cells revealed decreased levels of master erythroid 
genes that include the Scl and Gata-1 transcription factors. 
Accordingly, a gain of function of Scl rescues the erythroid 
deficiency in Otx1-/- mice. Combined, the results are consistent 
with the view that Scl and Otx1 may operate within the same 
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pathway to specify erythroid differentiation. In particular, Otx1 
might be required to maintain normal levels of Scl gene 
expression and, consequently, normal numbers of erythroid cells. 
In conclusion, Otx1, which plays a crucial role in brain 
morphogenesis, is also involved in the control of blood cell 
production, and it supports the view that common molecular 
mechanisms orchestrate differentiation of various tissues 
(Levantini et al., 2003). 
Recently, it has been reported that, in humans, the OTX2 gene is 
amplified in a relevant percentage (20%) of primary anaplastic 
medulloblastomas and expressed at high levels in most of them, 
suggesting that it may represent a medulloblastoma oncogene 
(Boon et al., 2005) Similarly, OTX1 is overexpressed in 
medulloblastomas of the nodular/desmoplastic subtype (de Haas 
et al., 2006). OTX1 and OTX2 expression was not detected in 
other brain tumors including astrocytomas, glioblastomas, 
oligodendrogliomas, meningiomas, ependymomas, or in several 
tumors of non-neural origin affecting breast, thyroid, prostate, 
liver, lung, stomach, pancreas, kidney, and colon. However, it has 
been showed that OTX1 expression was activated in 94% of 
diffuse large B-cell lymphomas, in all Burkitt lymphomas, and in 
90% of high-grade follicular lymphomas. In contrast, OTX1 was 
undetectable in precursor-B lymphoblastic lymphoma, chronic 
lymphocytic leukemia, and in most marginal zone and mantle cell 
lymphomas and multiple myeloma. OTX2 was undetectable in all 
analyzed malignancies. Analysis of OTX1 expression in normal 
lymphoid tissues identified a subset of resting germinal center 
(GC) B cells. This study identifies OTX1 as a molecular marker 
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for high-grade GC-derived Non-Hodgkin Lymphoma and 
suggests an involvement of this transcription factor in B-cell 
lymphomagenesis. Furthermore, OTX1 expression in a subset of 
normal GC B cells carrying plasma cell markers suggests its 
possible contribution to terminal B-cell differentiation (Omodei 
et al., 2009). 
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4. THE STEM CELL GENE KIT 
The Kit proto-oncogene encodes for a transmembrane tyrosine-
kinase receptor for Stem Cell Factor (SCF), and belongs to the 
same family of the Colony Stimulator Factor-1 receptor (CSF-1-
R) and Platelet Derived Growth Factor receptor (PDGFα and β) 
(Yasuda et al., 1993). 
v-kit, an oncogene identified in the HZ4-FeSV retrovirus (Hardy-
Zucherman 4 feline sarcoma virus), is the viral homolog of Kit 
(Besmer et al., 1986); this oncogene presents a deletion of the 
extracellular domain, of transmembrane segment and of 50 
aminoacids of the C-term. The result of this mutation is the 
continuous stimulation of proliferation, independently on SCF 
binding. 
In the mouse, Kit is located into the White (W) locus (Besmer et 
al., 1986; Chabot et al., 1988; Geissler et al., 1988) on 
chromosome 5, and the locus was denominated from the white 
spots characteristics of mice having Kit mutations that abolish its 
expression in melanocytes. The mouse Kit gene spans over a 80 
Kb region and consist of 21 exons, with a coding sequence of 3 
Kb (Gokkel et al., 1992). Exons have dimensions ranging from 
100 and 200 bp, with exclusion of the 21st that is 2.3 Kb; introns 
are more variable, from 100 bp to 15 Kb. The exon-intron 
boundaries show the classic consensus sequences for splicing 
donors and acceptor sites (GT….AG); only one alternative 
splicing donor site has been identified at the exon 9 level, where a 
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distal splicing donor site exist, that determines the maturation of a 
12 bp longer mRNA (Hayashi et al., 1991). 
The nucleotide sequence of human and mouse Kit promoter does 
not contain CAAT or TATA box: in both cases a transcription-
initiating site is present at -58 bp from the translating site is 
situated at -12 bp from translating-initiating codon, while in man 
it is situated at -62 bp. 
Regulatory sequences in cis have been identified in the promoter 
between +1 and -44 positions, between -44 and -81, between -81 
and -105. In correspondence to these regions, consensus 
sequences for transcription factors (Sp-1, Ap-2) and GA-rich 
elements have been evidenced (Yasuda et al., 1993). Similarly to 
the murine homolog, in the human KIT promoter regulatory 
sequences have been localized into the +1 and -200 region, 
containing GA-rich elements, 4 SP-1 binding sites and potential 
sites for AP-2 (Yamamoto et al., 1993). 
The Kit product is a 145 KDa transmembrane glycoprotein 
organized in: a signal sequence (1-22 aminoacids), that drives the 
localization of the protein in the endoplasmic reticulum; an 
extracellular domain (exons 1-9), with 9 potential N-glycosilation 
sites and 12 cysteines randomly spaced, that give rise to 5 loop 
immunoglobulin-like (Ig-like); a transmembrane hydrophobic 
region (exon 10); an intracellular kinase domain (exons 11-20). 
The last exon codes for a C-term whose function is still 
controversial (Gokkel et al., 1992) (Fig. 29). 
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Figure 29: Protein structure of Kit receptor. 	  
Studies of mouse phenotypic alterations similar to the ones 
caused by Kit mutations have allowed the identification of the 
Steel locus, on chromosome 10 (Zsebo et al., 1990), where the 
gene encoding for the Kit ligand, SCF, is located (Flanagan and 
Leder, 1990; Nocka et al., 1990; Huang et al., 1990). SCF is 
encoded as a secreted signal into the extracellular matrix, or can 
be retained as transmembrane signal involved in migration and 
cell adhesion (Flanagan et al., 1991): this transmembrane SCF is 
composed of a signal peptide, an extracellular domain (189 
aminoacids), a transmembrane segment (23 aminoacids) and a 
cytoplasmic domain (36 aminoacids) (Anderson et al., 1990); the 
soluble form of SCF is probably derived from the proteolytic cut 
of the transmembrane isoform and corresponds to its first 165 
aminoacids (Nocka et al., 1990; Williams et al., 1990). 
	  128	  	  
Introduction 
Upon SCF binding, two Kit protein dimerize and 
autophosphorylate the cytoplasmic domain: this recruits and 
phosphorylates other cytoplasmic mediators in a cascade leading 
to activation of specific transcription factors, resulting in a 
modulation of the expression of target genes (Ullrich and 
Schlessinger, 1990). 
During mouse development, Kit is expressed at low level in the 
pluripotent cells of the ICM and at higher level in Primordial 
Germ Cells (PGCs) and hematopoietic progenitors. In the adult 
Kit is expressed in a variety of cells, and the first to be identified 
were HSCs, hematopoietic progenitors, mastocytes, oocytes and 
melanoblasts (Broudy, 1997). Using monoclonal antibody 
directed against the extracellular domain of Kit, it has been 
possible to evaluate that 8% of total bone marrow cells express 
Kit on their surface. Kit is mainly expressed in undifferentiated 
cells, while its expression decreased during differentiation. Kit is 
necessary for the development of myeloid lineages, while it is not 
essential for B cell. In W homozygous mice hematopoiesis is not 
sustained after birth, indicating that Kit/SCF pathway is 
fundamental for adult hematopoiesis, particularly in the 
maintenance of hematopoietic precursors at different stages of 
differentiation (Ogawa et al., 1991).  
Kit is expressed also in non-hematopoietic tissues, showing a 
comparably fundamental role. In PGCs, for example, the 
disruption of the Kit/SCF pathway has no impact before day 
E9.5. However, after that stage of development, migration and 
survival of PGCs are strongly compromised (Bernex et al., 1996). 
In addition, Kit has great importance in the regulation of normal 
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pigmentation in the mouse as well as in man. KIT alterations in 
man produce piebaldism, an autosomal dominant disease that has 
strong homology with W/Wv mouse, the white spotting mutation: 
the affected individuals show hypopigmentation of skin areas and 
white spots in the hair. This is due to disruption in survival and 
migration of melanoblasts, the melanocytes precursors 
(Fleischman et al., 1991). 
Kit seems to have a significant role also in the intestinal Cajal 
cells (ICCs) of the gut, a cell population deriving from neural 
crests that determines the pacemaker activity causing phase 
contractions in peristalsis. It has been observed that the direct 
injection of anti-Kit antibodies can influence the contraction 
patterns in vitro of newborn mice small intestine (Huizinga et al., 
1995). These observations can explain the megacolon and other 
gut abnormalities usually associated to piebaldism (Bolognia and 
Pawelek, 1988), thus demonstrating that a Kit disregulation can 
lead to abnormalities involving different cell systems. 
Recently, Kit expression has also been observed in vivo in the 
cardiac tissue and in vitro in putative Cardiac Stem Cells (CSCs), 
both in mouse and man (Wu et al., 2006; Messina et al., 2004; 
Smith et al., 2007). Kit expression seems to be closely related to 
an early cardiac stem cells phenotype, at least during 
development. Experiments conducted in the adult rat heart 
revealed the presence of a population of Lin- Kit+ cells that in 
vitro and in vivo exhibit all the properties associated with CSCs. 
They are self-renewing, clonogenic and multipotent, giving rise 
to a minimum of three differentiated cell types: myocytes, smooth 
muscle and endothelial cells. Moreover, when injected into an 
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ischemic heart, a population of these cells or the clonal progeny 
of one of them can reconstitute a well-differentiated myocardial 
wall (Beltrami et al., 2003). These data point to Kit as a marker 
for CSCs, thus reinforcing the concept that stem cells of different 
tissues may have common phenotypic “signature”. 
 
4.1 Kit/GFP transgenic mouse lines 
The Kit/GFP transgenic mice have provided a suitable model to 
study the Kit expression. In these transgenic mice the sequence of 
the reporter gene coding for the enhanced Green Fluorescent 
Protein (GFP) is under the transcriptional control of Kit 
regulatory regions. Cairns and collaborators identified DNaseI 
hypersensitive sites in a region of 29 Kb of the Kit gene, 
including a 14 Kb of 5’ promoter region, exon 1 (124 bp) and 
intron 1 (14.8 Kb) (Fig. 30). Those 6 sites are situated in the 
promoter (HS1), close to exon 1 (HS2), and in intron 1 (HS3-
HS6). To better comprehend the functions of these regions of the 
Kit gene, three different constructs have been realized, using the 
GFP as reporter gene. The three vectors have different 
combinations of HS sites (Fig. 30): A has only HS1, B has 
HS1+HS2, C has HS1-HS6 (Cairns et al., 2003). 
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Figure 30: Expression vectors utilized to generate Kit/GFP transgenic 
lines. Construct A contains the Kit promoter and hypersensitive site HS1; B 
contains also site HS2; C contains all hypersensitive sites (HS1-HS6). 	  
The in vivo analysis of the transgenic embryos from the three (A, 
B, C) generated lines showed that GFP is always expressed in 
PGCs, independently on the vector type, while in hematopoietic 
sites it is only achieved when at least HS1 and HS2 are present. 
The addition of HS3-HS6 results in a most powerful expression. 
Thus, the addition of HS2 to the promoter is indispensable for Kit 
expression in immature hematopoietic progenitors; HS3-HS6 are 
not crucial for the expression itself, but their addition helps a 
correct identification of GFP expression in hematopoietic cells 
(Cairns et al., 2003). In fact, the transgene is efficiently expressed 
in fetal liver and adult bone marrow HSCs, and the level of 
transgene expression discriminates between HSCs (intermediate 
level GFP-expressors) and other progenitors, such as BFU-E and 
CFU-Mix (mostly high level GFP-expressors) (Cerisoli et al., 
2009). Moreover, the same transgene is expressed also in a 
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population of CSCs (Messina et al., 2004). Finally, taking 
advantage of the transgene expression both in HSCs and CSCs 
these transgenic mice have been used to study the trafficking 
between bone marrow and heart following infarction, in order to 
determine whether bone marrow cells can home into the damaged 
heart and contribute to the regeneration of a functional cardiac 
stem cells compartment. Kit/GFP bone marrow cells were 
transplanted into wild type irradiated recipients. Following 
hematological reconstitution and myocardial infarction, CSCs 
were cultured from cardiac explants to generate cardiospheres, a 
microtissue normally originating in vitro from CSCs. These were 
all green fluorescent and contained cells capable of initiating 
differentiation into cells expressing the cardiac marker Nkx2.5. 
These findings indicate that, at least in conditions of local cardiac 
damage, bone marrow cells can home into the heart and give rise 
to cells that share properties of resident Kit+ CSCs (Barile et al., 
2009). 
In conclusion, the expression of the transgene faithfully 
recapitulates the endogenous expression pattern of Kit. Moreover, 
the Kit/GFP transgenic model can be regarded as a powerful tool 
for the study of differentiation dynamics of normal and 
pathological tissues in which the Kit/SCF pathway exherts a 
fundamental regulative role. 
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5. AIM OF THE STUDY 
In recent years Mesenchymal Stem Cells (MSCs) have raised 
great interest for their properties and characteristics as potential 
therapeutical tools for a wide spectrum of pathologies. 
However, several aspects of their biology still need to be 
clarified, also in view of their potential use in cell and gene 
therapy for several human diseases. 
A growing body of evidence indicates that common molecular 
mechanisms may control different tissues, and that regulatory 
molecules orchestrating embryonic development are also 
involved in the differentiation of adult tissues. Thus, a number of 
genes coding for growth factors, receptors and transcription 
factors are involved in the regulation of both embryonic 
development and stem and progenitor cells of different tissues. In 
this view, the present study has been aimed at investigating the 
role that some key developmental regulators play in the control of 
mesenchymal stem and progenitor cells, particularly during their 
osteogenic and adipogenic differentiation. Previous studies 
carried out in our laboratory have highlighted the involvement of 
these molecular cues in the hematopoietic system. The rationale 
of this research project is that: 
• Together with endothelial cells, MSCs and mature 
osteoblasts provide the appropriate microenvironment 
(niche) for maintenance of the HSCs population 
• There is evidence suggesting that hematopoietic cells and 
osteoblasts are derived from a common progenitor 
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• The molecular mechanisms orchestrating MSCs 
differentiation and maturation processes are still poorly 
understood  
• MSCs may provide an interesting system to further study 
the function of “stem cell” regulatory genes 
 
The study has been mainly focused on homeobox-containing 
genes coding for transcription factors of different families (HOX, 
TALE, and Otx) and on the receptor of the Stem Cell Factor 
(Kit). 
 
Characterization of MSCs from different sources 
Homeobox-containing genes encode developmental regulators 
that have a broad spectrum of functions both in embryonic and 
adult tissues. Hox and Tale subfamilies contribute to skeletal and 
neural development as well as adult hematopoiesis. Moreover, 
growing evidence indicate that that the Hox family may have an 
enduring role in maintaining cell positional identity throughout 
the lifetime of an organism. Furthermore, it has been 
hypothesized that, in cell therapy applications, successful tissue 
regeneration may depend not only on the histologic compatibility 
between transplantable progenitor cells and damaged tissue, but 
also on the matching of their Hox codes. As an increasing number 
of MSCs populations have been described, some of which have 
different embryonic origin, a relevant question is whether they 
exhibit the same biological properties and may thus represent 
equivalent cell sources for regenerative medicine and tissue 
engineering. In this view, a major aim of my studies has been to 
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compare HOX and TALE expression profiles of human MSCs 
derived from different organs, and to correlate the molecular 
signatures with their immunophenotype and in vitro growth and 
differentiation ability. The characterization of MSCs derived 
from different anatomic sites is a critical issue for their clinical 
use. 
 
Role of Otx1 in the control of MSCs 
Otx homeobox-containing genes are key factors in brain 
morphogenesis and sense organs development. Moreover, it has 
been shown that Otx1 is active in hematopoietic stem and 
progenitor cells and it plays an important role in blood cell 
production, both in the erythroid and the myelo-monocytic 
lineages. Furthermore, it has been recently observed that OTX1 is 
expressed in a subset of normal germinal-center B cells and is 
involved in the development of aggressive Non-Hodgkin 
lymphoma. It is known that a close relationship exists between 
osteogenesis and hematopoiesis and that MSCs and osteoblasts 
play an important role not only in skeletal remodelling but also in 
the regulation of hematopoiesis. Therefore, a major question 
addressed in my studies is whether and how Otx1 is involved in 
the regulation of MSCs, particularly during their osteogenic 
differentiation.  The role of Otx1 has been investigated using 
different experimental strategies, including both expression and 
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Kit activity in the mesenchymal system 
Kit, coding for the Stem Cell Factor (SCF) receptor, is a pivotal 
regulator of several types of stem and progenitor cells, such as 
pigment, hematopoietic, cardiac, neural and germ cells. However, 
the role of this gene in the regulation of MSCs is still very 
controversial. In order to understand whether this receptor 
contributes also to the control of the mesenchymal system, I have 
analyzed Kit expression both at the mRNA and the protein level 
in primary murine and human MSCs. Moreover, as murine 
models allow a more detailed investigation, I also extended the 
expression studies using a transgenic mouse line, in which the 
reporter gene coding for the Green Fluorescence Protein (GFP) is 
under the transcriptional control of Kit regulatory sequences. 
In summary, the aim of this study has been to identify and 
characterize developmental regulators that play a role in the 
control of murine and human MSCs. The identification of new 
molecular cues controlling self-renewal, commitment and 
differentiation of mesenchymal stem and progenitor cells has 
biological and clinical relevance. 
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6. MATERIALS AND METHODS 
 
6.1 Mice 
Otx1-/- mice, in which exon 1 and 2 of the gene are replaced by 
Cre or LacZ sequences, have been described elsewhere 
(Acampora et al., 1996). Transgenic Kit/GFP mice, in which the 
GFP-coding sequence was placed under the control of Kit 
regulatory elements (construct 3) (Cairns et al., 2003), have been 
kindly provided by Dr. Sergio Ottolenghi, University of Milano 
Bicocca. Otx1-/- mice (C57Bl/6J background), Kit/GFP mice 
(BDF1 background) and wild type mice were kept according to 
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6.2 Isolation and expansion of murine MSCs 
Mice were sacrificed by cervical dislocation and their femurs and 
tibiae were carefully cleaned from adherent soft tissues. The tip 
of each bone was removed with a rongeur, and the bone marrow 
was harvested by inserting a syringe needle (21-gauge) into one 
end of the bone and flushing with Complete MesenCult® Medium 
(StemCell Technologies). The Complete MesenCult® Medium is 
prepared adding 20% Mesenchymal Stem Cell Stimulatory 
Supplements to MesenCult® MSC Basal Medium. Unprocessed 
bone marrow cells were plated into T-25 cm2 tissue culture-
treated flask (Falcon) at a density of 1 x 106 cells/cm2 in 10 mL of 
Complete MesenCult® Medium containing 100 u/mL penicillin 
(Biowest) and 100 u/mL streptomycin (Biowest). Cultures were 
kept at 37°C in a humidified atmosphere containing 95% air and 
5% CO2. When primary cultures became nearly confluent, the 
culture was treated with 0.025% Trypsin containing 0.02% 
EDTA (Biowest) and incubated at 37°C for 7 minutes. 
Trypsinized cells were collected into a 14 mL tube, and 
centrifugated at 300 x g (1200 rpm) for 8 minutes at room 
temperature with the brake on. Remove supernatant and 
resuspend pelleted cells in Complete MesenCult® Medium. Cells 
were plated into T-25 cm2 tissue culture-treated flask at a density 
of 1 x 105 cells/cm2 in Complete MesenCult® Medium. At weekly 
intervals, half-medium changes were performed. Once the 
cultures reached 70-80% confluence, the cells were trypsinized 
and plated for further passages, in order to expand the cultures. 
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6.3 Colony Forming Unit-Fibroblast (CFU-F) assay 
The clonogenic potential of the isolated cells was tested for the 
colony formation potentials. For this assay, cells were plated on 
tissue-treated 6-well plate at two different densities, 5 x 105 and 1 
x 106 cells/well. Cells were cultured in Complete MesenCult® 
Medium for 10 days at 37°C in 5% CO2. Subsequently, the plates 
were gently washed twice with PBS, fixed with methanol for 5 
minutes at room temperature and stained with Giemsa Staining 
Solution 5% for 5 minutes at room temperature. All visible 
colonies were counted. 
 
6.4 In vitro differentiation of murine MSCs 
MSCs established from murine bone marrow were cultured at 
passage 2 and grown near to confluence. Osteogenic 
differentiation was induced by culturing cells with osteoinductive 
medium, corresponding to standard medium supplemented with 
10% Mesenchymal Stem Cell Stimulatory Supplements, 50 
µg/mL of ascorbate-2-phosphate (Sigma-Aldrich), 10-7 M 
dexamethasone (Sigma-Aldrich) and 10 mM of β-
glycerophosphate (Sigma-Aldrich). The culture medium was 
changed twice at week for up 3 weeks. Calcium deposition was 
evaluated on plates with Alizarin Red S staining. Briefly, cells 
incubated in osteoinductive medium for 21 days were washed 
with PBS, fixed with 4% formaldehyde for 30 minutes at room 
temperature and stained with 1% Alizarin Red S solution (Sigma-
Aldrich) pH 4.2 for 15 minutes. Excess stain was removed by 
several changes of distilled water prior observation. Treated cells 
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at different time points (0, 3, 7, 14, 21 days) were also subjected 
to RNA extraction. 
To promote adipogenic differentiation, cells were induced for 3 
days with a adipogenic inductive medium, containing standard 
medium supplemented with 10% Mesenchymal Stem Cell 
Stimulatory Supplements, 1 µM dexamethasone (Sigma-Aldrich), 
0.5 mM methyl-isobutylxanthine (Sigma-Aldrich), 10 µg/mL 
insulin (Sigma-Aldrich) and 100 µM indomethacin (Sigma-
Aldrich). Subsequently, cells were cultured for 2 weeks in an 
adipogenic maintaining medium, containing standard medium 
supplemented with 10% Mesenchymal Stem Cell Stimulatory 
Supplements and 10 µg/mL insulin, with a medium change twice 
at week. Lipid droplets in the generated adipocytes were 
visualized by staining with Oil Red O. The adipogenic cultures 
were fixed with 4% formaldehyde for 30 minutes at room 
temperature and stained for 15 minutes with fresh Oil Red O 
working solution consisting of three parts stock solution (0.5% 
Oil Red O in isopropyl alcohol; Sigma-Aldrich) with two parts of 
water and filtered through a 0.2 µm filter. Cells were washed with 
distilled water. The cells at different stages of differentiation (0, 
3, 7, 14 days) were also used for RNA extraction. 
 
6.5 Cell cultures of murine pre-osteoblastic MC3T3-E1 cell 
line 
Stock MC3T3-E1 cells were recovered from liquid nitrogen and 
cultured in an undifferentiated state in basal medium consisting 
of Dulbecco’ s Modified Eagle’ s Medium (DMEM; Biowest) 
supplemented with 10% fetal bovine serum (FBS; EuroClone), 
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100 u/mL penicillin (Biowest) and 100 u/mL streptomycin 
(Biowest). Once the cultures reached 70-80% confluence, the 
cells were trypsinized and plated for further passages, in order to 
expand the cultures. To induce osteogenic differentiation, DMEM 
was supplemented with 2% FBS, 50 µg/mL of ascorbate-2-
phosphate (Sigma-Aldrich), 10-7 M dexamethasone (Sigma-
Aldrich) and 10 mM of β-glycerophosphate (Sigma-Aldrich). 
Culture media was replaced every three days. Cells were 
maintained at 37°C in a humidified 5% CO2 environment. 
Calcium deposition was evaluated with Alizarin Red S staining. 
 
6.6 Senescence Associated β-Gal Staining 
Senescence associated β-Gal staining was performed to detect the 
extent of senescent cells in the culture (Dimri et al., 1995). 
Briefly, cells at 70% confluence were fixed in 2% 
formaldehyde/0.2% glutaraldehyde and incubated with staining 
solution [1 mg/ml X-gal, 5 mM K3 [Fe(CN)6], 5 mM K4 
[Fe(CN)6] x 3H2O, 2 mM MgCl2, 150 mM NaCl in 40 mM citric 
acid/sodium phosphate (pH 6.0)] for 6-12 h at 37°C. Cells were 
then observed under microscope and photographed. 
 
6.7 In Situ Immunofluorescence 
Cells were plated at a density of 3 x 104 cells per well on 
coverslips in six-well plates. Cells were processed in situ for 
whole cell, and digital microscopic analyses were carried out as 
described previously (Javed et al., 2000). Cells were 
permeabilized, and non-specific antibody-binding sites were 
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blocked by incubating with: 0.3% Triton X-100 (Sigma-Aldrich) 
and 2.5% BSA (Sigma-Aldrich) in PBS for Otx1, Runx, 
Osteocalcin β-tubulin, and 0.1% Triton X-100 and 0.5% BSA in 
PBS for Kit. Otx1 (1:20), Runx2 (1:20), and Kit (1:40) were 
detected by appropriate goat polyclonal antibodies (R&D 
Systems). Osteocalcin (1:20; R&D Systems) and β-tubulin 
(1:200; Sigma-Aldrich) were detected by mouse monoclonal 
antibodies. Secondary antibodies used were donkey anti-goat 
IgG-FITC (1:100; Santa Cruz Biotechnology) Alexa Fluor® 514 
goat anti-rabbit or Alexa Fluor® 568 goat anti-mouse (1:500; 
Molecular Probes). Slides were mounted with DPX Mountant for 
histology (Fluxa) and examined on a Zeiss Observer.Z1 
microscope fitted with epifluorescence attached to a AxioCam 
MRc5 camera. Images were saved and processed by using 
AxioVision imaging software, version 4.6 (Carl Zeiss 
MicroImaging). 
 
6.8 Western Blot Analysis 
Whole-cell lysates from cells were resolved by SDS-PAGE 
electrophoresis, and proteins were transferred to an Immobilon 
(Millipore) membrane. For Otx1 and β-tubulin, the blots were 
blocked in TBS containing 1% Tween 20, 1% BSA and 5% 
nonfat dry milk, whereas for Kit, the blots were blocked in TBS 
containing 1% Tween 20 and 5% BSA, at room temperature for 1 
h. Blots were incubated over night at 4°C with 1:500 dilution of 
the primary antibody in TBS solution containing 2.5% BSA. The 
blots were washed three times with the TBST solution and 
incubated for 1 h at room temperature with a horseradish 
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peroxidase-conjugated rabbit anti-goat secondary antibodies 
(Sigma-Aldrich), at a dilution of 1:3.000 for Otx1 and 1:10.000 
for Kit. For detecting β-tubulin, the blot was incubated for 1 h at 
room temperature with a horseradish peroxidase-conjugated goat 
anti-mouse secondary antibodies (Sigma-Aldrich), at a dilution of 
1:4.000. After four washes with TBST solution, the 
immunoreactive bands were detected with ECL (SuperSignal® 
West Pico Trial Kit, Thermo Scientific) by exposing blots to 
BioMax MR film (Kodak). 
 
6.9 Flow cytometric analysis 
In general, 1 x 106 cells in 50 µl PBS and 1% BSA were 
incubated with a goat polyclonal antibody anti-Kit (10 µg/mL) 
for 30 minutes in ice, washed three times in PBS and 1% BSA. 
Cells were then incubated for 30 minutes in ice with the 
fluoresceinated secondary antibody anti-goat (1:100) in 50 µl 
PBS and 1% BSA, washed again three times and analyzed. 
Cytofluorometric analysis was performed on a FACScan flow 
cytometer (BD Bioscience) and CellQuest Analysis Software 
(BD Bioscience). Propidium iodide positive dead cells were 
excluded. 
 
6.10 Real-Time PCR 
Total RNA was isolated from cells with the RNeasy® Plus Micro 
Kit (Qiagen). Genomic DNA (gDNA) contamination was 
eliminated using both a gDNA Eliminator spin column and a 
RNase-free DNase digestion (Qiagen). The amount of RNA was 
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determined by measuring absorbance at 260 nm with a NanoDrop 
spectrophotometer (ND-1000; Celbio) and RNA quality was 
verified by agarose electrophoresis and the measurement of 
OD260/OD280 and OD260/OD230. First-strand cDNA synthesis 
was performed using 0,5 µg total RNA and the QuantiTect® 
Reverse Transcription Kit (Qiagen) with oligo-dT and random 
primers, to allow high cDNA yields from all region of RNA 
transcripts. An identical reaction without the reverse transcriptase 
was performed to verify the absence of gDNA. 
PCR were performed as described by the manufacturer using the 
QuantiTect® SYBR® Green PCR Kit (Qiagen) and the Rotor 
Gene 3000 (Corbett). The final reaction contained 7,5 µl 2x 
QuantiTect SYBR Green PCR Master Mix (HotStar Taq DNA 
Polymerase, QuantiTect SYBR Green PCR Buffer, 5 mM MgCl2, 
dNTP mix, SYBR Green I), 0.3 µM each primer and 2 µl of 
cDNA, in a total volume of 15 µl. PCR conditions were 95°C for 
15 min, followed by 45 cycles of 95°C for 15 s, 50-60°C for 30 s 
and 72°C for 30 s. The specificity of each PCR reaction was 
assessed by performing melting curves analysis after each 
reaction. β-actin and Hprt were  used to normalize the transcript 
levels of target genes. All results were repeated in two 
independent experiments and performed in duplicate each time. 
 
6.11 Statistical analysis 
The significance of the data is calculated with unpaired two-tailed 
Student’ s t-test. A p value <0.05 was considered statistically 
significant. 
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7. CHARACTERIZATION OF MSCS DERIVED FROM 
DIFFERENT BODY SITES-RESULTS 
An increasing number of distinct MSC populations have recently 
been described, some of which have different embryonic origin. 
A relevant question is whether MSCs derived from different body 
sites exhibit equivalent biological properties and may thus 
represent equally useful cell sources for regenerative medicine 
and tissue engineering. Interestingly, it has been shown that 
similar cell types derived from different body sites exhibit 
different molecular signature, particularly with regard to the 
global expression profile of the HOX gene family (HOX code) 
(Chang et al., 2002). In this study we have compared cellular and 
molecular characteristics of human MSCs derived from different 
body locations, such as bone marrow of iliac crest (Ic-MSCs), 
sternum (St-MSCs) and vertebrae (V-MSCs), as well as colon 
(Co-MSCs) and dental pulp (DPCs) of adult donors. These 
populations have been analyzed with regard to 
immunophenotype, in vitro growth and differentiation, and 
molecular signature. In particular we have investigated whether 
HOX genes and their co-factors TALE may provide specific 
molecular markers for MSC populations of different sources. 
 
7.1 Immunophenotype and in vitro growth and differentiation 
MSC cultures derived from cells isolated in distinct body districts 
have been FACS analyzed, at their second passage in vitro, using 
a panel of surface antigens, commonly used to define 
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mesenchymal stromal cells, excluding the presence of 
contaminant hematopoietic cells. 
Despite their different origin, all the MSCs populations displayed 
similar immunophenotypic profiles, being negative for CD45 and 
positive for CD44, CD90, CD105 and SSEA-4. 
In addition, we have selected and compared MSCs populations 
derived from iliac crest and dental pulp that were positive or 
negative for the CD146 antigen, a characteristic marker of 
pericytes, as it has been hypothesized that MSCs are members of 
the pericyte family of cells. 
We have next investigated the growth characteristics of MSCs 
derived from different body sites and observed distinct growth 
kinetics even within bone marrow derived cell populations. As 
illustrated in fig. 1, MSCs obtained from vertebrae continued to 
propagate much longer than iliac crest derived MSCs, which, 
after two months in culture, in our conditions, underwent 
senescence. Mesenchymal cultures derived from dental pulp and 
colon grew very rapidly and could be expanded much more 
significantly than Ic-MSCs and St-MSCs (BM-MSCs). 
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Figure 1: Growth kinetics of MSCs derived from different body sites. 
Growth characteristic of MSCs isolated from iliac crest and sternum (BM-
MSCs), vertebrae (V-MSCs), dental pulp (DPSCs) and colon (Co-MSCs). 
 
The MSCs from different sources were also induced to 
differentiate in vitro into osteogenic, adipogenic and 
chondrogenic cells and although they were all able to undergo 
differentiation, as assessed by specific histochemical stainings, 
they displayed distinct efficiences in generating cells of the 
various lineages. Once again, the best results were produced by 
V-MSCs, which yielded the highest percentage of differentiated 
bone, cartilage and fat cells. In contrast, DPCs and Co-MSCs, 
showed a lower ability to differentiate along the adipogenic 
lineage (data not shown). This part of study has been carried out 
in collaboration with the groups of Prof. Mario Petrini, University 
of Pisa, and Dr. Mauro Valtieri, Istituto Superiore di Sanità 
(Roma). 
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Thus, MSCs derived from different anatomical sites display a 
common phenotype, but distinct growth and differentiation 
kinetics. 
 
7.2 Distinct HOX codes of MSCs of different sources 
It has been reported that in the mouse MSCs derived from 
different tissues/organs display distinct overall patterns of Hox 
gene expression. Furthermore, in a murine model, there is 
evidence suggesting that in cell therapy applications Hox match 
between donor skeletal stem cells and damaged tissue may be a 
critical factor for efficient bone regeneration. Here we asked 
whether also human MSCs of different origin exhibit 
characteristic HOX codes and, using quantitative Real-Time 
PCR, we analyzed the expression of the 39 HOX genes in our 
MSCs populations. Fig 2 illustrates the expression profiles of the 
4 HOX clusters, highlighting several significant differences both 
in the number of transcriptionally active genes and in their levels 
of expression. Bone marrow-derived MSCs express the great 
majority of the HOX network and MSCs grown from iliac crest, 
vertebrae and sternum exhibit qualitatively identical profiles, 
however significant differences were detected in the expression 
levels of a number of HOX members. St-MSCs show higher 
levels of expression in individual genes of the HOXA (A3), 
HOXB (B6, B7), HOXC (C4, C5, C10), as compared to Ic-MSCs, 
although the most divergent patterns were observed for C8, 
expressed at much higher levels, and D9, expressed at very low 
levels. In contrast, an opposite trend was observed in V-MSCs 
which exhibited lower levels of HOX expression, particularly 
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within the HOXA cluster (A6, A7 and A11). Only B8 and B9 were 
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Figure 2: HOX genes expression in MSCs derived from different body 
sites. Gene expression is normalized with the HPRT gene. *, P<0.05; **, 
P<0.005; ***, P<0.001. 
 
Fig. 2 and Fig. 3 summarize also the overall HOX patterns of 
MSCs derived from colon and from dental pulp. Results show 
that Co-MSCs expressed most genes of the HOXA, HOXB and 
HOXD clusters, but only two HOXC genes (C4 and C5), at rather 
low levels. Interestingly, we observed discrete expression of A13, 
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barely detectable in all the other cell populations analyzed and a 
relatively high activity of the HOXD members. Among them, 
noteworthy is the expression of D12, which is completely silent 
in bone marrow-derived MSCs and may therefore provide a 
molecular marker for Co-MSCs. A strikingly different HOX code 
is displayed by DPCs, which have only 5 weakly active HOX 
genes, A10, B2, C8, C9 and D1, consistent with their 
neuroectodermal origin. 
 
Figure 21: Schematic rapresentation of specific HOX codes of MPCs and 
MSCs derived from different body sites. 	  
We subsequently addressed the question of whether MSCs 
exhibiting such different HOX codes might, following osteogenic 
induction, activate and/or up-regulate common HOX members. 
Differentiation was monitored at different time points by 
cytochemical staining and Real-Time PCR. Results showed that 
differentiated cells are positive for Alizarin Red staining, and 
molecular analysis of the osteogenic markers showed an 
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increased expression of RUNX2 and ALP during the 












Figure 4: Osteogenic differentiation of human MSCs derived from 
different body sites. Alizarin Red staining of A) untreated cells and B) 
differentiated cells. C) Real-Time PCR of the osteogenic markers RUNX2 and 
ALP. 
 
HOX expression analysis show that during osteogenic 
differentiation of MSCs derived from the bone marrow (Ic-
MSCs, St-MSCs and V-MSCs) the expression of 3 specific HOX 
genes (A10, A11, D9) is increased (Fig. 5). Furthermore, V-
BMSCs in the same conditions up-regulate an additional gene of 
the HOXD cluster, D10. Interestingly, D9 shows the most 
significant increase upon osteogenic induction of Co-MSCs, 
which already express relatively high levels of HOXD genes at an 
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undifferentiated state. In contrast, DPCs although almost HOX 
negative, when induced toward an osteogenic fate, strikingly up-
regulate only one HOX member, A10, expressed at very low 
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Figure 5: HOX genes expression during osteogenic differentiation. Gene 
expression is normalized with HPRT gene. *, P<0.05; **, P<0.005; ***, 
P<0.001. 
 
These results indicate that human MSCs of different sources 
display characteristic HOX signatures (codes) and that osteogenic 
differentiation is associated with the up-regulation of common 
HOX genes. 
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7.3 Differential expression of TALE genes in MSCs of 
different origin 
It is well established that Hox function and DNA-binding 
specificity is frequently dependent on interactions with other 
DNA-binding proteins, which act as cofactors. These include the 
Pbx and Meis/Prep classes of homeodomain proteins (TALE). 
Thus, together with the HOX code, we investigated the 
expression patterns of TALE genes in MSCs of various sources. 
As illustrated in Fig. 6, it is clear at first glance that all TALE 
members are expressed in all the undifferentiated populations 
analyzed. In bone marrow-derived MSCs particularly MEIS1 and 
MEIS2 are expressed, at comparable levels as the housekeeping 
HPRT. In contrast, MEIS genes are expressed at rather lower 
levels in DPCs, although in these cells TALE genes are generally 
much more transcriptionally active than the HOX clusters. 
However, similarly to what observed in the HOX network, the 























Figure 22: TALE genes expression in MSCs derived from different body 
sites. Gene expression is normalized with HPRT gene. ***, P<0.001. 
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Following osteogenic induction, MSCs from iliac crest and 
sternum (indicated as BM-MSCs in fig. 7) showed an increased 
expression of PBX1 and PBX2. In contrast the transcriptional 
activity of these genes remains constant in V-MSCs which, 
instead, exhibited higher levels of MEIS1 expression during 
osteogenic differentiation. However it is in Co-MSCs and DPCs 
that commitment toward an osteogenic fate induces the most 
remarkable changes in TALE gene expression. Co-MSCs up-
regulate PBX3, PREP1, MEIS1 and, mostly MEIS2, and DPCs 
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Figure 7: TALE genes expression during osteogenic differentiation. Gene 
expression is normalized with HPRT gene. *, P<0.05; **, P<0.005. 	  
Thus, the overall data indicate that TALE genes are expressed in 
all types of MSCs analyzed and that different members of the 
family are up-regulated during osteogenic differentiation of cells 
derived from distinct anatomic sites. 
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7.4 HOX and TALE gene expression in Mesodermal 
Progenitor Cells (MPCs) 
Recently, in the bone marrow it has been identified a mesodermal 
progenitor cell population, that can be cultured in vitro in the 
presence of autologous serum and is able to differentiate into 
mesenchymal cells (MSCs) upon appropriate culture conditions, 
and undergo further differentiation into osteoblats, chondrocytes, 
or adipocytes. Moreover MPCs are capable of generating 
endothelial cells (ECs) showing characteristics similar to 
microvessel endothelium cells. Mesodermal progenitors cells 
have a defined phenotype and carry embryonic stem cell markers, 
such as OCT-4, expressed at higher levels than in MSCs, and 
NANOG, not present in mesenchymal cells, although they do not 
display the same gene profiles found in human ES cells. 
Moreover MPCs strongly express aldehyde dehydrogenase 
activity, usually present in hematopoietic precursors but absent in 
mesenchymal cells. When these progenitors are pulsed to 
differentiate by substituting autologous serum for human cord 
blood serum or fetal calf serum, they lose these markers and 
acquire the mesenchymal ones. Interestingly, mesenchymal cells 
may not be induced to reverse back to MPCs. Here we have 
compared the expression of the HOX network and TALE co-
factors in MPCs and in the MSCs they generated, when grown in 
differentiation condition. Fig 8 shows that MPCs express a lower 
number of HOX genes than MSCs and, mostly, at much lower 
levels. All genes of the HOXA cluster, except A13, are active as 
well as 6 out of 9 HOXB members. In the HOXC cluster, only 
four genes are expressed, at barely detectable levels and the 
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HOXD locus is completely silent. Therefore, the transition from 
MPC to MSCs is associated with a shift in the HOX code. This is 
consistent with the observation that ES cells are basically HOX 
negative and MPCs express some ES cell markers and represent a 
more primitive cell population than MSCs. 















	  163	  	  












































	  164	  	  
Results and Discussion 
Figure 23: HOX and TALE genes expression in MPCs and in the MSCs 
they generate. Gene expression is normalized with HPRT gene. *, P<0.05; **, 
P<0.005; ***, P<0.001. 
	  165	  	  
Results and Discussion 
 
8. CHARACTERIZATION OF MSCS DERIVED FROM 
DIFFERENT BODY SITES-DISCUSSION 
MSCs have been originally identified in the bone marrow, 
however a growing body of evidence indicates that they are 
present in other tissues or organs, such as teeth, fat, muscle, skin 
and vessels, virtually in every post-natal connective tissue 
(Wagner et al., 2005; Jiang et al., 2002; Gronthos et al., 2002). 
Thus, an increasing number of distinct MSC populations have 
recently been described, some of which have different embryonic 
origin. Whereas MSCs derived from the bone marrow are of 
mesodermal origin, mesenchymal progenitors identified in dental 
pulp and the cranio-facial bones develop from the neural crests 
(Counly et al., 2002). A relevant question is whether they exhibit 
equivalent biological properties and may thus represent equally 
useful cell sources for regenerative medicine and tissue 
engineering. Bone regeneration studies in murine models have 
raised the hypothesis that successful tissue regeneration and 
repair may depend not only on the histologic compatibility 
between transplantable stem cells and injured or damaged tissue, 
but also on the matching of their Hox code (Leucht et al., 2008). 
In this study we have investigated cellular and molecular 
characteristics of human MSCs derived from different anatomical 
districts, showing that cell populations exhibiting the same 
immunophenotipic profile display distinct in vitro growth and 
differentiation properties, and are characterized by specific HOX 
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codes and TALE signature, supporting the view that they do not 
provide equal cell sources for clinical application. 
 
8.1 Immunophenotype and in vitro growth and differentiation 
A growing body of publications reports on the proliferative and 
differentiative ability of MSCs derived from different sources, 
including bone marrow and non-bone marrow tissues. Results are 
often contradictory and the conclusions rather controversial, 
depending on the cell/tissue explantation technique, the culture 
conditions and the assays used in the different laboratories. Most 
studies rely on in vitro growth and differentiation assays, 
although one major caveat in the interpretation of the results is 
that cultures of MSCs are inherently heterogenous, as they 
contain multipotent cells capable of self-renewal, together with 
committed progenitors and spontaneously differentiated cells. 
These cell types may have different kinetics, therefore the 
number of passages in culture reflects the growth of the entire 
cell population, rather than stem cell proliferation capacity 
(Bianco et al., 2008). Nevertheless, MSCs are commonly assayed 
in vitro, on the basis of two main considerations: i. rigourous, but 
handy and reproducible in vivo assays are not yet available, ii. 
MSCs are frequently expanded in vitro prior to clinical use, and 
therefore characterizing MSCs grown ex vivo is anyway a 
relevant issue. In this view we have compared the in vitro growth 
and differentiation properties of MSCs from different anatomical 
sites.  Results indicate that Ic-MSCs and St-MSCs are the most 
limited in terms of growth ability, whereas V-MSCs can still be 
maintained ex vivo beyond 4 months in culture, suggesting that 
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even MSCs derived from the same tissue, the bone marrow, 
display different properties. Notably, DPCs and Co-MSCs 
showed a significantly greater rate of proliferation and ability to 
undergo a massive expansion, however they were not as efficient 
as bone marrow-derived cells in differentiating along the 
adipogenic and chondrogenic lineage, although they could 
promptly generate osteogenic cells. Our data confirm and extend 
previous studies reporting that DPCs exhibit a lower ability to 
mature into cells of the adipogenic and chondrogenic lineages. In 
this line, it has been previously suggested that BM-MSCs could 
be more prone to osteogenic differentiation than those isolated 
from fat (Noel et al., 2008). Moreover, other experiments showed 
some variation among the cultures in the frequency of cells which 
actually differentiated in the osteogenic or adipogenic phenotype, 
as well as on the degree of differentiation, related to their site of 
origin (da Silva Meirelles et al., 2006). This might be due to the 
influence of the local environment from which they originate, 
reflecting the importance of the niche in establishing the 
phenotype of the stem cells it interacts with (Fuchs et al., 2004). 
In addition, also when transplanted in vivo MSCs show 
preferential differentiation pathways, as cells from dental pulp or 
adipose tissue will form dentin or fat, respectively, rather than 
bone (Gronthos et al., 2002; Katz et al., 2005). 
Interestingly, a recent report has highlighted that MSCs show a 
non linear hierarchy of lineage commitment, accounting for the 
presence of osteo-adipogenic, osteo-chondrogenic and even 
adipo-chondrogenic bipotent progenitors within the MSCs cell 
heterogeneity (Russell et al., 2010). 
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Remarkably, MSCs isolated from the vertebrae provide the best 
performance in terms of both expansion and differentiation in 
vitro. This finding is consistent with a previous observation that 
vertebrae contain a higher number of CFU-F (McLain et al., 
2005) and with the direct correlation between MSCs potency and 
proliferation ability, recently suggested by Russell et al. They 
reported that MSCs with trilineage potential display a higher 
proliferative ability than bipotent or unipotent progenitors 
(Russell et al., 2010). Our results, may be accounted for by a 
higher concentration of tripotent progenitors in vertebrae with 
respect to other bone marrow and non bone marrow MSCs. This 
may be relevant for spine regeneration, suggesting that V-MSCs 
might be more suitable than iliac crest-derived cells, which are 
routinely used, to achieve rapid spine fusion. 
 
8.2 HOX expression signatures 
Several aspects of MSCs have been extensively investigated and 
debated to understand whether MSCs of different sources share 
identical biological properties. These studies include 
transcriptional profiles using differentiation, stemness and 
signaling pathways, however a global comparison of HOX and 
TALE expression signatures among different human MSCs has 
not been reported (Menicanin et al., 2009; Kulterer et al., 2007). 
We have mainly focused our attention on these gene families for 
several reasons: they encode transcriptional regulators that 
orchestrate embryonic development of multiple tissues and 
organs (Lumsden and Krumlauf, 1996); they also contribute to 
the control of adult stem and progenitor cells, such as the 
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hematopoietic ones (Magli et al., 1997; Lappin et al., 2006); 
mesenchymal cells provide the supportive stroma for 
hematopoiesis (HSCs) (Calvi et al., 2003). Furthermore, Ackema 
and Charite have provided evidence that in the mouse MSCs 
derived from different bone marrow and non bone marrow sites 
are characterized by distinct topographic Hox codes (Ackema and 
Charite, 2008). Our study on human bone marrow- and non bone 
marrow-derived MSCs has addressed the question of whether 
global HOX expression profiles of MSCs might reflect the tissue 
and/or the body district of origin. We found that MSCs from 
different tissues, such as bone marrow, dental pulp and colon are 
characterized by specific HOX codes, differing in the number and 
type of active genes, as well as in their level of expression. In 
contrast, MSCs from iliac crest, vertebrae and sternum exhibit 
qualitatively identical HOX profiles, and can be distinguished 
only for the expression levels of some individual genes. 
However, despite some intrinsic variability among the samples 
collected from the same anatomical site, reproducible and 
statistically highly significant differences were revealed. Overall, 
BM-MSCs express the highest number of HOX genes (35/39) and 
three of the inactive HOX members (B1, C12 and D11) are silent 
also in MSCs from the other sources. A different HOX signature 
characterize MSCs of colon origin: virtually the entire HOXC 
cluster is inactive, as the only two detectable transcripts (C4 and 
C5) are very weak. In contrast, the other clusters are expressed at 
higher levels, as compared to bone marrow-derived MSCs and 
D12 seems to be a unique marker of MSCs from the colon tissue. 
An opposite trend is observed in DPCs, which exhibited low 
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levels of expression of a few HOX genes, confirming previous 
findings (D' Anto et al., 2006), consistently with the 
neuroectodermal origin of DPCs. It is known that neural crests 
are Hox negative (Couly et al., 2002) and indeed the few active 
HOX genes in DPCs are expressed at barely detectable levels. 
The greatest heterogeneity in HOX expression patterns among the 
cell populations of different sources was observed in the groups 
located towards the 5’ of the clusters, and within bone marrow-
derived cells the most significant differences were concentrated 
in groups 6, 8, 9 and 11. Interestingly, A11, involved in skeletal 
development (Carapuco et al., 2005), is barely detectable in 
undifferentiated V-MSCs, however it is strongly up-regulated  
during their osteogenic differentiation. Interestingly, in the 
mouse, Hoxa11, active in skeletal stem cells of the tibia and silent 
in the same cells of the mandible, seems to be critical for Hox 
matching and bone regeneration (Leucht et al., 2008). In contrast, 
V-MSCs express higher levels of HOXB8, which, conversely, is 
weakly transcribed in the other MSCs populations. 
The different HOX signatures exhibited by MSCs derived from 
bone marrow, dental pulp and colon are in line with the view that 
also in adult human cells HOX genes provide positional memory, 
reflecting their embryonic origin. However, the HOX patterns 
exhibited by MPCs suggest that they provide information also 
about the position of a cell within the progenitor hierarchy. The 
HOX expression profiles of MPCs and of the MSCs that they 
generate, although apparently rather distinct, mainly differ in 
terms of levels of expression, which in MPCs are significantly 
reduced. Transcripts of the HOXA and HOXB clusters, highly 
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represented in MSCs, are still detectable in MPCs, although with 
low signals. A similar reduction in the expression of the HOXC 
and HOXD clusters leads to a complete stop of the HOX activity. 
The overall decrease of HOX expression in MPCs may be 
accounted for by higher levels of OCT4 activity. Recent data by 
Fainsod (unpublishied results) indicate that this embyonic marker 
may act as HOX repressors and it is known that small variations 
in OCT4 expression may be sufficient to induce dramatic effects 
on the gene molecular targets. This is in line with the very poor 
Hox activity exhibited by ES cells, which, conversely, express 
high levels of Oct4 (Lemischka, 2010). 
The different levels of HOX expression detected within bone 
marrow-derived populations strongly suggest that also 
quantitative differences in HOX activity may be equally 
important as qualitative differences, raising the hypothesis that 
they might reflect MSCs potency. This view might also reconcile 
distinct HOX functions, such as positional and hierarchical cell 
memory. Actually, the importance of the expression levels has 
been highlighted for the Tale gene Prep1, which, during mouse 
embryonic development, is required at different threshold levels 
for distinct functions (Di Rosa et al., 2007). 	  
8.3 TALE expression profiles 
We compared MSCs of different sources also with respect to the 
expression of TALE genes, encoding transcription factors that 
cooperate with HOX proteins and play critical roles in embryonic 
development. Actually, ablation of some TALE genes has a 
pleiomorphic, embryonic lethal phenotype, while inactivation of 
	  172	  	  
Results and Discussion 
Hox genes results in less severe and more restricted defects 
(Mallo and Magli, 2006; Ferretti et al., 2007). Furthermore, Prep1 
can control Hox expression both at the transcriptional and 
translational level (Villaescusa et al., 200). Our data indicate that 
in MSCs of different sources all TALE genes are transcriptionally 
active in all the cell populations analyzed, generally at higher 
levels than HOX genes. Similarly, they are active also in MPCs, 
where strikingly high levels of PBX3 expression are present. All 
TALE members are very strongly expressed in Co-MSCs whereas 
bone marrow-derived MSCs show high levels of MEIS1 and 
MEIS2. In contrast, MEIS genes are poorly expressed in 
undifferentiated DPCs, however, interestingly, during their 
osteogenic differentiation MEIS1, and to a less extent MEIS2 
expression exhibit a several fold increase. Actually, a striking 
finding is that, during osteogenic differentiation, whereas in bone 
marrow-derived cell populations and in Co-MSCs the expression 
of at least 3 HOX members (A10, A11 and D9) is enhanced, in 
DPCs a single HOX gene, A10, is up-regulated. It is known that 
Hoxa10 is involved in vertebral specification (Carapuco et al., 
2005) and that it plays a major role in the control of 
osteoblastogenesis by directly activating bone regulatory and 
phenotypic genes (Hassan et al., 2007), through  interactions with 
co-factors. 
Interestingly, following osteogenic induction, each of the MSCs 
population that we have studied upregulate a different 
combination of TALE genes: in colon cells, the most significant 
variations occur in the expression of PBX3, MEIS2 and PREP1, 
whereas in bone-marrow-derived cells mainly transcription of 
	  173	  	  
Results and Discussion 
PBX1 and PBX2 is enhanced. In contrast, most TALE genes are 
markedly up-regulated in DPCs induced towards an osteogenic 
fate, suggesting that threshold levels of at least some members of 
the family, such as MEIS genes, might be required for bone cell 
formation. Future functional studies, using gene silencing or 
enforced gene expression will provide a means to test this 
hypothesis. 
Distinct HOX and TALE signatures in both undifferentiated and 
differentiated MSCs of various sources indicate that these genes 
are finely tuned also in adult stem cells and that not only during 
embryonic development gene dosage may affect their function. 
 
8.4 Conclusion 
Taken together, our results show that, although all the cell 
populations studied exhibit similar immunophenotyic profiles, 
they display different in vitro growth and differentiation 
properties, and, mainly, are characterized by distinct HOX codes 
and TALE expression profiles. Thus, our observations support the 
view that, likewise murine cells, human MSCs derived from 
different body sites may not represent equivalent cell sources for 
the regeneration of specific tissues/organs. This finding may have 
important clinical implications, suggesting that successful tissue 
regeneration may depend on the source of MSCs employed for 
cell therapy or tissue engineering. 
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9. ROLE OF OTX1 IN THE CONTROL OF MSCs-
RESULTS 
In order to understand whether and how Otx genes may play a 
role in the regulation of MSCs I have employed different 
experimental strategies, including expression studies both in 
murine and human MSCs, particularly during their osteogenic 
differentiation, and functional studies in Otx1 knock-out 
transgenic mice. 
 
9.1 Otx1 expressions in murine and human cells 
The MC3T3-E1 cell line has provided a useful means for 
optimizing methodological aspects and initial analysis of gene 
expression, as it is a non transformed cell line and represents a 
relatively homogeneous cell population at a specific stage of 
differentiation, containing mostly pre-osteoblastic cells. 
Moreover, these cells can be induced to differentiate into mature 
osteoblasts. Therefore, cells were grown in vitro and maintained 
in expansion conditions or induced to osteogenic differentiation 
following exposure to specific agents. Osteoblast differentiation 
was monitored at different time points by cytochemical staining 
and Real-Time PCR. As a first step, I analyzed the expression of 
Otx genes by comparative RT-PCR in cells maintained in the 
undifferentiated state. The results show that in pre-osteoblastic 
cells, Otx1 is expressed, whereas no Otx2 activity has been 
detected (Fig. 9). 
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Figure 24: Expression of Otx genes in undifferentiated MC3T3-E1 cells by 
RT-PCR. Brain represents the positive control, as Otx genes are highly 
expressed in this tissue; Hprt represents the costitutive gene, and it is used to 
normalized the samples. 	  
Following osteogenic induction cells became positive to the 
Alizarin Red staining, which reveals the presence of osteoblasts. 
Furthermore, molecular analysis of the osteogenic markers Alp 
and Runx2 at different time intervals showed an increased 
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Figure 25: Osteogenic differentiation of MC3T3-E1 cells. Alizarin Red 
staining of A) untreated cells and B) differentiated cells after 21days of 
osteogenic induction. C) Real-Time PCR for the expression of the osteogenic 
markers Runx2 and Alp. *, P<0,05; **, P<0,005. 
 
Analysis of Otx1 expression by Real-Time PCR revealed that the 
gene is transcriptionally active in undifferentiated cells, and is up-
regulated, reaching a significant increase at 21 days after 

























Figure 26: Otx1 expression during osteogenic differentiation of MC3T3-
E1 cells. Quantitative PCR; samples are normalized with Hprt gene. **, 
P<0,005. 
 
The next step has been to investigate Otx1 expression in primary 
murine MSCs. Bone marrow cells from wild type mice have been 
plated in condition supporting MSCs growth and expansion in an 
undifferentiated state through repeated passages in vitro. 
Moreover, MSCs were induced to differentiate along the 
osteogenic lineage, following treatment with specific inducers. 
Cells maintained in the undifferentiated state and at different time 
intervals after osteogenic induction have been analyzed by 
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cytochemical staining and Real-Time PCR. Results showed that 
differentiated cells were positive for the Alizarin Red staining, 
and the augmented expression of the early osteogenic markers 
Runx2 and Alp confirmed the differentiation also at the molecular 





























Figure 27: Osteogenic differentiation of primary murine MSCs. Alizarin 
Red staining of A) untreated cells and B) differentiated cells after 21days of 
osteogenic induction. C) Real-Time PCR for the expression of the osteogenic 
markers Runx2 and Alp. *, P<0,05; **, P<0,005. 
 
Analysis of expression showed that Otx1 is transcribed also in 
undifferentiated primary murine mesenchymal cells, although at 
lower levels as compared to MC3T3-E1 cells, and it is 
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significantly up-regulated during osteogenic differentiation, 





























Figure 13: Otx1 expression during osteogenic differentiation of primary 
murine MSCs. Quantitative PCR; samples are normalized with Hprt gene. *, 
P<0,05. 
 
The next question to understand the importance of this homeobox 
gene in the control of MSCs was to investigate whether OTX1 is 
active also in human cells. Therefore, I analyzed OTX1 
expression in MSCs cultures derived from bone marrow samples 
collected from several normal donors, provided by Istituti 
Ortopedici Rizzoli (Bologna) and Cattedra di Ematologia of the 
University of Pisa. Cells were grown in vitro and maintained in 
expansion conditions or induced to osteogenic differentiation 
following exposure to specific inducing agents. Differentiation 
was monitored at different time points by cytochemical staining 
and Real-Time PCR. The results showed that differentiated cells 
are positive for Alizarin Red staining, and the molecular analysis 
of the osteogenic markers RUNX2 and ALP showed an increased 
expression during the differentiation processes (Fig. 14). 
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Figure 14: Osteogenic differentiation of primary human MSCs. Alizarin 
Red staining of A) untreated cells and B) differentiated cells after 21days of 
osteogenic induction. C) Real-Time PCR for the expression of the osteogenic 
markers RUNX2 and ALP. **, P<0,005; ***, P<0,001. 
 
Results show that OTX1 is expressed in primary human stromal 
bone marrow cells, at low levels and, like in murine cells, its 
expression is increased during osteogenesis, once more at early 
stages of the process (Fig. 15). 
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Figure 28: OTX1 expression during osteogenic differentiation of primary 
human MSCs. Quantitative PCR; samples are normalized with HPRT gene. *, 
P<0,05; **, P<0,005. 
 
The results obtained both in murine and human cells suggested an 
involvement of Otx1 at early stages of osteogenic differentiation. 
Therefore, I compared the expression patterns of Otx1 and the 
early osteogenic marker, highlighting a strict correlation in the 
expression profiles of Otx1 and Runx2, in the cell line as well as 
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Figure 29: Correlation of the expression levels of Otx1 and Runx2 during 
osteogenic differentiation of murine and human cells. Otx1 expression 
levels are represented in dark green, whereas the expression levels of Runx2 
are represented in light green. 	  
9.2 Otx1 protein expression in murine cells 
As homeobox genes are frequently regulated by miRNA-
mediated post-transcriptional control, Otx1 activity had to be 
confirmed at the protein level. As a first step, I analyzed the 
expression of the gene product both in undifferentiated MC3T3-
E1 cells and primary MSCs by Western Blot. Results show that 
Otx1 protein is expressed in murine undifferentiated cells, both in 
MC3T3-E1 and primary MSCs (Fig. 17), although the signal 
detected in the mesenchymal cells is weaker than the one 
displayed by the brain tissue, used as a positive control. 
 
Figure 30: Otx1 protein expression in undifferentiated MC3T3-E1 cells 
and primary murine MSCs (mMSCs) by Westrn Blot. Brain is the positive 
control. β-Tubulin represents the costitutive protein. 	  
As MSCs are a heterogeneous population  the subsequent step has 
been to analyze Otx1 expression by in situ immunofluorescence, 
in order to identify the positive cells. Once again I first carried 
out the immunocytochemistry in undifferentiated MC3T3-E1 
cells, observing that all the cells are fluorescent and that the 
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transcription factor is localized into the nucleus of these cells 
(Fig. 18). 
 
Figure 31: Nuclear localization of Otx1 in undifferentiated MC3T3-E1 
cells. In situ immunofluorescence analysis of Otx1 protein (green). Cells were 
also counterstained with DAPI (blue) to visualize the nucleus. 	  
I then monitored Otx1 expression in primary murine MSCs, 
before and after osteogenic induction. Results show that only 
some undifferentiated MSCs are positive and weakly fluorescent, 
confirming the low levels of Otx1 expression detected by 
Western blot. Moreover, unlike the cell line, primary mMSCs 
exhibit a cytoplasmic localization of the Otx1 signal. However, 
already 3 days after the osteogenic stimulus, the number of Otx1-
expressing cells increased, as well as the fluorescence intensity in 
the positive cells. Furthermore, after 14 days of induction, some 
cells started to show nuclear fluorescence, suggesting that during 
the differentiation process the trascription factor is translocated 
from the cytoplasm to the nucleous. This is confirmed also by the 
nuclear staining of the pre-osteoblastic cell line (Fig. 19). 
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Figure 32: Otx1 expression during osteogenic differentation of murine 
MSCs. The cells were immunostained for Otx1 (green) and counterstaining 
with DAPI (blue) to visualize the nucleus. Arrows indicate the cells in which 
Otx1 is localized into the nucleus. 	  
9.3 Effects of Otx1 inactivation 
In order to gain insights into the function of Otx1 in MSCs, I 
looked at the effect of Otx1 inactivation in knock-out mice, in 
which exon 1 and 2 of the gene are replaced by Cre or LacZ 
sequences. Otx1-/- mice, which provided a precious model to 
study the role of Otx1 in hematopoiesis, have been a suitable 
system also to investigate the function of this gene in 
mesenchymal cells. Therefore, I set up MSCs cultures from WT 
mice and Otx1-null mutants. First, I analyzed the cultures for the 
ability of MSCs to form CFU-F in vitro. The comparison showed 
that there not significant differences in the number and in the size 
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of CFU-F, suggesting that WT and Otx1-null mice exhibit similar 
numbers of functional MSCs (data not shown), although the 
CFU-F assay does not provide a rigorous means for MSCs 
evaluation. I have compared MSCs cultures in proliferating 
conditions through repeated passages in vitro in an 
undifferentiated state, and observed that Otx1-null MSCs have a 
different morphology, as they appear flatter by β–tubulin in situ 








Figure 33: Morphology of WT and KO MSCs. In situ immunofluorescence 
analysis of wild-type (WT) and mutant (KO) cells. The cells were 
immunostained for microtubules (β-Tubulin) to assess the size of the cells. 
Cells were also counterstaining with DAPI to visualize the nucleus. 	  
Moreover, mutant cells were more adherent to plastic as 
compared with WT cells, and, consistently, exhibited 
significantly higher levels of two specific integrins, α2 and α4 
(Fig. 21). 
	  185	  	  


























Figure 34: Expression of integrins in Otx1-/- MSCs. Real-Time PCR for the 
expression of the integrinα2 (Itga2) and integrinα4 (Itga4) in wild-type (WT) 
and mutant MSCs. *, P<0,05; **, P<0,005. 	  
Furthermore, Otx1-null cells exhibited a different growth kinetic. 
In fact, WT MSCs showed a progressively decreased proliferative 
rate, and stopped growing after eight passages in culture. In 
contrast, null cells at the same passage, kept actively proliferating 
and could still be further expanded (Fig. 22). 
 
Figure 22: Growth kinetic of WT and Otx1-/- MSCs. MSCs were cultured 
ex vivo and cells were counted at each passage and replated at the initial 
density. The line graph represents the number of cells at the time of each 
passage. WT cells showed a considerable decrease in their rate of proliferation 
as a function of increasing number of passages. 	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Such different proliferating curves suggested that mutant cells did 
not undergo senescence as WT cells. Therefore, I performed the 
senescence-associated β-Gal activity assay at different passages, 
observing that WT cells showed senescence already at passage 2, 
whereas null cells were negative at the β-Gal staining. The 
number of senescent WT cells significantly increased at the 
following passages, reaching the highest number at passage 4, 
when almost all the cells are positive at the β-Gal staining. In 
contrast, at the same passage, null cells were still essentially 







Figure 23: Senescence-associated β-Gal activity. WT and KO MSCs grown 
at passage 4 were stained for the activity of of SA β-Gal. WT cells (A-B) 
showed significantly higher β-Gal staining (blue), compared with KO cells (C-
D). 	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Subsequently, I compared the differentiation ability of WT and 
KO MSCs. As a first step, I analyzed the expression of 
osteogenic markers in undifferentiated WT and mutant MSCs by 
Real-Time PCR, and found that Otx1-/- cells exhibited a 
significantly decreased expression of Runx2, Alp and Dlx5. In 




















































Figure 35: Expression of osteogenic genes in undifferentiated Otx1-/- 
MSCs. Real-Time PCR for the expression of the osteogenic markers (Runx2 
and Alp) and osteogenic regulators (Dlx5 and Msx2) in wild-type (WT) and 
mutant MSCs. **, P<0,005; ***, P<0,001. 	  
I also analyzed the expression of adipogenic markers in 
undifferentiated cells. Results indicated that there were no 
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significant differences in the expression levels of these markers 
between WT and KO cells (data not shown). 
Subsequently, MSCs were induced to differentiate along the 
osteogenic and adipogenic lineages, following treatment with 
specific inducers. Differentiation was monitored by cytochemical 
staining with Alizarin Red, that binds extracellular matrix of 
mature osteoblasts, and Oil Red, which binds lipid droplets of 
adipocytes. The results show that mutant cells exhibit a decreased 
number of mature osteoblasts (Fig. 25B), as compared to WT 
cells that instead showed a greater Alizarin Red staining (Fig. 
25A). In contrast, null cells display a higher number of 
adipocytes (Fig. 25C-D). Together, the results suggested that KO 






Figure 36: Differentiation ability of WT and Otx1-/- MSCS. Osteogenic (A-
B) and adipogenic (C-D) differentiation of WT and KO MSCs. 
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To further characterize the osteogenic ability of Otx1-null MSCs, 
I monitored the differentiation process at the molecular level. 
Expression analysis of Runx2 by Real-Time PCR showed that 
during osteogenic differentiation, mutant cells exhibited lower 
level of this early transcription factor. In WT cells, Runx2 
expression reached the highest level at 14 days after induction, 
followed by a subsequent decrease. Conversely, in mutant cells, 
at 14 days the mRNA level is not greatly augmented, and Runx2 




























Figure 37: Real-Time PCR for the expression of Runx2 during osteogenic 
differentiation of WT and Otx1-/- MSCs. 	  
Analysis of Runx2 at the protein level reflected the 
transcriptional activity of the gene. In situ immunofluorescence 
assay confirmed Runx2 up-regulation at 14 days in WT cells, as 
shown by the intense fluorescence. Moreover, results also 
confirmed the lower expression at all times of the assay, in 
mutant cells (Fig. 27). 
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Figure 38: Expression of Runx2 protein during osteogenic differentiation 
of WT and KO MSCs. In situ immunofluorescence analysis of wild-type 
(WT) and mutant (KO) cells. The cells were immunostained for Runx2 (green) 
and counterstaining with DAPI to visualize the nucleus. 	  
I also quantified the number of positive fluorescence cells, by 
scoring them at the fluorescence microscope. During osteogenic 
differentiation of WT cells, the number of fluorescent cells 
reached the highest level at 14 days after induction. In contrast, 
the highest number of fluorescent mutant cells was observed after 
21 days of induction, although the number of positive cells was 
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Figure 39: Schematic rapresentation of the number of cells expressing 
Runx2. % of cells that not express Runx2 (light green), low expression 
(green), high expression (dark green). 	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Finally, I also analyzed by in situ immunofluorescence the 
expression of the terminal osteogenic marker Osteocalcin. The 
results showed that, even after 28 days of osteogenic induction, 
Otx1-null cells exhibited a significantly decreased expression of 
this marker, with respect to WT cells (Fig. 29). 
WT 
KO 
OC DAPI Merge 
 
Figure 40: Expression of the terminal osteogenic marker Osteocalcin (OC) 
after 28 days of osteogenic induction in WT and KO MSCs. In situ 
immunofluorescence analysis of wild-type (WT) and mutant (KO) cells. The 
cells were immunostained for OC (red) and counterstaining with DAPI to 
visualize the nucleus. 
	  192	  	  
Results and Discussion 
 
10. ROLE OF OTX1 IN THE CONTROL OF MSCs-
DISCUSSION 
The Otx1 homeobox gene plays a pivotal role in mouse brain and 
sense organs morphogenesis, being temporally and spatially 
expressed during neural embryonic patterning (Acampora and 
Simeone, 1999). Moreover, Otx1 is active in various 
hematopoietic sites (fetal liver, bone marrow and spleen), 
particularly in pluripotent precursors and erythroid cells at 
various stages of differentiation (Levantini et al., 2003). Otx1-/- 
mice show several specific anomalies in different tissues, among 
which the most severe affect the central nervous system and sense 
organs (Acampora et al., 1996; Cantons et al., 2000). Analysis of 
the hematopoietic system of Otx1-/- mutants has indicated that 
these mice are characterized by erythroid impairment, due to an 
intrinsic defect of hematopoietic stem cells (HSCs) (Levantini et 
al., 2003). The important role played by Otx1 both in 
neurogenesis and hematopoiesis, supports the view that common 
molecular mechanisms may be used by multiple cellular systems. 
It is known that a close relationship exists between osteogenesis 
and hematopoiesis and that mesenchymal stem cells (MSCs) and 
osteoblasts play an important role not only in skeletal 
development but also in the regulation of hematopoiesis. In fact, 
together with endothelial cells, MSCs and mature osteoblasts 
provide the appropriate microenvironment (niche) for 
maintenance of the HSCs population. Moreover, there is evidence 
suggesting that hematopoietic cells and osteoblasts are derived 
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from a common progenitor. On this basis, my studies have been 
focused on the possible role of Otx1 in the regulation of MSCs, 
particularly during their osteogenic differentiation. The molecular 
mechanisms orchestrating MSCs self-renewal and differentiation 
are still poorly understood, and MSCs also provided an 
interesting system to identify Otx1 as a candidate “stem cell 
gene”. 
Different experimental strategies, including both expression and 
functional studies in mouse models and human cells, have been 
employed during my studies, in order to understand whether and 
how Otx1 may contribute to regulate MSCs. Results have shown 
that Otx1 is active in MSCs at the transcriptional as well as the 
protein level and its expression is modulated during in vitro 
osteogenic differentiation of both murine and human MSCs. 
Furthermore, its inactivation in knock-out mice is associated with 
phenotypic alterations and enhanced survival and proliferation of 
MSCs, as well as an impaired ability in vitro to generate bone 
cells. 
 
10.1 Otx1 activity during in vitro osteogenic differentiation of 
murine and human MSCs 
As a first step, I have analyzed Otx1 expression, by quantitative 
PCR both in murine and human MSCs, particularly during their 
osteogenic differentiation. Results showed that the gene is 
expressed at low levels in undifferentiated MSCs and its 
expression is up-regulated during osteogenic differentiation, 
starting already at early stages, both in mouse and human cells. 
Interestingly, comparing the expression profiles of Otx1 and the 
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osteogenic master gene Runx2, I found a strict correlation 
between the expression patterns of the two genes, providing a 
preliminary evidence that Otx1 may be involved at early stages of 
the osteogenic process. 
It is generally postulated that osteogenesis is a sequential 
multistep cascade. Bone morphogenetic proteins (BMPs) belong 
to the transforming growth factor β (TGF-β) superfamily and 
regulate the proliferation of MSCs and their osteogenic 
differentiation (Cheng et al., 2003; Suttapreyasri et al., 2006). 
BMPs initiate their signaling cascade by binding to a dimeric 
complex of two transmembrane serine-threonine kinase receptors. 
The activated receptor kinases subsequently phosphorylate 
transcriptional factors, called Smads, which activate the 
expression of target genes, such as Msx2, Dlx5 and Runx2. The 
homeobox gene Msx2 is involved in the proliferation of osteo-
progenitor cells and it is a negative regulator of osteogenic 
differentiation, as it inhibits the expression of osteogenic genes, 
such as Runx2 and Alp (Hassan et al., 2006; Hyun et al., 2005). 
The distal-less homeobox gene 5 (Dlx5) plays a key role in the 
differentiation and maturation of the osteoblast phenotype and 
works in conjunction with other transcription factors such as 
Dlx6 and Msx2 (Shirakabe et al., 2001; Ducy, 2000). Dlx5 may 
act as an indirect negative regulator, down-regulating the Msx2 
transcript as the osteoblasts cease to proliferate (Ryoo et al., 
1997). The transcriptional properties of Msx and Dlx proteins 
display reciprocal inhibition. Specifically, Msx proteins act as 
transcriptional repressors and Dlx proteins act as activators, while 
in combination, Msx and Dlx proteins counteract each other's 
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transcriptional activities (Merlo et al., 2000). Dlx5 mediates 
BMP-2 induced Runx2 expression and osteoblast differentiation 
(Lee et al., 2003). Runt-related transcription factor 2 (Runx2) is 
considered to be the central control gene within the osteoblast 
phenotype. In recent years, numerous investigations have 
indicated its role in the regulation of a broad spectrum of 
osteoblastic genes. In fact, Runx2 interacts with the promoter 
regions and directly stimulate the transcription of genes such as 
alkaline phosphatase (Alp), osteocalcin, osteopontin, collagen I, 
bone sialoprotein (Ducy et al., 1997; Selvamurugan et al., 1998; 
Kern et al., 2001; Harada et al., 1999; Shimizu-Sasaki et al., 
2001; Newberry et al., 1997; Otto et al., 2003). Two major 
isoforms of the Runx2 gene are expressed by alternative promoter 
usage: Runx2 type I (Runx2-I) is derived from the proximal 
promoter (P2), and Runx2 type II (Runx2-II) is produced by the 
distal promoter (P1). Dlx5 specifically regulates Runx2-II 
expression by binding to homeodomain-response elements in the 
Runx2 distal promoter (Lee et al., 2005). 
As the homeobox gene Otx1 is active at early stages of osteoblast 
differentiation and its expression is well correlated with the 
expression of Runx2, it is conceivable that Otx1 may act within 
the BMP-activated pathway, contributing, together with Msx2 
and Dlx5, to control Runx2 activity. Interestingly, consistent with 
this view, an Otx-response element is present in the Runx2 
proximal promoter P2, and future experiments, including 
Elettroforetic Mobility Shift Assay (EMSA) and Chromatin 
Immunoprecipitation (ChIP) assays will test this hypothesis. 
 
	  196	  	  
Results and Discussion 
10.2 Expression and localization of the Otx1 protein during 
osteogenic differentiation of murine MSCs 
As homeobox genes are frequently regulated by miRNA-
mediated post-transcriptional control, I then analyzed by Western 
Blot the expression of the Otx1 product in murine cells. Similarly 
to the transcript profile, the Otx1 protein is expressed in murine 
undifferentiated MSCs at low levels. As MSCs are a 
heterogeneous population, I analyzed MSCs cultures by in situ 
immunofluorescence in order to understand whether the 
transcription factor is present at very low levels in all cells or, 
alternatively, it is expressed in specific cell sub-populations. 
Results show that Otx1 is expressed at low levels only in some 
undifferentiated murine MSCs, and that it is localized in the 
cytoplasm. I then monitored Otx1 expression following in vitro 
osteogenic induction of murine MSCs, and observed an increased 
expression already at 3 days after osteogenic treatment. 
Furthermore, interestingly, the Otx1 protein is translocated from 
the cytoplasm into the nucleus of some cells undergoing 
differentiation. This observation, together with the nuclear 
localization of the Otx1 protein found in the pre-osteoblastic cell 
line MC3T3-E1 suggests that differentiation is associated with 
the translocation of the transcription factor from the cytoplasm to 
the nucleus. 
The regulated translocation of transcription factors, including 
homeodomain proteins, from the cytoplasm into the nucleus is an 
increasingly common theme in developmental biology. Examples 
are provided by homeoproteins of different subfamilies, as well 
as by the same homeoprotein within organisms evolutionary 
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rather distant Transcription factors and other large proteins are 
transported actively inside and outside of cell nuclei through the 
action of importins/karyopherins (reviewed in Jans et al., 2000). 
These molecules recognize specific targeting signals on 
intracellular proteins and initiate their transport through the 
nuclear pore complex, which mediates the exchange of 
macromolecules through the nuclear envelope. Nuclear import is 
typically triggered by one or more clusters of basic amino acids 
known as the nuclear localization signal (NLS), whereas export is 
regulated by the less well understood nuclear export signal 
(NES), which is generally composed of nonpolar residues. 
Whether a protein bearing such a target signal is localized to the 
cytoplasm or nucleus can be regulated actively: the targeting 
sequence can be masked through protein-protein interactions, or 
it may be modified directly by phosphorylation. These strategies 
provide mechanisms by which the transcriptional machinery can 
respond to changes in the environment or to cell-cell signaling 
(Turpin et al., 1999). For example, the rapid import of NF-ĸB 
into the nucleus during lymphocyte stimulation (Liou and 
Baltimore, 1993) or Pho4 into yeast nuclei during phosphate 
starvation (Komeili and O’Shea, 2000) enables cells to alter gene 
expression in rapid response to changing environmental 
conditions or cell-cell signaling. During development, even 
homeodomain proteins involved in patterning or cell fate 
regulation can undergo dynamic and highly regulated changes in 
subcellular localization. For example, the Extradenticle (Exd) 
protein in Drosophila is present in most cells of the fly embryo 
but is translocated into the nuclei of only a subset, in response to 
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Wingless and Decapentaplegic signaling (Mann and Abu-Shaar, 
1996; Aspland and White, 1997). In each of these cases the 
presence of a transcription factor in the cytoplasm precludes 
transcriptional activity yet poises the cell to respond rapidly and 
efficiently to signals from the environment. The transcription 
factor Otx1 is required for axon refinement by neurons in the 
deep layers of the developing cerebral cortex (Weimann et al., 
1999). Analysis of the subcellular localization of Otx1 in 
progenitors and neurons during cortical development have shown 
that Otx1 is retained in the cytoplasm of progenitor cells and 
undergoes nuclear translocation during the first week of post-
natal life in the rodent, a time that corresponds to the onset of 
axon remodeling by layer 5 neurons. The translocation 
mechanism, studied by the introduction of GFP-Otx1 fusion 
proteins into cell lines revealed that Otx1 is imported actively 
into cell nuclei. The N-terminal region of the protein 
(RKQRRER) is necessary for nuclear import, and a basic 
sequence contained within this region is sufficient to direct the 
import of fusion proteins into cell nuclei, suggesting that this 
sequence functions as an NLS. All variants of GFP-Otx1 that 
contain this domain target to the nuclei of both neuronal and non-
neuronal cell lines. However, GFP-Otx1 fusion proteins that 
contain the N-terminal domain are retained in the cytoplasm of 
cortical progenitor cells, suggesting that these cells actively direct 
the localization of Otx1 to the cytoplasm rather than the nucleus 
(Zhang et al., 2002). Interestingly, an Otx homolog in sea urchin 
embryos appears also to undergo a regulated translocation from 
the cytoplasm to the nucleus, although this is unrelated to axonal 
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connectivity. The sea urchin homolog of Otx (SpOtx) is found in 
the cytoplasm during early development at the 16-cell stage and 
only later translocates into cell nuclei (Chuang et al., 1996), 
where it is thought to activate aboral ectoderm-specific gene 
expression (Mao et al., 1996; Li et al., 1999). Two-hybrid 
analysis revealed that a proline-rich region of SpOtx resembling 
an SH3-binding domain can bind to α-actinin, suggesting that the 
protein may be anchored to the cytoskeleton prior to nuclear 
import (Chuang et al., 1996).  
In this view, my results showed that Otx1 undergoes a 
translocation from cytoplasm of undifferentiated MSCs to the 
nucleus of osteo-progenitor cells, suggesting that the regulated 
translocation observed in the neural system, also occurs in the 
mesenchymal system, particularly during osteogenic 
differentiation. 
A number of possible mechanisms, including the expression of 
proteins that bind to Otx1 and modify its subcellular distribution 
or the phosphorylation of nuclear targeting sequences, could 
regulate the localization of Otx1. One possibility is that 
phosphorylation of Otx1 regulates its recognition by import or 
export receptors. Direct phosphorylation of a target recognition 
site can mask the site and prevent its interactions with importins, 
as is the case for the NLS of Pho4 (Komeili and O’Shea, 1999, 
2000). Phosphorylation can also enhance the affinity of importin 
or exportin proteins for targeting sequences, as exemplified by 
the NLS of the Drosophila transcription factor Dorsal (Briggs et 
al., 1998), the NLS of NF-AT (Jans et al., 2000; Komeili and 
O’Shea, 2000), and the NES of Pho4 (Komeili and O’Shea, 1999, 
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2000). There is no evidence suggesting that Otx1 is differentially 
phosphorylated at distinct stages of differentiation. There is, 
however, a potential phosphorylation site that overlaps the Otx1 
NLS sequence. The sequence TPR (amino acids 34–36) overlaps 
with RKQRRER (amino acids 36-42) and presents a potential site 
for Protein Kinase C phosphorylation. Furthermore, the nearby 
site SQLD (amino acids 48-51) could serve as a site for Casein 
Kinase II action. All other consensus phosphorylation sites in 
Otx1 are in C-terminal regions of the protein that are not required 
for cytoplasmic localization (Zhang et al., 2002). Another 
mechanism that might regulate the subcellular distribution of 
Otx1 is the masking of target sequence recognition by protein-
protein interactions. The localization of several transcription 
factors is regulated by binding partners: for example, the binding 
of I-ĸB to the NLS of NF-ĸB prevents nuclear import (Liou and 
Baltimore, 1993; Jans et al., 2000), and the NES of NF-AT binds 
to calcineurin when calcium levels are low, thus blocking nuclear 
export (Komeili and O’Shea, 2000). The intermolecular 
interactions that regulate localization can be surprisingly 
complex, as exemplified by the homeodomain protein 
Extradenticle (Exd), which binds the Meis family member 
Homothorax (Hth) in cells of the developing Drosophila embryo 
(Rieckhof et al., 1997). Exd contains both NLS and NES 
sequences. In the absence of Hth, the NES is dominant and Exd is 
found in the cytoplasm. However, when bound to Hth, the NES 
of Exd is effectively inactivated, shifting the balance from export 
to import and resulting in nuclear localization (Abu-Shaar et al., 
1999; Affolter et al., 1999; Berthelsen et al., 1999). The 
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additional presence of an NLS in Hth may contribute to the 
formation of a nuclear complex (Abu-Shaar et al., 1999). Otx1 
may bind to a protein that normally sequesters Otx1 in the 
cytoplasm of undifferentiated cells. The simplest explanation is 
that the putative interacting protein binds directly to the Otx1 
NLS and blocks nuclear import in undifferentiated cells; 
degradation or loss of the interacting protein in progenitor cells 
would result in nuclear localization as the Otx1 NLS is 
unmasked. 
 
10.3 Effects of Otx1 inactivation 
In order to gain insights into the function of Otx1 in MSCs, I 
looked at the effect of Otx1 inactivation in knock-out mice. 
Otx1-/- mice, which provided a precious model to study the role 
of Otx1 in hematopoiesis, have been a suitable system also to 
investigate the function of this gene in mesenchymal cells. 
Therefore, I set up MSCs cultures from WT mice and Otx1-null 
mutants and at first compared their ability to form CFU-F in 
vitro. No significant differences in the number and size of CFU-F 
were detected, suggested that WT and Otx1-null mice exhibit 
similar numbers of functional MSCs, although the CFU-F assay 
does not provide a rigorous means for MSCs evaluation. 
 
10.4 Phenotypic alterations 
In contrast, it was soon clear that MSCs derived from mutant 
mice exhibited morphological alterations, as they appeared flatter 
and more adherent to the plastic. Consistently, Otx1-null cells 
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exhibit a higher expression of specific integrins, such as integrin 
α2 and α4. It is tempting to speculate that Otx1 may regulate the 
expression of specific adhesion molecules, and therefore 
contribute to structure the extracellular matrix (ECM) of MSCs. 
This observation may be important as ECM plays a key role in 
modulating function and phenotype of the embedded cells and 
contains the integrins as adhesion receptors mediating cell-cell 
and cell-matrix interactions. These receptors activate intercellular 
signalling pathways and control gene expression leading to many 
cellular processes, including actin cytoskeleton re-arrangement, 
proliferation, differentiation, survival, motility and apoptosis. 
Interactions between cells and the ECM are important for wound 
repair and tissue regeneration. Therefore, it is not surprising that 
MSCs have been shown to express integrin receptors, which 
when activated, can control proliferation, differentiation, survival, 
adhesion and migration (Docheva et al., 2007). It has been 
reported that in rodents ECM may affect osteogenic 
differentiation of MSCs: rat MSCs cultured with type I collagen 
showed high ALP activity, mineralization, collagen synthesis, 
and up-regulation of osteoblastic gene expression. Moreover, 
integrin-mediated signalling seems to play an important role in 
the generation and maintenance of the osteogenic and 
chondrocytic phenotype during MSCs differentiation (Mizuno 
and Kuboky, 2001; Salasznyk et al., 2004; Gronthos et al., 2001; 
Bosnakovski et al., 2006; Chen et al., 2005). Furthermore, the 
ECM provides the ultrastructure for the stem-cell niche. Integrin 
α4 is an important adhesion molecule of HSCs or hematopoietic 
progenitor cells to stromal cells (Kinashi and Springer, 1994). 
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Although the vast majority of HSCs in the adult mouse are 
located in the bone marrow, HSCs show remarkable motility. In 
response to specific signals they can exit and re-enter the 
endosteal bone-marrow HSCs niche, processes known as 
mobilization and homing, respectively. Homing is a process that 
is controlled by a number of adhesion molecules, including 
Integrin α4 (reviewed in Wilson and Trumpp, 2006). Therefore, it 
is possible that Otx1 may contribute to control the adhesive 
properties of the endosteal niche by modifying the functional 
state of specific integrins. Analysis of the hematopoietic system 
of Otx1-/- mice has indicated that these mice are characterized by 
an erythroid impairment, due to an intrinsic defect of HSCs 
(Levantini et al., 2003). However, our previous study indicates 
that these mutants exhibit also higher numbers of circulating 
multipotent progenitors (CFU-Mix), as compared to WT animals 
(unpublished data). Thus, taken together, our results on 
hematopoietic and mesenchymal cells raise the possibility that 
Otx1 might regulate HSCs also at level of microenvironment, 
particularly in maintaining the HSCs population into the 
endosteal niche. 
 
10.5 Enhanced survival and proliferation 
Another effect of Otx1 inactivation is observed in the growth 
characteristics of MSCs in vitro. Comparison of the growth 
curves of WT and null MSCs showed that Otx1-null cells 
exhibited a significantly higher proliferative ability, as compared 
to WT cells, as they keep proliferating even after eight passages 
in culture. Moreover, analysis of MSCs cultures by β-Gal staining 
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highlighted that whereas a significant percentage of WT cells 
showed senescence already at passage 2, null cells were 
essentially negative at the staining even at later passages. These 
results strongly suggest that Otx1 may be involved in the control 
of survival and proliferation of MSCs. Interestingly, loss of Otx1 
function in MSCs determined a phenotype similar to the one 
observed in Runx2-/- osteoblasts, supporting once again the view 
that Otx1 and Runx2 may act within the same pathway in the 
regulation of MSCs. Runx2-deficient primary osteoblasts fail to 
undergo senescence as indicated by the absence of β-Gal activity 
and p16INK4a tumor suppressor expression. Primary Runx2-null 
osteoblasts have a growth advantage and exhibit loss of 
p21WAF1/CIP1 and p19ARF expression. Reintroduction of WT 
Runx2, but not a subnuclear targeting-defective mutant, induces 
both p21WAF/CIP1 and p19ARF mRNA and protein resulting in cell-
cycle inhibition. These results demonstrate that Runx2 deficiency 
and defective subnuclear targeting contribute to the ex vivo 
growth advantage of null osteoblasts through a p21-dependent 
mechanism. In addition, accumulation of spontaneous phospho-
H2A.X foci, loss of telomere integrity and the 
Mre11/Rad50/Nbs1 DNA repair complex, and a delayed DNA 
repair response all indicate that Runx2 deficiency leads to 
genomic instability (Zaidi et al., 2007). Interestingly, I found that 
loss of Otx1 function is often associated with a decreased 
expression of the negative regulators of the cell cycle p21WAF/CIP1 
and p53, as well as an altered expression of proteins involved in 
the telomere integrity, such as the telomerase reverse 
transcriptase (TERT) and the telomeric repeated-binding factor 2 
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(Trf2). Therefore, the inactivation of Otx1 determines the bypass 
of senescence, and mutant MSCs also exhibit genomic instability. 
Strikingly, it has been shown that the osteogenic Runx2 
transcription factor negatively regulates proliferation and 
ribosomal gene expression in normal diploid osteoblasts, but is 
up-regulated in metastatic breast and prostate cancer cells. Thus, 
Runx2 may function as a tumor suppressor or an oncogene 
depending on the cellular context. Runx proteins are mutated, 
deleted, silenced, or ectopically expressed in a variety of solid 
tumors and leukemias (Blyth et al., 2005; Speck and Gilliland, 
2002; Bae and Choi, 2004). The Runx1 gene is a frequent target 
of chromosomal translocations in acute myeloid leukemia (AML) 
patients (Speck and Gilliland, 2002), whereas Runx3 is often 
deleted or silenced in gastric cancer cells (Li et al., 2002; Bae and 
Choi, 2004). These findings strongly suggest that Runx1 and 
Runx3 function as tumor suppressors. In contrast, Runx2 up-
regulation in breast and prostate cancer cells, which metastasize 
to bone, correlates with their metastatic potential and coincides 
with higher expression of metastatic gene markers such as MMP9 
(Pratap et al., 2006; Pratap et al., 2005; Javed et al., 2005). 
Furthermore, Runx2 up-regulation does not impede cell-cycle 
progression in cancer cells. In contrast, in normal osteoblasts, 
Runx2 ablation accelerates proliferation and increases ribosomal 
gene expression (Young et al., 2007; Pratap et al., 2003; Galindo 
et al., 2005). Taken together, these observations indicate that 
Runx2 may function as a tumor suppressor in some cell types and 
have oncogenic potential in others. This seems to be true also for 
Otx1. It has been reported that, in humans, the OTX1 gene is 
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overexpressed in medulloblastomas of the nodular/desmoplastic 
subtype (de Haas et al., 2006), suggesting that it may represent a 
medulloblastoma oncogene. Moreover, recent analysis of OTX1 
expression in B-cell lymphomagenesis has shown that OTX1 is 
involved in the development of high-grade germinal center (GC) 
B cells-derived Non-Hodgkin Lymphoma. It has been shown that 
OTX1 expression was activated in 94% of diffuse large B-cell 
lymphomas, in all Burkitt lymphomas, and in 90% of high-grade 
follicular lymphomas (Omodei et al., 2009). 
However, in this study, I showed that Otx1 deficiency in primary 
MSCs is associated with the bypass of senescence, suggesting 
that Otx1 negatively regulate proliferation and raising the 
hypothesis that Otx1 may function as tumor suppressor in 
primary MSCs. Thus, it is possible that, like Runx2, Otx1 may 
function as a tumor suppressor or an oncogene depending on the 
cellular context. These finding may have not only biological but 
also clinical relevance, as it may be hypothesized that 
dysregulation of Otx1 might be associated with the development 
of bone diseases, such as osteosarcomas. 
 
10.6 Impaired osteogenic differentiation 
In order to characterize adult osteogenesis in Otx1-null mice, I 
first analyzed the expression of osteogenic markers both in 
undifferentiated WT and mutant MSCs, and subsequently during 
osteogenic differentiation. Interestingly, results indicated that loss 
of Otx1 function is associated with a significant decrease in the 
expression of Runx2, Alp and Dlx5 in the undifferentiated Otx1-
null cells. Conversely, in these cells, the negative regulator of 
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bone formation Msx2 is up-regulated. This is in agreement with 
the higher proliferation of Otx1-null cells, as Msx2 promotes the 
proliferation of the osteo-progenitor cells and inhibits the 
expression of osteogenic genes, such as Runx2 and Alp (Hassan et 
al., 2006; Hyun et al., 2005). 
I next compared WT and Otx1-/- cells for their ability to 
differentiate along two alternative mesenchymal differentiation 
pathways, the osteogenic and the adipogenic lineages. The results 
showed that mutant cells exhibit an altered differentiation ability, 
as they are able to differentiate toward the adipogenic lineage 
more efficiently than WT cells. In contrast, Otx1-null cells 
generate a reduced number of mature osteoblasts, upon induction, 
as compared to WT MSCs. To further characterize the osteogenic 
ability of Otx1-null MSCs, I monitored the differentiation process 
analyzing the expression of the early marker Runx2 and the late 
marker Osteocalcin, both at the transcriptional and the protein 
level. Immunocytochemistry assays highlighted that although 
Runx2 is upregulated upon osteogenic induction of null cells, the 
level of expression are significantly lower than the ones found in 
WT cells. Furthermore, also the expression of the terminal    
osteogenic marker osteocalcin is significantly reduced, even at 
very late times of the differentiation process in vitro. Thus, both 
the cellular and the molecular data indicate that loss of Otx1 
function is associated with an impaired osteogenic differentiation. 
An interesting observation is that Otx1-/- mice are characterized 
by very fragile bones, suggesting that the data obtained in vitro 
may reflect an alteration of the bone structure in vivo. This view 
will be tested by comparing bones of WT and Otx1 deficient mice 
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using a positron-emission tomography (PET) scan imaging. 
These finding may have not only biological but also clinical 
relevance, as deregulation of bone formation and maintenance is 
an important component of common human diseases, such as 
osteoporosis and arthritis. Notably, RUNX2 haploinsufficiency 
causes cleidocranial dysplasia, a condition characterized by 
hypoplastic clavicles, various dental defects, delayed ossification 
of the skull bones and a number of other skeletal abnormalities, 
while homozygous mutation of Runx2 in mice is lethal due to a 
complete lack of mineralized bone (Komori et al., 1997; Otto et 
al., 1997; Mundlos et al., 1997). 
Taken together, my results are consistent with the view that Otx1 
and Runx2 may operate within the same pathway to specify 
osteogenic differentiation. The study raises the possibility that 
Otx1 might be required to maintain normal levels of Runx2 gene 
expression and, consequently, normal numbers of osteoblasts. It 
remains to be determined whether Runx2 may be a direct Otx1 
molecular target, as suggested by the presence of an Otx-response 
element in the Runx2 proximal promoter P2. 
 
10.7 Conclusion 
In conclusion, my results indicate that Otx1, which plays crucial 
roles in brain morphogenesis and in blood cell production, is also 
implicated in the control of MSCs, both at the level of 
proliferation and differentiation. Several lines of evidence in my 
study suggest that Otx1 may contribute to control Runx2 activity, 
including: 1) similar expression profiles of Otx1 and Runx2 
during osteogenic differentiation of both murine and human cells; 
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2) lower Runx2 expression levels both in undifferentiated MSCs 
of Otx1-/- mice and during their osteogenic differentiation, as 
compared to their normal counterparts; 3) loss of Otx1 function, 
like Runx2 haploinsufficiency, results in enhanced survival and 
proliferation of MSCs and alterations in their differentiation 
ability. 
Thus, Otx1 seems to regulate hematopoietic and mesenchymal 
stem and progenitor cells using a similar mechanism of action, 
contributing to control directly or indirectly the master genes of 
the erythroid and the osteogenic lineages, Scl and Runx2. We 
know that Scl is a direct target of Otx1 (Levantini et al., 2003 and 
unpublished data), and that Otx-consensus sequences are present 
on promoter P2 of the Runx2 gene. 
These findings provide further evidence that common molecular 
mechanisms orchestrate differentiation of various tissues and 
point to Otx1 as a candidate new stem cell gene. 
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11. KIT ACTIVITY DURING IN VITRO ADIPOGENESIS-
RESULTS 
Kit, coding for the Stem Cell Factor (SCF) receptor, is a pivotal 
regulator of several types of stem and progenitor cells. However, 
the role of this gene in the regulation of MSCs is still very 
controversial. In order to investigate whether this receptor 
contributes also to the control of the mesenchymal system, I have 
analyzed Kit expression in both mouse and primary human 
MSCs. Moreover, as murine models allow a more detailed 
investigation, I also extended the expression studies using a 
transgenic mouse line, in which the reporter gene encoding the 
Green Fluorescence Protein (GFP) is under the transcriptional 
control of Kit regulatory sequences (Cairns et al., 2003). 
 
11.1 Kit expression in human and murine MSCs 
As a first step, I analyzed the transcriptional activity of the KIT 
gene in human MSCs derived from bone marrow samples of 
several normal donors, provided by Istituti Ortopedici Rizzoli 
(Bologna) and Cattedra di Ematologia of the University of Pisa. 
Cells were grown in vitro and maintained in expansion conditions 
or induced to osteogenic and adipogenic differentiation following 
exposure to specific inducing agents. Osteogenic and adipogenic 
differentiation were monitored at different time points by 
cytochemical staining and Real-Time PCR. The results showed 
that differentiated cells along the osteogenic and adipogenic 
lineages are positive for Alizarin Red and Oil Red staining, 
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respectively. Moreover, molecular analysis of the osteogenic and 
adipogenic markers showed an increased expression during the 
differentiation processes, RUNX2 and ALP for the osteogenic 
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Figure 41: Osteogenic	   and adipogenic differentiation of primary human 
MSCs. Alizarin Red staining of A) untreated cells and B) differentiated cells 
after 21 days of osteogenic induction. Oil Red staining of D) untreated cells 
and E) differentiated cells after 14 days of adipogenic induction. Real-Time 
PCR for the expression of C) the osteogenic markers RUNX2 and ALP and F) 
the adipogenic markers PPARγ and C/EBPα. **, P<0,005; ***, P<0,001.	  	  
Analysis of the expression by Real-Time PCR showed that the 
KIT gene is transcribed in primary human bone marrow stromal 
cells, although at low levels, and following osteogenic treatment, 
its expression dropped down, already at 3 days of differentiation 
(Fig. 31). 
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Figure 42: KIT expression during osteogenic differentiation of primary 
human MSCs. Quantitative PCR; samples are normalized with HPRT gene. *, 
P<0,05. 	  
In contrast, KIT is up-regulated during adipogenic differentiation, 
even at early stages, as its expression reached a significant 


























Figure 43: KIT expression during adipogenic differentiation of primary 
human MSCs. Quantitative PCR; samples are normalized with HPRT gene. *, 
P<0,05; **, P<0,005. 	  
As mouse models allow a more detailed investigation, the next 
step was to test whether Kit is expressed also in primary murine 
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MSCs, particularly during their adipogenic differentiation. Bone 
marrow cells from wild type mice have been plated in condition 
supporting MSCs growth and expansion in an undifferentiated 
stage through repeated passages in vitro. Moreover, MSCs were 
induced to differentiate along the adipogenic lineage, following 
treatment with specific inducers. Undifferentiated MSCs and cells 
at different times after adipogenic induction have been analyzed 
by cytochemical staining and Real-Time PCR. Results showed 
that differentiated cells are positive for the Oil Red staining, and 
the increased expression of the adipogenic markers Pparγ and 
C/EBPα confirmed MSCs differentiation also at the molecular 































Figure 44: Adipogenic differentiation of primary murine MSCs. Oil Red 
staining of A) untreated cells and B) differentiated cells after 14 days of 
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adipogenic induction. C) Real-Time PCR for the expression of the adipogenic 
markers Pparγ and C/EBPα. *, P<0,05.	  
 
Similarly to what observed in human cells, Kit is expressed at low 
levels in undifferentiated primary murine mesenchymal cells, and 
it is up-regulated during adipogenic differentiation, even at early 


























Figure 45: Kit expression during adipogenic differentiation of primary 
murine MSCs. Quantitative PCR; samples are normalized with Hprt gene. *, 
P<0,05. 	  
Results obtained both in mouse and human, suggest an 
involvement of the gene during in vitro adipogenic differentiation 
of MSCs. 
 
11.2 Kit protein expression and localization in murine cells 
Subsequently, Kit expression has been analyzed at the protein 
level in undifferentiated MSCs by Western Blot. The results 
showed that the receptor is expressed at lower levels in primary 
murine mesenchymal cells as compared to the K562 
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erytromyeloblastoid leukemic cell line, used as a positive control 
(Fig. 35). 
Kit 
K562            mMSC  
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Figure 46: Kit protein expression in undifferentiated primary murine 
MSCs (mMSCs) by Westrn Blot. The K562 erytromyeloblastoid leukemic 
cell line is the positive control. β-Tubulin represents the costitutive protein. 	  
Furthermore, Western Blot analysis of MSCs during adipogenic 
differentiation showed that the expression of the receptor is 
increased after 7 days of adipogenic induction, confirming what 
observed at the mRNA level (Fig. 36). 
Kit 
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Figure 47: Kit protein expression during adipogenic differentiation of 
murine MSCs by Westrn Blot. β-Tubulin represents the costitutive protein. 
 
The next step was to investigate the distribution of the receptor 
within the heterogeneous population of MSCs cultures, also 
during their adipogenic differentiation. Results showed that only 
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some undifferentiated cells are positive and weakly fluorescent, 
confirming the low levels of Kit expression detected by Western 
blot. However, the expression is increased already at 3 days after 
adipogenic induction, reaching the highest expression peak at 7 
days of differentiation. Finally, at 14 days, corresponding to the 
terminal stages of differentiation, both the number of positive 
cells and the fluorescence intensity decreased (Fig. 37). 
Interestingly, results showed a clear clusterization of the receptor 
in specific regions of the plasma membrane, particularly clear 




Figure 48: Kit expression during adipogenic differentation of murine 
MSCs by in situ immunofluorescence. The cells were immunostained for Kit 
(green) and counterstaining with DAPI (blue) to visualize the nucleus. 
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Finally, I carried out a preliminary indirect flow cytometry 
analysis to further prove Kit expression during adipogenic 
differentiation by. I have used a polyclonal unconjugated 
antibody recognizing the extracellular domains of the receptor. A 
secondary antibody Fluorescein isothiocynate (FITC)-conjugate 
has been employed to visualize the primary antibody. An 
important principle of flow cytometry data analysis is to select 
the cells of interest while eliminating results from unwanted 
particles, such as dead cells and debris. Subcellular debris and 
clumps can be distinguished from single cells by size, estimated 
by forward scatter (FSC-H). Also, dead cells have lower forward 
scatter and higher side scatter (SSC-H) than living cells. 
Morphological analysis by FSC-H and SSC-H allowed to identify 
a specific population excluding debris and clumps, and including 
living cells (R1) (Fig. 38A). Propidium iodide (PI) is an 
intercalating agent and a fluorescent molecule that can be used to 
stain DNA. It is membrane impermeant and generally excluded 
from viable cells. Therefore, I also used PI for identifying dead 
cells in the population of the R1 region. In this way, I identified 
only living cells, contained in the R2 population (Fig. 38B). 
MSCs were analyzed at different stages of adipogenic 
differentiation, and cells incubated only with the secondary 
antibody have been used as negative control (Fig. 38C left panel), 
in order to selectively analyze the specific fluorescence (R3) (Fig. 
38C right panel). Preliminary results showed that during 
adipogenic differentiation Kit expression is increased, already at 
3 days of induction. 
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Figure 49: Flow cytometry analysis of Kit expression during adipogenic 
differentiation of murine MSCs. A) Morphological analysis; B) Propidium 
iodide analysis C) Subpopulation with specific signal. 	  
11.3 Analysis of Kit/GFP MSCs 
We have previously used a transgene Kit/GFP mouse line to 
study Kit expression in other tissues, such as the hematopoietic 
and cardiac ones, as the expression of the transgene faithfully 
recapitulates the expression of the endogenous Kit. Therefore, I 
used also this approach to investigate Kit activity in MSCs. I set 
up MSCs cultures from wild type and Kit/GFP mice, and I 
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monitored GFP expression by epifluorescence microscope, both 
in undifferentiated cells and during their osteogenic and 
adipogenic differentiation. Preliminary results showed that the 
expression of the transgene is absent in undifferentiated cells 
(Fig. 39A-B), and during the osteogenic process (Fig. 39C-D). In 
contrast, the transgene is active following adipogenic induction, 
already after 24 hours, as confirmed by the presence of GFP-





Figure 50: Fluorescence analysis of Kit/GFP MSCs. Undifferentiated MSCs 
(A-B), osteogenic induction (B-C), adipogenic induction (E-F). 
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12. KIT ACTIVITY DURING IN VITRO ADIPOGENESIS-
DISCUSSION 
Kit, coding for the Stem Cell Factor (SCF) receptor, is a pivotal 
regulator of several types of stem and progenitor cells, such as 
pigment, hematopoietic, cardiac, neural and germ cells (Cairns et 
al., 2003; Messina et al., 2004; Wu et al., 2006; Smith et al., 
2007). However, the role of this gene in the regulation of MSCs 
is still very controversial. In order to understand whether this 
receptor contributes also to the control of the mesenchymal 
system, I have analyzed Kit expression using different techniques 
both at the mRNA and the protein level in primary murine and 
human MSCs, particularly during their adipogenic differentiation. 
Moreover, I started to analyze Kit activity, using a Kit/GFP 
transgenic mouse line, previously characterized in our laboratory. 
All the approaches produced similar results, highlighting that Kit 
is expressed at low levels in undifferentiated cells, and that its 
expression is modulated during the differentiation processes. In 
particular, Kit seems to be involved at early stages of adipogenic 
differentiation in vitro, raising the hypothesis that it may play a 
role in the survival and/or proliferation of adipogenic progenitor 
cells. 
 
12.1 Kit receptor is involved in the adipogenic differentiation 
Kit activity was analyzed both in human and mouse MSCs, first 
at the mRNA level by Real-Time PCR and subsequently at the 
protein level by Western Blot and in situ immunofluorescence. 
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Despite some differences in the transcriptional profiles between 
human and mouse cells, Kit activity is very similar in both human 
and murine MSCs. Results showed that the Kit receptor is 
expressed only by a subset of MSCs. Following adipogenic 
induction, Kit expression is promptly increased and maintained at 
higher levels until day 7, whereas in the terminal steps of the 
differentiation process it returns back to basal levels. 
Interestingly, during the differentiation process, Kit receptor 
clearly clusterized in specific regions of the plasma membrane. 
The early up-regulation of the Kit receptor during the adipogenic 
process is confirmed also by preliminary results obtained by 
FACS analysis and the expression of the Kit/GFP transgene. 
Taken together, these expression studies provide the first 
evidence that the Kit pathway may be involved also in the 
regulation of the adipose tissue. Furthermore, these data indicate 
that Kit function may be required at early times of the adipogenic 
process. As previously described, adipogenesis is a two-step 
process. The first step comprises the generation of committed 
pre-adipocytes from MSCs. The second step involves the 
terminal differentiation of these pre-adipocytes into mature 
functional adipocytes. Much progress has been made in the last 
two decades in defining transcriptional events controlling the 
differentiation of MSCs into adipocytes. A complex network of 
transcription factors and cell-cycle regulators, in concert with 
specific transcriptional coactivators and corepressors, respond to 
extracellular stimuli to activate or repress adipocyte 
differentiation. Although the differentiation of pre-adipocytes 
into adipocytes has been extensively studied in vitro, the early 
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steps leading to the commitment of MSCs and the generation of 
pre-adipocytes remain largely unknown. 
The differentiation of pre-adipocytes into adipocytes is regulated 
by an elaborate network of transcription factors that coordinate 
expression of hundreds of proteins responsible for establishing 
the mature fat-cell phenotype. At the center of this network are 
the two major adipogenic factors, PPARγ and C/EBPα, which 
oversee the entire terminal differentiation process. In particular, 
PPARγ is considered the master regulator of adipogenesis; 
without it, precursor cells are unable of expressing any known 
aspect of the adipocyte phenotype (Rosen et al., 2002). On the 
other hand, cells deficient in C/EBPα are capable of adipocyte 
differentiation; however, these C/EBPα-deficient cells are insulin 
resistant (El-Jack et al., 1999; Wu et al., 1999). Much of our 
knowledge of this complex network and the importance of 
PPARγ and C/EBPα come from studies performed in established 
pre-adipocyte cell lines as well as mesenchyme-derived precursor 
cells. More recently, data from a variety of knockout mice have 
confirmed these in vitro studies showing that many components 
of this network are required regulators of adipocyte development 
and function (reviewed in Farmer, 2006). The involvement of the 
receptor Kit in the adipogenic differentiation is supported by 
studies carried out on the transcriptional factor Slug. The 
activation of the Kit receptor by SCF specifically induces the 
expression of a specific member of the Snail gene family of zinc-
finger transcription factors, Slug, indicating a clear relationship 
between SCF/Kit activation and Slug expression in hematopoietic 
cells. Analysis of a targeted null mutation that deleted all Slug 
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coding sequences revealed that Slug mutant mice, like Kit and 
SCF-defective mice, have a complex phenotype including 
pigmentation, gonadal defect, and hematopoietic defects (Pérez-
Losada et al., 2002). 
Recently, it has been shown that Slug expression is tightly 
controlled during adipocyte differentiation. Slug is expressed in 
vivo, but it is only transiently expressed in cultured cells, 
suggesting that it may play a role in initiating and/or maintaining 
adipogenesis in vivo. Expression of Slug was observed before the 
differentiation induction in 3T3-L1 cells (which are lineage-
determined pre-adipocytes) and MEFs (which are uncommitted 
progenitor cells) and to be downregulated within the first 6 h after 
applying the hormonal stimuli in both cell types (Pérez-Mancera 
et al., 2007). A similar expression pattern is observed in the 
haematopoietic system in which differentiation of uncommitted 
progenitor cells is associated with down-regulation of Slug (Inoue 
et al., 2002; Pérez-Losada et al., 2002). 
In this view, it is temping to speculate that Kit may play a role in 
initiating and/or maintaining adipogenesis in vitro, by regulating 
Slug expression in mesenchymal stem and progenitor cells. 
Other observations supporting this hypothesis, derived from 
results obtained by in situ immunofluorescence analysis. During 
adipogenic differentiation, Kit receptor clearly clusterized into 
specific regions of the plasma membrane. These finding are in 
agreement with the work of Jahn and collaborators, which 
showed that Kit recruitment to lipid rafts is required for efficient 
activation of the phosphatidylinositol 3-kinase (PI3-K)/Akt 
pathway and Kit-mediated survival and proliferation. Lipid rafts 
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are characterized by the presence of high levels of cholesterol, 
sphingolipids, and glycosylphosphatidylinositol (GPI)-linked 
proteins and contain signalling molecules like the Src family 
kinase (SFKs). Recent studies of other receptor systems have 
demonstrated the importance of localization of receptors at high 
density into plasma membrane microdomains or lipid rafts. For 
example, the multimeric T-cell receptor (TCR) and associated 
signaling molecules are recruited to lipid rafts upon engagement 
of the TCR with cognate ligands composed of major 
histocompatibility complex (MHC) and peptides (Xavier et al., 
1998). It has been shown that, in human megakaryoblastic 
leukemia cell line Mo7e, SCF engagement is essential for the 
redistribution of Kit to the rafts. Activation of Kit is required for 
raft recruitment, but then raft recruitment is required for Kit 
signalling. Once receptor engagement by ligand has occurred, Kit 
recruitment to the lipid rafts allows interaction with the SFKs. 
Association of Kit with p85 leads to assembly of the PI3-K 
complex. Diffusion of PI3-K generates PIP3 in the cytosol, which 
binds to the serine/threonine kinases PDK1 and Akt via the 
pleckstrin homology (PH) domains. This interaction determines 
the translocation of PDK1 and Akt to the plasma membrane, 
where they become activated. Activation of Akt mediates Kit-
dependent survival and proliferation. Moreover, lipid rafts-
dependent signalling can be abrogated by methyl-β-cyclodextrin 
(MβCD), which depletes the rafts of essential cholesterol 
molecules. Cholesterol depletion prevents Kit-mediated 
activation of the PI3-K downstream target Akt and inhibits 
cellular proliferation (Jahn et al., 2007). 
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In this view, it is tempting to speculate that, during adipogenic 
differentiation of MSCs, the clusterization of Kit in specific 
plasma membrane microdomains could be associated with the 
localization of the receptor in the lipid drafts, and it might be 
required for Kit-mediated survival and proliferation of progenitor 
cells. 
 
12.2 Expression of the transgene Kit/GFP in the mesenchymal 
system 
As murine models allow a more detailed investigation, I have 
started to study Kit expression using a transgenic mouse line, in 
which the reporter gene coding for the Green Fluorescence 
Protein (GFP) is under the transcriptional control of Kit 
regulatory sequences (Cairns et al., 2003). MSCs cultures from 
wild type and Kit/GFP mice were monitored for GFP expression 
by epifluorescence microscope, both in undifferentiated cells and 
during their osteogenic and adipogenic differentiation. 
Preliminary results showed that the expression of the transgene is 
absent in undifferentiated cells, and it is not active during 
osteogenic differentiation. In contrast, the transgene is active 
following adipogenic induction, already after 24 hours, 
suggesting that Kit may contribute to the activation of the 
adipogenic program, and switched off at terminal stages of 
differentiation. Previous studies have shown that the transgene is 
efficiently expressed in fetal liver and adult bone marrow HSCs, 
and the level of transgene expression discriminates between 
HSCs (intermediate level GFP-expressors) and progenitors, such 
as BFU-E and CFU-Mix (mostly high level GFP-expressors) 
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(Cerisoli et al., 2009). However, the transgene is switched off 
during terminal differentiation. Moreover, the same transgene is 
expressed also in a population of CSCs (Messina et al., 2004). In 
particular, cardiospheres (CSs) Kit/GFP grow by expansion of a 
central core of immature cells, which initiate differentiation in the 
course of their displacement to the periphery of the sphere. 
Immature cells exhibit a high GFP expression, while the cells, 
which occasionally commit to cardiomyocyte differentiation, 
progressively extinguish Kit/GFP expression, while up-regulating 
cardiac-specific genes (Barile et al., 2009). Taken together, these 
results show that the expression of the transgene faithfully 
recapitulates the activity of the endogenous Kit. Moreover, my 
observations have provided preliminary evidence of the 
activation of the transgene in early stages of adipogenic 
differentiation, as previous observed in hematopoietic and cardiac 
differentiation. Thus, the transgenic mouse line Kit/GFP provides 




In conclusion, these preliminary studies provided the first 
evidence of an involvement of the Kit receptor in the regulation 
of adipogenesis in vitro, strongly suggesting that it may be active 
in the survival/proliferation of progenitor cells. However, 
elucidation of the role that Kit receptor plays within the 
adipogenic lineage will require functional studies, that will 
include analysis of W/Wv Kit mutant mice and in vitro 
inactivation of Kit activity using specific drugs. 























All three gene families investigated in this study are active in the 
control of MSCs: 
• MSCs derived from different body sites exhibite the same 
immunophenotype, but different in vitro growth and 
differentiation kinetics. Moreover, they are characterized 
by specific HOX codes and TALE signatures, and may 
thus not provide equivalent cell sources for tissue 
regeneration. 
• Otx1, which plays crucial roles in brain morphogenesis 
and in blood cell production, is also implicated in the 
control of MSCs, both at the level of proliferation and 
differentiation, likely by controlling Runx2 activity. These 
findings provide further evidence that common molecular 
mechanisms orchestrate differentiation of various tissues 
and point to Otx1 as a candidate new stem cell gene. 
• The stem cell gene Kit, a pivotal regulator of several stem 
cell types, is also active inboth human and murine MSCs. 
This preliminary study provides the first evidence that the 
Kit receptor may contribute to the control also of the 
adipogenic lineage. 
The identification of new molecular cues controlling 
mesenchymal stem and progenitor cells provides new insights 
into our knowledge of their biology and may also have clinical 
relevance.
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